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9GENERAL INTRODUCTION
1
Preeclampsia is a hypertensive disease in pregnancy and an important cause of 
maternal and fetal morbidity and mortality worldwide. After a pregnancy complicated 
by preeclampsia women have an increased risk to develop cardiovascular disease. 
This thesis aims to improve our understanding of the underlying circulatory risk profile 
for cardiovascular disease that is characterized by low plasma volume in women with 
a history of preeclampsia and to examine the effects of aerobic exercise training on 
this profile.
Preeclampsia is a hypertensive disorder of pregnancy unique to primates. It is 
characterized by the combination of hypertension and proteinuria and complicates 
approximately 2-5% of pregnancies1. The ultimate treatment of preeclampsia is 
delivery of the fetus and placenta, which can be postponed while giving antihyper-
tensive treatment in an effort to improve fetal outcomes if gestational age at time of 
diagnosis is still limited. After delivery, the clinical syndrome of preeclampsia usually 
resolves within days1. 
Many women who experienced pregnancy complicated by preeclampsia are puzzled 
why they developed this condition during pregnancy despite their supposed good 
health and are concerned about their physical recovery after the complicated 
pregnancy. Thereafter, questions follow regarding recurrence risk in future pregnancies 
and implications for their future health. In an effort to answer these questions, studies 
have been performed to characterize women with a history of preeclampsia2-6 and 
estimated recurrence risk based on the presence or absence of specific risk factors7-10. 
The least we can learn from these studies is, that there exists considerable hetero -
geneity among formerly preeclamptic women. Various risk factors are nowadays 
linked to preeclampsia, one more consistent than the other. So far no single risk 
factor could uniformly explain why these women developed preeclampsia in previous 
pregnancy. This made most clinicians and scientist believe that preeclampsia has a 
multifactorial aetiology. Gestational age at onset of preeclampsia is the strongest 
predictor for recurrent disease; the earlier women developed preeclampsia the higher 
the recurrence risk in next pregnancy9. 
After pregnancy complicated by preeclampsia, traditional risk factors for cardio-
vascular disease or, in other words, components of the metabolic syndrome 
(hypertension, obesity, hyperinsulinemia, dyslipidemia and/or micro-albuminuria) are 
among the most consistently demonstrated abnormalities in these women. This suggests 
that preeclampsia and cardiovascular disease may have disease mechanisms in 
common4. The scientific interest in the cardiovascular risk profile in women with a 
history of preeclampsia was fuelled by a meta-analysis by Bellamy in 200711. This 
study clearly demonstrated an increased lifetime risk to develop cardiovascular 
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disease after a pregnancy complicated by preeclampsia. Women with a history of 
preeclampsia have a 4-fold higher risk of chronic hypertension and a 2-fold higher 
risk for subsequent cardiovascular disease over the 5 to15 years after preeclampsia11, 12. 
The life expectancy after preeclampsia is reduced by approximately 6 years, mainly 
due to cardiovascular death.
In this perspective, pregnancy can be considered as a unique cardiovascular “stress 
test”; and therefore preeclampsia in apparently healthy women may unmask a 
previously unrecognized cardiovascular risk profile. (Figure 1A)13. Whether preeclampsia 
itself has a direct effect contributing to the development of cardiovascular disease is 
still matter of debate4. 
Figure 1  Schematic diagrams showing how pregnancy can be a window to future health by 
uncovering predispositions for cardiovascular diseases in women who develop pregnancy 
complications (A), and how early intervention after these women are identified following their 
pregnancy can improve outcome of future pregnancy and prevent long term diseases (B). 
From J.W.Rich-Edwards et al. Hypertension 2010;56:331-334. Used with permission from BMJ 
publishing group and Wolters Kluwer Health Inc.
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Nowadays many women undergo cardiovascular and metabolic testing after their 
preeclamptic pregnancy to identify risk factors for future cardiovascular disease, 
based on the assumption that these risk factors are modifiable14. It is hypothesized 
that targeted screening, lifestyle modification and early treatment in women with a 
history of preeclampsia can improve outcome of future pregnancy and prevent long 
term diseases (Figure 1B).
The observed relationship between preeclampsia and future cardiovascular disease 
can only be partly explained by the increased prevalence of traditional cardiovascular 
risk factors alone. In an effort to explain this “risk factor gap” additional risk factors 
have been linked to both preeclampsia and cardiovascular disease, often referred 
to as non-traditional cardiovascular risk factors. Examples of non-traditional risk 
factors are markers of systemic inflammatory responses, thrombophilia15, hyperhomo- 
cysteinemia15, signs of renal disease16 and specific circulatory abnormalities like 
cardiac dysfunction17, endothelial dysfunction18-20 and low plasma volume21. In women 
with a history of preeclampsia the hemodynamic profile characterized by low plasma 
volume is particularly interesting because low plasma volume status was demonstrated 
in almost 50% of formerly preeclamptic women; more frequent than any other studied 
cardiovascular risk factor so far21. 
Plasma volume refers to the total intravascular blood volume minus the cellular 
components of blood. In resting conditions, two-thirds of the plasma volume is 
localized in the venous system22. The venous system acts as a volume reservoir and if 
needed extra volume can be mobilized into the circulation by means of sympathetically 
mediated venoconstriction resulting in an increase of cardiac preload. Consequently, 
low plasma volume status reflects a reduced venous reserve capacity of the 
circulation and therefore a reduced ability to increase cardiac preload in times of 
increasing demands, like in pregnancy for example. 
Previous studies have demonstrated that formerly preeclamptic women with prepregnant 
low plasma volume demonstrate a smaller increase of plasma volume during 
pregnancy compared with healthy parous control subjects23. Reduced plasma 
volume expansion in pregnancy provokes abnormal compensatory hemodynamic 
changes in an effort to cope with the increasing demands of advanced pregnancy. 
These changes can be characterized by a sympathetically driven hyperdynamic 
circulation with consequential increased shear stress on the vascular endothelium. 
These abnormal hemodynamic changes are thought to contribute to the hypertensive 
deterioration of pregnancy and eventually preeclampsia. 
12
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Low plasma volume is also linked with latent chronic hypertension24. Longitudinal 
studies in individuals with low plasma volume, other than formerly preeclamptic 
women, demonstrated a gradual change in hemodynamics from a hyperdynamic/
low resistance circulation into a more hypodynamic/high resistance circulation with a 
consequent gradual increase in blood pressure over the years25. Resultantly low 
plasma volume is regarded as a form of latent hypertension in normotensive or 
borderline hypertensive individuals.
Based on the observed relationships between low plasma volume and both pree- 
clampsia and chronic hypertension, studying plasma volume in women with a history 
of preeclampsia may advance our pathophysiological knowledge of cardiovascular 
disease in women. Ultimately, in order to translate and implement this knowledge into 
possible strategies of cardiovascular risk management in formerly preeclamptic 
women, it is necessary to test if low plasma volume and the associated hemodynamic 
consequences are amenable to modification. 
The cornerstone of primary cardiovascular risk management is lifestyle intervention. 
Exercise training induces plasma volume expansion and represents a potent strategy 
to reduce the risk of future cardiovascular events in asymptomatic subjects and those 
with pre-existing disease26. Despite the overall health benefits of exercise training, 
recent studies have described heterogeneous cardiovascular adaptation to training27. 
In subjects who undertook similar exercise training interventions, some demonstrated 
large improvements in parameters such as cardiopulmonary fitness, blood pressure, and 
cholesterol, while others exhibited smaller increases or even “adverse” responses28, 29. 
In formerly preeclamptic women it is unknown to what extent plasma volume and 
associated hemodynamic characteristics change with exercise training. Based on 
the maternal maladaptation to the cardiovascular stimulus of pregnancy, formerly 
preeclamptic women may as well be maladaptive to the cardiovascular stimulus of 
exercise training.
13
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Outline of this thesis
This thesis is based on five main research questions:
1. To what extent does nonpregnant plasma volume relate to the onset of preeclampsia 
and to the co-occurrence of other cardiovascular risk factors in women with a 
history of preeclampsia? (Chapter 2)
2. To what extent is the adult plasma volume determined at birth? (Chapter 3)
3. To what extent does nonpregnant plasma volume relate to the recurrence rate of 
preeclampsia and to the development of chronic hypertension after a pregnancy 
complicated by preeclampsia? (Chapter 4 and 5)
4. To what extent can plasma volume in formerly preeclamptic women be improved 
by means of aerobic exercise training in comparison with healthy parous control 
subjects? (Chapter 6)
5. What are the hemodynamic consequences of aerobic exercise training aimed at 
increasing plasma volume in women with a history of preeclampsia compared 
with healthy parous controls? (Chapter 6, 7 and 8)
In summary, this thesis aims to explore the implications of low plasma volume in 
normotensive women with a history of preeclampsia. We studied in these women the 
effects of low plasma volume status on outcomes of the subsequent pregnancy and 
the occurrence of chronic hypertension in the years following the complicated 
pregnancy. To test if plasma volume can be increased in women with a history of 
preeclampsia we examined the effects of 12-weeks aerobic exercise training on 
plasma volume and associated hemodynamic parameters like venous compliance, 
autonomic balance, endothelial function and shear characteristics of the arterial 
blood flow.   
14
CHAPTER 1
Reference list
1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-799
2. Forest JC, Girouard J, Masse J, Moutquin JM, Kharfi A, Ness RB, Roberts JM, Giguere Y. Early 
occurrence of metabolic syndrome after hypertension in pregnancy. Obstetrics and gynecology. 
2005;105:1373-1380
3. Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs C, van Geijn HP. 
Underlying disorders associated with severe early-onset preeclampsia. American journal of obstetrics 
and gynecology. 1995;173:1042-1048
4. Romundstad PR, Magnussen EB, Smith GD, Vatten LJ. Hypertension in pregnancy and later 
cardiovascular risk: Common antecedents? Circulation. 2010;122:579-584
5. Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. Hypertensive disorders in pregnancy and 
subsequently measured cardiovascular risk factors. Obstetrics and gynecology. 2009;114:961-970
6. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, White RR, Roddy M, Hladunewich M, 
Pre-Eclampsia New Emerging T. A history of preeclampsia identifies women who have underlying 
cardiovascular risk factors. American journal of obstetrics and gynecology. 2009;200:58 e51-58
7. Hernandez-Diaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: 
Prospective cohort study. Bmj. 2009;338:b2255
8. Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: Effects of gestational age at 
delivery of the first pregnancy, body mass index, paternity, and interval between births. American journal 
of obstetrics and gynecology. 2008;199:55 e51-57
9. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstetrics and gynecology. 
2008;112:359-372
10. Hjartardottir S, Leifsson BG, Geirsson RT, Steinthorsdottir V. Recurrence of hypertensive disorder in 
second pregnancy. American journal of obstetrics and gynecology. 2006;194:916-920
11. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and 
cancer in later life: Systematic review and meta-analysis. Bmj. 2007;335:974
12. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/
eclampsia: A systematic review and meta-analyses. American heart journal. 2008;156:918-930
13. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: Opportunities for 
intervention and screening? Bmj. 2002;325:157-160
14. Spaan J, Peeters L, Spaanderman M, Brown M. Cardiovascular risk management after a hypertensive 
disorder of pregnancy. Hypertension. 2012;60:1368-1373
15. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency 
of genetic thrombophilia in women with complications of pregnancy. The New England journal of 
medicine. 1999;340:9-13
16. McDonald SD, Han Z, Walsh MW, Gerstein HC, Devereaux PJ. Kidney disease after preeclampsia: A 
systematic review and meta-analysis. American journal of kidney diseases : the official journal of the 
National Kidney Foundation. 2010;55:1026-1039
17. Zandstra M, Stekkinger E, van der Vlugt MJ, van Dijk AP, Lotgering FK, Spaanderman ME. Cardiac 
diastolic dysfunction and metabolic syndrome in young women after placental syndrome. Obstetrics and 
gynecology. 2010;115:101-108
18. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial 
dysfunction with preeclampsia. Jama. 2001;285:1607-1612
19. Hamad RR, Eriksson MJ, Silveira A, Hamsten A, Bremme K. Decreased flow-mediated dilation is present 
1 year after a pre-eclamptic pregnancy. Journal of hypertension. 2007;25:2301-2307
20. Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney DZ, Hladunewich MA. Vascular 
dysfunction in women with a history of preeclampsia and intrauterine growth restriction: Insights into 
future vascular risk. Circulation. 2010;122:1846-1853
21. Spaanderman ME, Ekhart TH, van Eyck J, Cheriex EC, de Leeuw PW, Peeters LL. Latent hemodynamic 
abnormalities in symptom-free women with a history of preeclampsia. American journal of obstetrics and 
gynecology. 2000;182:101-107
15
GENERAL INTRODUCTION
1
22. Guyton AC. The venous system and its role in the circulation. Modern concepts of cardiovascular 
disease. 1958;27:483-487
23. Spaanderman M, Ekhart T, van Eyck J, de Leeuw P, Peeters L. Preeclampsia and maladaptation to 
pregnancy: A role for atrial natriuretic peptide? Kidney international. 2001;60:1397-1406
24. Julius S, Pascual AV, Reilly K, London R. Abnormalities of plasma volume in borderline hypertension. 
Archives of internal medicine. 1971;127:116-119
25. Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target. American journal of 
hypertension. 1996;9:113S-120S
26. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular 
events: Potential mediating mechanisms. Circulation. 2007;116:2110-2118
27. Skinner JS, Jaskolski A, Jaskolska A, Krasnoff J, Gagnon J, Leon AS, Rao DC, Wilmore JH, Bouchard C, 
Study HF. Age, sex, race, initial fitness, and response to training: The heritage family study. Journal of 
applied physiology. 2001;90:1770-1776
28. Bouchard C, Blair SN, Church TS, Earnest CP, Hagberg JM, Hakkinen K, Jenkins NT, Karavirta L, Kraus 
WE, Leon AS, Rao DC, Sarzynski MA, Skinner JS, Slentz CA, Rankinen T. Adverse metabolic response 
to regular exercise: Is it a rare or common occurrence? PloS one. 2012;7:e37887
29. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Medicine and 
science in sports and exercise. 2001;33:S446-451; discussion S452-443
30. Blair SN, Morris JN. Healthy hearts--and the universal benefits of being physically active: Physical activity 
and health. Annals of epidemiology. 2009;19:253-256

Ralph R. Scholten
Maria T.E. Hopman
Fred C.G.J. Sweep
Maureen J. van de Vlugt
Arie P. van Dijk
Wim J.G. Oyen
Fred K. Lotgering
Marc E.A. Spaanderman
Obstet Gynecol. 2013; 121(1): 97-105
Co-occurrence of  
cardiovascular and  
prothrombotic risk factors  
in women with a history  
of preeclampsia
CHAPTER 2
18
CHAPTER 2
Abstract
Formerly preeclamptic women are at increased risk for remote cardiovascular and 
thrombotic diseases. We studied co-occurrence of cardiovascular and prothrombotic 
risk factors within a cohort of formerly preeclamptic women, and tested if prevalence 
of these risk profiles related to onset of preeclampsia in previous pregnancy. 
We evaluated 1297 nonpregnant formerly preeclamptic women (6-12 months post- 
partum) for the presence of four risk profiles: 1. circulatory risk profile (hypertension 
or latent hypertension [low plasma volume, increased vascular resistance or both]); 
2. metabolic syndrome (World Health Organization criteria); 3. thrombophilia (factor V 
Leiden, prothrombin mutation or protein C/S deficiency); and 4. hyperhomocysteinemia. 
Trends between prevalence of these four profiles and onset of preeclampsia were 
studied using linear regression analysis. 
After exclusion of 63 women (4.9%), because of incomplete data, 1234 women were 
included. One or more risk profiles were detected in 958/1234 (77.6%) formerly 
preeclamptic women. Circulatory risk profile was more prevalent (66.1%) than hyper-
homocysteinemia (18.7%), metabolic syndrome (15.1%) or thrombophilia (10.8%). 
Prevalence of circulatory risk profile, metabolic syndrome and hyperhomocysteinemia 
decreased significantly with gestational age at delivery, whereas thrombophilia did 
not (p=0.22). There was minimal overlap (<2%) between metabolic syndrome, 
thrombophilic profile and hyperhomocysteinemia. 
Circulatory risk profile is present in two thirds of formerly preeclamptic women. 
Metabolic syndrome, thrombophilia and hyperhomocysteinemia are prevalent in 
10-20%. There is considerable overlap between circulatory risk profile and other 
profiles, but not among the three other profiles. Prevalence of these risk factors, except 
thrombophilia, decreases with gestational age at delivery in preceding pregnancy.
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Introduction
Preeclampsia complicates 2 to 7% of all pregnancies and is associated with 
considerable maternal and fetal morbidity1. Studies in the past decade show that 
women with a history of preeclampsia have an increased risk of development of 
thrombotic and cardiovascular disease later in life2-6. Preeclampsia and cardiovascular 
diseases are thought to have disease mechanisms in common7-9. Traditional cardio- 
vascular risk factors are present in nulliparous women who subsequently develop 
preeclampsia8,9. Therefore, the cardiovascular risk profiles in formerly preeclamptic 
women are likely to reflect the pre-existing constitution rather than a consequence 
of hypertensive pregnancy itself8,9. 
Early onset of preeclampsia is clinically considered as the most important indicator 
of severity of preeclampsia1. The remote risk for cardiovascular disease is higher the 
earlier the onset of preeclampsia, and is sevenfold increased if preeclampsia occurs 
at less than 32 weeks of gestation compared with term onset preeclampsia5. 
Preeclampsia has been linked with a circulatory risk profile (hypertension or latent 
hypertension)7,10,11, metabolic syndrome12-14, thrombophilia15-18, and hyperhomo- 
cysteinemia15-18. Most studies involved a single risk profile in relation to preeclampsia 
in the preceding pregnancy. Therefore, any possible interrelation between these 
profiles within women with a history of preeclampsia is currently unclear. 
The extent to which the prevalence of underlying cardiovascular and prothrombotic 
risk factors increases after earlier onset of preeclampsia is unknown. In the present 
study we have attempted to elucidate this question. A secondary aim of this study 
was to estimate the possible overlap between separate risk profiles within women 
with a history of preeclampsia. We therefore evaluated the prevalence of four risk 
profiles (circulatory risk profile, metabolic syndrome, thrombophilia and hyperho-
mo-cysteinemia) in a cohort of women 6 to 12 months after a pregnancy complicated 
by preeclampsia. 
Materials and methods
We conducted a retrospective analysis of 1297 women with a history of preeclampsia 
who were consecutively screened for possible cardiovascular and prothrombotic risk 
factors (January 2004 and December 2010). All women were screened at our 
preconception clinic, a tertiary referral center of the Radboud University Nijmegen 
Medical Center. All measurements were performed in the nonpregnant state, 6 to 12 
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months after pregnancy complicated by preeclampsia. Preeclampsia was diagnosed 
if women had blood pressure of 140/90 mm Hg or higher, measured twice, six or 
more hours apart, and consistent proteinuria of 300 mg/24 hours or more after 
gestational week 20 in previously normotensive women19. HELLP (hemolysis, elevated 
liver enzymes, low platelets) syndrome was defined according to the criteria of the 
International Society on the Study of Hypertension in Pregnancy20. Intrauterine growth 
restriction (IUGR) was defined as birth weight less than the10th centile of the national 
birth weight chart21. Gestational age at delivery was taken as a proxy for onset of 
preeclampsia. At the time of measurements, none of the women used hormonal 
contraceptives, nor were they breastfeeding. All women were native Dutch. The study 
was approved by the Medical Ethics Committee of the Radboud University Nijmegen 
Medical Center (2007/252).
At enrollment, all participants collected urine in the 24 hours preceding the 
measurements. The 24- hour urine sample was assayed for albumin, protein and 
creatinine to calculate the (micro) albuminuria corrected for creatinine output (g/mol 
creatinine) and total protein level (g/24 hours) (Aeroset).
All measurements were performed in the morning, in the fasting state (overnight). 
Height and body mass (Seca 888 scale) were measured. Body surface area (BSA) 
was calculated using the Du Bois and Du Bois formula22 for the normalization of 
plasma volume. 
Blood pressure and heart rate were measured oscillometrically (Dinamap, Vital Signs 
Monitor 1846) at 3-minute intervals for 30 minutes at the right upper arm in the upright 
position. We used the median of nine consecutive measurements. Measurements 
were performed with the cuff size recommended for the arm circumference. We 
recorded systolic and diastolic blood pressures (BPsys and BPdia, mm Hg), mean 
arterial blood pressure (MAP, mm Hg) and heart rate (HR, beats per minute). 
Venous blood samples were taken from an antecubital vein and analyzed for 
metabolic parameters: glucose, insulin, total cholesterol, high and low density 
lipoproteins and triglycerides (Aeroset). To estimate insulin resistance (homeostasis 
model assessment index (HOMA)) was calculated (insulin [mU/L] x glucose 
[mmol/L]/22.5) as the product of fasting glucose and insulin23. Factor V Leiden (F5 
R506Q) and prothrombin (G20210A) mutation analyses were performed by routine 
polymerase chain reaction techniques. Citrated blood was centrifuged and plasma 
was assayed for total protein S, free protein S and the protein C activity. Total 
homocysteine levels were measured using high-performance liquid chromatograph-
ic assay. 
21
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Plasma volume (PV, ml) was measured using the 125I-Human Serum Albumin indicator 
dilution technique (125I-HSA). Plasma volume was calculated by dividing the total 
injected radioactivity by the virtual volume-specific radioactivity at time zero, as 
described elsewhere24. Plasma volume was normalized by dividing total plasma 
volume by body surface area (mL/m2).
Echocardiographic measurements were obtained by an experienced cardiology 
technician. Measurements were performed in left lateral position, using a cross- 
sectional phased array echocardiographic Doppler system (Vivid 7). Left ventricular 
outflow tract velocity was measured using pulse wave Doppler, and midsystolic left 
ventricular outflow diameter also was measured. Stroke volume was calculated by 
multiplying the left ventricular outflow tract velocity integral and the left ventricular 
outflow tract area (as calculated from the left ventricular outflow tract diameter (2). 
Heart rate was determined as the reciprocal of the time interval between the R waves 
of the electrocardiogram measured during the Doppler measurements. This heart 
rate was used only for the calculation of cardiac output. Cardiac output (CO) was 
calculated as stroke volume multiplied by heart rate. Total vascular resistance (TPVR) 
was calculated as 80 times the mean arterial pressure, divided by the cardiac output 
(80 x MAP/CO). 
Circulatory risk profile: Circulatory risk profile was defined as hypertension, or the use 
of antihypertensive medication, or signs of latent hypertension, in the absence of 
metabolic syndrome. Hypertension was defined as BPsys of 140mmHg or higher or 
BPdia 85 mmHg or higher; latent hypertension as reduced plasma volume (PV less 
than 1405 mL/m2) or increased total peripheral vascular resistance (TPVR: more than 
1600 dynes.sec/cm5). Hypertensive women who additionally met the criteria for 
metabolic syndrome were allocated to the metabolic syndrome profile to prevent 
women to be counted twice on the basis of their blood pressure. Women who used 
antihypertensive medication were excluded from analysis of plasma volume and 
vascular resistance in order to prevent any confounding effect of medication.
Metabolic syndrome: Metabolic Syndrome was defined using World Health Organization 
criteria25 by the concomitant presence of insulin resistance (fasting insulin 9.2 mU/L 
or higher or fasting glucose 6.1 mmol/L or higher or HOMA of 2.2 or more) and two or 
more of the following factors: hypertension (systolic blood pressure  140mm Hg or 
higher or diastolic blood pressure 85 mm Hg or higher or the use of antihypertensive 
medication); obesity (body mass index 30 kg/m2 or higher); dyslipidemia (triglycerides 
1.69 mmol/L or higher or high-density lipoprotein 0.9 mmol/L or less); or micro-
albuminuria (urine albumin 0.30 g/mol creatinine or more or urine protein 0.30 g/ 
24 hours or more). 
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Thrombophilia: Hereditary thrombophilia was defined as the presence of Factor V 
Leiden or prothrombin 20210A mutation or protein S levels or protein C activity below 
the normal range (free protein S less than 55%, protein C activity less than 70%). 
Hyperhomocysteinemia: Hyperhomocysteinemia was defined as a fasting homocysteine 
more than 12.1µmol/L26.
Statistical analysis
To illustrate the relationship between gestational age at delivery in previous pregnancy 
and the prevalence of cardiovascular and prothrombotic risk factors, the study group 
was divided into four subgroups based on the gestational age at previous delivery 
(more than 22 to 28 weeks or less, more than 28 to 32 weeks or less, more than 
32 weeks to 37 weeks or less, and more than 37 weeks of gestation). Outcome variables 
are presented as frequencies and percentage including 95% confidence interval (CI) 
for estimated proportions. For all risk factors, the relative risks with corresponding 
95% CIs for each gestational age group were calculated, with the more than 37 weeks 
of gestation group used as reference. Trends in risk factors by onset of preeclampsia 
in the previous pregnancy were studied by linear regression analysis; gestational age 
at delivery was used as a continuous variable.
The change in cardiovascular and prothrombotic risks with each additional week of 
gestation in the preceding pregnancy was expressed by hazard ratios. Hazard ratios 
were estimated using multivariable regression analysis, with adjustments made for 
the following predefined factors: age, parity, smoking, or HELLP or IUGR in the 
preceding pregnancy. Statistical significance (two-sided P-value) was set at P ≤ .05. 
The statistical analyses were performed using the standard statistical software 
package SPSS 16.0.
The inter-relation between the four risk profiles within formerly preeclamptic women 
was studied with the use of a scaled rectangle diagram similar to Venn diagrams in 
which each rectangle area is scaled according to the prevalence of the attribute27. 
Overlapping areas are proportional to the prevalence of joint occurrence of attributes. 
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Results
From the 1297 formerly preeclamptic women included in our study, 63 women had to 
be excluded because of one or more missing values in any of the studied risk profiles. 
The remaining 1234 women with a complete set of study variables were available for 
analysis. The characteristics of these women are shown in Table 1. Women delivered 
at a median of 33 weeks of gestation [interquartile range 29-36; range 19] in their 
previous pregnancy. The screening for possible risk factors was performed at a 
median of 7 months postpartum [interquartile range 6-10; range 6].
Any of the four risk profiles (circulatory profile, metabolic syndrome, thrombophilia, or 
hyperhomocysteinemia) was present in 958 of 1234 (77.6%; 95%CI 75.3-80.0%) 
formerly preeclamptic women (Table 2). The prevalence of having any risk profile 
decreased with gestational age at delivery in the preceding pregnancy (P for linear 
trend <.01). Absence of any of the four risk profiles occurred in 276 of 1234 (22.4%; 
95%CI 20.0-24.7%) of the formerly preeclamptic women. 
Table 1  General characteristics of the included formerly preeclamptic women 
General characteristics
N 1234
Age (years) 32 ± 4
BMI (kg/m2) 25.6 ± 5.3
Systolic blood pressure (mmHg) 120 ± 15
Diastolic blood pressure (mmHg) 73 ± 11
Mean arterial pressure (mmHg) 90 ± 12
Antihypertensive medication (n (%)) 180 (15)
Smoking (n (%)) 207 (17)
Primiparous  (n (%)) 991 (80)
Additional diagnoses in index pregnancy: 
- HELLP (n (%)) 654 (53)
- Growth restricted infant (n (%)) 432 (35)
Gestational age of delivery in previous pregnancy (weeks) 33 [29-36]
Screening, time after delivery (months) 7 [6-10]
HELLP, hemolysis, elevated liver enzymes, and low platelet count. Data are mean ± standard deviation, 
n (%), or median [range].
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Hypertension was present in 318 of 1234 formerly preeclamptic women (25.8%; 
95%CI 23.3-28.2%). From these, 152 of 1234 women (12.4%; 95%CI 10.5-14.2%) had 
hypertension in the absence of metabolic syndrome; 166 of 1234 (13.4%; 95%CI 
11.5-15.4%) additionally fulfilled the WHO criteria for metabolic syndrome and were 
analyzed as such. 
Circulatory risk profile was present in 816 of 1234 women (66.1%; 95%CI 63.5-68.8%) 
(Table 3). The prevalence decreased with gestational age at delivery in the preceding 
pregnancy (P for linear trend <.01). In addition to the 12.4% women with overt 
hypertension, 664 of 1234 formerly preeclamptic women (53.8%; 95%CI 51.0-56.6%) 
had latent hypertension. In formerly preeclamptic women, not using antihypertensive 
medication 512 of 1054 (48.6%; 95%CI 45.6-51.6%) had low plasma volume and 
247 of 1054 (23.4%; 95%CI 20.9-26.0%) had increased vascular resistance.
Metabolic syndrome was present in 191 of 1234 women (15.4%; 95%CI 13.5-17.5%) 
(Table 4). The prevalence decreased with gestational age at delivery in the preceding 
pregnancy (P for linear trend <.01). The prevalence of all components of the metabolic 
syndrome also decreased with gestational age at previous delivery (P for linear 
trend<.01), except for obesity. Hyperinsulinemia was present in 742 of 1234 (60.1%; 
95%CI 57.4-62.9%) of formerly preeclamptic women. From these 206 of 742 (27.7%; 
95%CI 24.5-31.0) met the criteria of metabolic syndrome; 536 of 742 (72.3%; 95%CI 
69.0-75.5%) did not.
Thrombophilia was present in 133 of 1234 (10.8%; 95%CI 9.1-12.5) formerly 
preeclamptic women (Table 5). 130 of 133 (98%; 95%CI 95.2-99.2%) of the women 
with thrombophilia had only one thrombophilic factor. Women with either Factor V 
Leiden or prothrombine 20210A mutation all were heterozygous. The prevalence of 
Table 2   Prevalence of any risk profile (either circulatory profile or metabolic 
syndrome or thrombophilia or hyperhomocysteinemia) in formerly 
preeclamptic women stratified by gestational age at delivery in 
preceding pregnancy.
22-28 wks
n=143
28-32 wks
n=357
32-37 wks
n=501
>37 wks
n=233
Total
n=1234
P for 
trend
Any risk 
profile
n (%)
RR [95%CI]
123 (85.9)
1.3 [1.2-1.4]
288 (80.9)
1.2 [1.1-1.3]
 394 (78.8)
1.2 [1.1-1.3]
154 (66.8)
reference
 958 (77.6)
<.01
Data are n(%) or relative risk [95% confidence interval]
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thrombophilia did not change with gestational week at previous delivery (P for trend 
.22). Factor V Leiden was the most prevalent thrombophilic factor 60 of 1234 (4.9%; 
95%CI 3.7-6.1%). 
Hyperhomocysteinemia was present in 231 of 1234 (18.7%; 95%CI 16.5-20.9%) 
formerly preeclamptic women (Table 6). The prevalence decreased with gestational 
age at delivery in the preceding pregnancy (P for linear trend <.01).
Table 7 summarizes the hazard ratios for all four studied profiles associated with 
each additional week at delivery in the preceding pregnancy. Except for thrombophilia 
all profiles show a decreasing prevalence with each additional week at delivery in 
the preceding pregnancy (ie, the later onset of preeclampsia). These trends were 
preserved after adjustment for age, parity, smoking and the additional diagnoses of 
HELLP syndrome or IUGR as indicated by the adjusted hazard ratios. 
Table 6   Prevalence of hyperhomocysteinemia in formerly preeclamptic women 
stratified by gestational age at delivery in preceding pregnancy.
22-28 wks
n=143
28-32 wks
n=357
32-37 wks
n=501
>37wks
n=233
Total
n=1234
P for 
trend
Hyper homo-
cysteinemia
n (%)
RR [95%CI]
32 (22.6)
2.0 [1.2-3.2]
80 (22.3)
1.9 [1.3-2.9]
92 (18.4)
1.6 [1.1-2.4]
27 (11.5)
reference
231(18.7)
<.01
Data are n(%) or relative risk [95% confidence interval]
Table 7   Hazard ratios for the prevalence of the risk profiles with each additional 
gestational week at delivery in preceding pregnancy.
Hazard Ratio [95%CI] Adjusted-Hazard Ratio [95%CI]*
Circulatory risk profile 0.96 [0.93-0.99] (P <.001) 0.96 [0.93-0.99] (P <.001)
Metabolic syndrome 0.92 [0.88-0.95] (P <.001) 0.91 [0.87-0.96] (P <.001)
Any thrombophilia 0.99 [0.95-1.02] (P =.81) 1.0 [0.96-1.03] (P =.68)
Hyperhomocysteinemia 0.95 [0.91-0.98] (P =.004) 0.95 [0.91-0.99] (P =.01)
*  Hazard ratio after adjustments for age, parity, smoking and additional diagnosis of HELLP and growth 
restricted infant in the index pregnancy.
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Figure 1 demonstrates the prevalence of the four studied risk profiles and their 
interrelation. In total 958 of 1234 (77.6%; 95%CI 75.3-80.0%) formerly preeclamptic 
women had one or more risk profiles. Three hundred seventeen of 1234 (25.7%; 95%CI 
23.3-28.1%) women with a history of preeclampsia had more than one risk profile, 
more specifically 278 of 1234 (22.5%; 95%CI 20.2-24.9%) women had two concurrent 
risk profiles, 37 of 1234 (3%; 95%CI 2.1-4.0%) women had three concurrent risk 
profiles and only 2 of 1234 (0.2%; 95%CI 0.0-0.4%) women had all four risk profiles 
after a pregnancy complicated by preeclampsia. Metabolic syndrome, thrombophilia 
Figure 1  Scaled rectangle diagram indicating the prevalence and co-occurrence of circulatory 
risk profile, metabolic syndrome, thrombophilia and hyperhomocysteinemia in formerly 
preeclamptic women. Numbers represent percentages relative to the total study population. 
Each rectangle area is scaled according to the prevalence of the attribute. Overlapping areas 
are proportional to the prevalence of joint occurrence of attributes.
42.1 
6.4 
10.6 4.5 
3.9 
3.6 
0.8 0.4 
0.2 0.1 
0.7 0.5 
22.4 
5.3 
1.4 0.7 
= Circulatory risk profile (66.1%)
= Hyperhomocysteinemia (18.7%) 
= Metabolic syndrome (15.4%) 
= Thrombophilic profile (10.8%)  
= No abnormalities (22.4%) 
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and hyperhomocysteinemia each co-occurred considerably with the highly prevalent 
circulatory risk profile. Co-occurrence of risk profiles other than the circulatory risk 
profile was uncommon (less than 2%).
Discussion
We have tested in each patient the four most common risk factors associated with 
preeclampsia. This allowed us to study the interrelationship between the risk profiles.
Two thirds of formerly preeclamptic women demonstrated a (latent) hypertensive 
hemodynamic profile 6 to 12 months post partum. One fourth of formerly preeclamptic 
women had hypertension and 50% of these hypertensive women additionally met the 
criteria for metabolic syndrome. The high prevalence of the circulatory risk profile 
(66%) was mainly attributable to reduced plasma volume status. Low plasma volume 
after preeclampsia predisposes to recurrent preeclampsia, IUGR and preterm birth in 
subsequent pregnancy24. Low plasma volume reflects reduced cardiovascular reserve 
capacity, a condition that, together with increased vascular resistance, relates to the 
development of chronic hypertension within the next decade. Timely blood pressure 
lowering leads to reductions in vascular disease risk and premature death28,29. 
Therefore, formerly preeclamptic women may well benefit from circulatory follow-up, 
most accessibly by blood pressure measurements, even in women who are 
normotensive in the first year after pregnancy. Circulatory follow-up does not 
necessitate the measurement of plasma volume status and total peripheral vascular 
resistance per se.
 
The prevalence of the metabolic syndrome in formerly preeclamptic women (15%) 
was approximately three times higher than that of the general Dutch female population 
of comparable age (5%)30. The prevalence of metabolic syndrome and all its 
components – except obesity – decreased with gestational age at delivery. This 
observation suggests that the other components relate to severity of preeclampsia, 
whereas obesity does not. Metabolic syndrome not only increases the risk of 
(recurrent) preeclampsia13,14,31,32, but also increases the risk of later cardiovascular 
disease33,34, and diabetes mellitus33,35,36. These risks can be reduced by weight 
management and physical activity, or by medical treatment when lifestyle adjustments 
are ineffective37-39. Recognizing the metabolic syndrome in formerly preeclamptic 
women is likely efficient and cost effective40, 41. 
The prevalences of Factor V Leiden (4.9%) and prothrombin 20210A (2.7%) mutation 
in our study were comparable to those in the Dutch general population42,43, whereas 
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those of Protein C (1.7%) and S (1.8%) deficiency were slightly increased44,45. The 
added value of routine screening for these factors in formerly preeclamptic women 
seems limited. However a recent randomized trial in women with hereditable 
thrombophilia and previous early-onset hypertensive disease in pregnancy has 
demonstrated a reduction of recurrent preeclampsia by combined treatment with low 
molecular weight heparin and aspirin46. Our study was not designed to answer 
definitively the question of to what extent the association between thrombophilia and 
preeclampsia is causal or if women should be routinely screened and treated for 
possible thrombophilia after preeclampsia. If the decision to screen and treat is 
made, it would seem more reasonable to test all formerly preeclamptic women rather 
than only those with early-onset disease. 
Almost one out of five formerly preeclamptic woman had hyperhomocysteinemia 
(19%), which is four times higher than in the general population. Hyperhomo-cysteinemia 
co-occurred with the circulatory risk profile in 69% of the cases. This evident overlap 
might be explained by increased vascular tone, given that hyperhomocysteinemia 
induces vascular damage by the formation of free oxygen radicals, ultimately resulting 
in proliferation of smooth-muscle cells and alterations in endothelial function and 
structure47. Screening and treatment for hyperhomo-cysteinemia could be considered for 
four reasons. First, hyperhomocysteinemia increases the risk of future cardiovascular 
disease, however supplementation has not been proven effective in reducing that 
risk48. Second, two multivitamin supplementation containing folic acid in women with 
hyperhomocysteinemia reduces the risk of preeclampsia49, 50. Third, hyperhomo-
cysteinemia increases the risk of venous and arterial thrombosis that can be reduced 
by vitamin supplementation15, 16, 51. Fourth, hyperhomocysteinemia is associated with 
fetal closure defects that can be reduced by vitamin B supplementation52. For these 
reasons it seems warranted to screen formerly preeclamptic women for hyperhomo-
cysteinemia. Formerly preeclamptic women are likely to benefit from screening and 
tailored treatment for their risk profile(s)53. 
Our study may have some methodological limitations. First, our study population 
represents that of a tertiary clinic. This may limit generalization of the results to the general 
population of formerly preeclamptic women because of possible overrepresentation 
of women with a history of more severe preeclampsia. It is conceivable that this 
may have resulted in overestimation of the prevalence of risk profiles. This effect is 
probably small, because adjustments for co-occurrence of HELLP and the delivery 
of IUGR, as indicators of severity of preeclampsia, did not affect the results. Second, 
the formerly preeclamptic women in our study were evaluated 6 to 12 months post 
partum. We cannot rule out a possible overestimation of the prevalence of cardio- 
vascular risk factors because improvement may still continue thereafter. Although 
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further recovery has been reported up to two years postpartum57, the literature 
suggests that abnormal hemodynamic variables in formerly preeclamptic women 
largely (>80%) resolve within 6 months after giving birth. Third, our study includes 
only Caucasian women. This may limit generalization, since other ethnic groups may 
display different profiles.
In conclusion, 77.6% of women with a history of preeclampsia have one or more 
cardiovascular or prothrombotic risk factors. The circulatory risk profile was most 
prevalent. The prevalence of the circulatory risk profile and also components of the 
metabolic syndrome other than obesity and hyperhomocysteinemia relate inversely 
with the gestational age at delivery in preceding pregnancy.  Although these trends 
were statistically significant the differences were small. The prevalence of 
thrombophilia is unaffected by the gestational age at delivery. Apart from the highly 
prevalent circulatory risk profile we found minimal overlap between the metabolic 
syndrome, hyperhomocysteinemia and thrombophilia. Early identification and 
management of cardiovascular risk factors have the potential to favorably influence 
the incidence of recurrent hypertensive disease in future pregnancies and also the 
long-term cardiovascular morbidity and mortality in this specific population of women 
at high risk. 
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Abstract
Low plasma volume precedes chronic hypertension. In line with the fetal origins of 
adult disease theory, our aim was to estimate whether normotensive women who were 
born small for gestational age have low plasma volume in adult life.
In 280 normotensive women with a history of hypertension in pregnancy we recorded 
recalled gestational age and weight at birth and measured plasma volume (I125-HSA 
indicator dilution method). To correct for possible confounders, we recorded recent 
obstetric history and measured in each individual all constituents of the metabolic 
syndrome (World Health Organization criteria), sex hormones (progesterone and estradiol), 
renal function, and cardiac performance at rest (echocardiography). We estimated 
daily activity level with validated questionnaire (Short Questionnaire to Asses Health- 
enhancing physical activity). We studied the relation between women’s own birth 
weight centile and her adult plasma volume (mL) and adjusted for the effects of 
confounding variables using multiple linear regression analysis. 
Birth weight correlated positively with adult plasma volume (P<0.001). Linear regression 
analysis demonstrated that each 10-centile change in birth weight is associated with 
an average change of 46.6 mL [95%CI: 30.8-62.3] in adult plasma volume. This 
association persisted after adjustment for confounding factors (current body surface 
area, mean arterial pressure, total vascular resistance, glomerular filtration rate, and 
total 24 hours of sodium output). After adjustment, each 10-centile change in birth 
weight was associated with an average change of 32.1 mL [95%CI: 19.6-44.6] in adult 
plasma volume. Birth centile contributes 14% to the variation in total adult plasma 
volume.
Impaired fetal growth is associated with low plasma volume in adult life. 
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Introduction
The association between low birth weight and increased blood pressure in adult life 
and mortality from cardiovascular disease has been well established1,2. So far, 
possible mechanisms linking fetal growth restriction to higher blood pressures in 
adulthood may be found in persisting changes in vascular structure, including loss of 
elasticity in vessel walls3 or increased insulin resistance4,5, altered glucocorticoid 
balance6 or abnormal cholesterol metabolism7. 
Low plasma volume in the absence of hypertension is related to the early, often latent, 
phase of chronic hypertension8-10. At rest, two-third of the human blood volume is 
localized in the venous system11. Quantitatively, most of the total venous return (47%) 
comes from veins within splanchnic organs and kidneys11. Therefore the splanchnic 
vascular bed is often regarded as the quantitatively most important system to ‘store’ 
blood volume. Theoretically, a structural small venous abdominal compartment 
negatively affects the total plasma volume. 
Asymmetrical fetal growth restriction is characterized by a disproportionately small 
abdominal circumference as a consequence of loss in liver, kidney and intestinal 
volume12. This is thought to originate from selective growth failure of splanchnic 
organs as a consequence of circulatory redistribution away from this abdominal 
region13. Because only arteries have regenerative capacity11, limited venous intra- 
uterine development may have long-lasting effects on total plasma volume. 
In line with the fetal origins of adult disease theory, we hypothesized that women 
born small for gestational age (SGA) have lower plasma volume levels in adult life, 
compared to women born appropriate or large for gestational age (LGA).  
Materials and methods
We conducted a retrospective observational study in 347 consecutive healthy women 
with a history of hypertension in pregnancy in whom plasma volume was measured 
between January 2008 and December 2010. We used a database of women who 
were extensively evaluated in our tertiary hospital after hypertensive disorders in 
pregnancy. We recorded recalled birth weight and gestational age at birth. If women 
were unsure of these characteristics, women were excluded from this analysis. 
Women with pre-existing medical conditions or who used any medication were also 
excluded. 
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All measurements were performed, in the non-pregnant state, 6 to 12 months after a 
pregnancy complicated by preeclampsia and/or HELLP syndrome. The diagnoses of 
gestational hypertension, preeclampsia and HELLP were according to the criteria of 
the American College of Obstetricians and Gynecologists (ACOG)15. Except for their 
history of complicated pregnancy all women were healthy. 
Birth weight centiles of women included in this analysis were calculated according to 
the national reference population of women born in the same era14. Study group was 
stratified into four birth weight groups. Small for Gestational Age (SGA) was defined 
as birth centile less than 10%. Women born Appropriate for Gestational Age (AGA) 
were subdivided in women born 10th or more and less than 50th centile (AGA-1) and 
women born between 50th centile and 90th centile (AGA-2). Large for Gestational Age 
(LGA) was defined as belonging to the more than 90% birth centile. 
At the time of measurements none of the women used hormonal contraceptives, nor 
were they breastfeeding. All women were white. The study was approved by the 
institutional review board of the Radboud University Nijmegen Medical Centre.
Experimental procedures
Plasma volume (PV, ml) was measured using the 125I-Human Serum Albumin indicator 
dilution technique (125I-HSA). During the measurement, subjects stayed in a semi- 
supine position on a comfortable bed. An intravenous catheter was inserted in the left 
antecubital vein for the repetitive blood sampling. A standardized dose (0.2 MBq) 
of 125I-HSA was injected intravenously in the right antecubital vein. Every 10 minutes 
a venous blood sample was taken from the contra lateral intravenous catheter until 
40 minutes after administration of the 125I-HSA. Blood samples were analyzed using 
a gamma counter. Plasma volume was calculated by dividing the total injected 
radioactivity by the virtual volume-specific radioactivity at time zero, as described 
elsewhere16. Plasma volume was indexed for body surface area (PV/BSA, mL/m2). 
The technician measuring plasma volume was unaware of the birth weight and 
medical history of participants. 
To explore possible confounding effects of hemodynamic, metabolic, endocrine, or 
lifestyle factors we systematically determined these profiles in each participant on the 
same day as the plasma volume measurement.  
 
All participants collected urine in the 24 hours preceding the measurements. The 24- 
hour urine sample was assayed for sodium output (mmol/24 hour), micro-albumine 
corrected for creatinine output (g/mol creatinine) and creatinine (mmol/L). 
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Height and body mass were measured. Body surface area (BSA) for the normalization 
of the plasma volume, was calculated using the Dubois and Dubois formula17. 
Subsequent measurements were performed after an acclimatization period of at 
least 20 minutes in the supine position in a temperature controlled room (20-22 ºC). 
All measurements were performed in the morning, in the fasting state (overnight). 
Blood pressure and heart rate were measured oscillometrically at 3-minute intervals 
for 30 minutes at the right upper arm. We used the median values of 9 consecutive 
measurements. Measurements were done with the cuff size recommended for the 
arm circumference. We recorded systolic (BPsys) and diastolic (BPdia) blood pressures 
(mmHg) and heart rate (HR; bpm). Pulse pressure (dP; mmHg) was calculated as the 
difference between median systolic and diastolic blood pressures. We calculated 
mean arterial pressure (MAP; mmHg) using the formula: (2*BPdia + BPsys)/3.
Echocardiographic measurements were obtained by an experienced cardiology 
technician. Measurements were performed in left lateral position, using a cross-sec-
tional phased array echocardiographic Doppler system (Vivid 7, General Electric, 
Horten, Norway). Left atrial diameter was measured in the four-chamber view. 
Subsequently left ventricular outflow traject velocity integral, and left ventricular 
outflow diameter were measured. Heart rate (HR) was determined by the reciprocal 
of the RR interval of the ECG measured during the echo Doppler measurements. This 
heart rate was used only for the calculation of cardiac output. Stroke volume (SV) was 
calculated by multiplying the left ventricular outflow tract velocity integral and the left 
ventricular outflow tract diameter. Cardiac Output (CO) was calculated as SV*HR. 
Total peripheral vascular resistance (TPVR) was calculated as eighty times the mean 
arterial pressure (MAP), divided by the cardiac output (80*MAP/CO). Global Vascular 
Compliance (GVC) was calculated from stroke volume and pulse pressure using the 
equation: GVC= SV/ dP (mL/mmHg).
Venous blood samples were taken from the in situ intravenous catheter and analyzed 
for metabolic parameters: glucose (mmol/L), insulin (mU/L), total cholesterol, low- 
density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), 
triglycerides (mmol/L), sex hormone levels (progesterone (nmol/l), and estradiol 
(pmol/L)) and renal function (serum creatinine level (µmol/L)). HOMA-IR was 
calculated using the formula: [fasting serum insulin (mU/L) x fasting plasma glucose 
(mmol/L)/22.5]. Creatinine clearance was calculated from the 24-hour urine creatinine 
concentration and the plasma creatinine concentration, corrected for BSA and 
expressed in mL/min/1.73m2. 
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Daily activity was assessed with a validated questionnaire (Short Qestionaire to 
Asses Health enhancing physical activity; SQUASH)18. Participants were asked to 
describe an average week. Intensity was expressed as metabolic equivalent of task 
(MET), a physiological concept of expressing the energy of physical activities as 
multiples of resting metabolic rate (RMR), set by convention to 3.5 mL O2·kg
-1·min-1. 
Activities were subdivided into three intensity categories 2.0 to < 4.0 MET (light), 4.0 
to < 6.5 MET (moderate), and ≥ 6.5 MET (vigorous), using Ainsworth’s compendium 
of physical activities19. Activities below 2 MET value were not included, since they are 
considered to contribute negligibly to habitual activity levels. The SQUASH questionnaire 
quantifies commuting and work related activities, leisure activities (including sports) 
and household activities. Physical activity is presented as minutes/day (median [inter 
quartile range]) for each intensity category (light, moderate and vigorous). For each 
individual, the sum of the physical activity in each intensity category (total daily 
activity level; min/day) was used in the multivariable analysis.
Statistical analysis
Data were expressed as means ± standard deviations or as medians with interquartile 
range for normally and non-normally distributed data, respectively. Normality of each 
variable was evaluated using Kolmogorov-Smirnov tests. Trends were analyzed by 
linear regression of the adult characteristics on birth centile as a continuous variable 
and not categorical.  
We calculated the change in adult plasma volume (mL) associated with a 10 centile 
increase in birth centile by linear regression analysis. The effects of possible confounding 
variables based on their known potential association with adult plasma volume 
included: current age, body mass index, smoking, daily activity level, progesterone 
level, estradiol level, mean arterial pressure, global vascular compliance, insulin level, 
glomerular filtration rate, 24-hour sodium output and interval between delivery and 
measurement. In the end, adjustments were made by multiple linear regressions for 
those factors that also related to birth centile (body surface area, mean arterial pressure, 
total vascular resistance, creatinine clearance and total 24-hours’ sodium output).
To identify factors contributing to the adult plasma volume status, we first tested 
univariably (Pearson’s) which variables correlated with total adult plasma volume 
(mL). Subsequently, factors correlating with plasma volume (P<0.05) were introduced 
in a backward stepwise linear regression analysis to weigh the potential determinants 
of the adult total plasma volume (mL). To quantify the independent contribution of 
each variable in our final model for adult plasma volume, we consecutively removed 
factors from our model, starting with the quantitatively most important factor based 
on the largest change in the explained variance (R2) after removal. We present the 
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explained variance (R2) of the final model, and the R2 of the subsequent models after 
consecutive removal of a variable. Statistical significance (2-sided P-value) was set at 
≤.05. The statistical analyses were performed using the standard statistical software 
package SPSS 16.0.
Results
Two hundred eighty women were available for analysis after exclusion of 67 women. 
Exclusion followed after inability to recall their own birth characteristics (n=51); 
14 women had to be excluded because of pre-existing medical conditions or use of 
medication. Two women in whom plasma volume could not be adequately determined 
due to technical reasons were also excluded (Fig. 1). Women who were excluded for 
not being able to recall their own birth weight (n=51) did not differ from the women 
included in our study (n=280) in plasma volume (2775 vs. 2761 mL, P=.58), current 
body surface area (1.81 vs.1.81 m2, P= 0.71), mean arterial pressure (85 vs. 84 mmHg, 
P=.62), total vascular resistance (1297 vs. 1329 dynes·s/cm5, P=.42), glomerular 
filtration rate (109 vs. 110 mL/min/1.73m2, P=.81) and total 24-hour sodium output 
(134 vs. 135 mmol/24 hour, P=.75).
Table 1 demonstrates the general adult characteristics and the characteristics at birth 
of the women included in the analysis stratified by the four birth centile groups. With 
Figure 1  Overview of the in- and excluded women. 280 women were eligible for final analysis.
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increasing birth weight centile, both adult height and weight increased, this pattern in 
body composition was also reflected in the body surface area (P for trend =.004). 
The gestational age at birth did not differ between birth centile groups. 
Linear regression analysis demonstrated that each 10-centile change in birth weight 
relates to an associated with an average change of 46.6 mL [95%CI: 30.8-62.3] in 
adult plasma volume (Fig. 2). When plasma volume was normalized for adult body 
surface area, the positive correlation between birth centile and adult plasma volume 
persisted (P for trend: <.001) (Table 2). Women born SGA had 11% lower plasma 
volume (mean: 1349 ± 200 mL/m2) compared to women born AGA-1 (mean: 1518 ± 
156 mL/m2).  Furthermore, women born LGA had 10% higher plasma volume (mean: 
1663 ± 229 mL/m2) compared to women born AGA-1. Plasma volume in women born 
AGA-2 (mean: 1544 ± 137 mL/m2) did not differ from AGA-1. 
Table 1   General characteristics and characteristics at birth of included women, 
stratified by birth weight centile group (N=280). 
SGA
(<p10)
(n=40)
AGA-1
(p10-p50)
(n=112)
AGA-2
(p50-p90)
(n=84)
LGA
(>p90)
(n=44)
P for 
trend
General adult characteristics
Age (years) 31 ± 5 32± 4 32 ± 5 32 ± 5 .88
Height (cm) 166 ± 6 169 ± 7 170 ± 6 174 ± 7 .001
Weight (kg) 70 ± 14 70 ± 14 72 ± 17 75 ± 16 .02
BSA (m2) 1.76 ± 0.16 1.79 ± 0.18 1.82 ± 0.21 1.91 ± 0.18 .004
BMI (kg/m2) 25 [22-27] 23 [21-26] 24 [21-28] 24 [21-28] .22
Smoking (%) 21 12 13 18 .74
Characteristics at birth
Birth weight (grams) 2457 ± 288 2932 ± 336 3413 ± 362 3883 ± 563 <.001
Gestational age at birth 
(days)
281 ± 10 277± 13 276 ± 14 276 ± 15 .17
Birth weight centile 5 ± 2 26 ± 11 71 ± 11 96 ± 3
SGA, small for gestational age; AGA, appropriate for gestational age; LGA, large for gestational age; 
BSA, body surface area; BMI, body mass index. Data are mean (±standard deviation) or median [range] 
unless otherwise noted. P-value indicates linear trend based on regression analysis with birth weight 
centile used as a continuous variable.
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Hemodynamically, birth centile related inversely to the mean arterial blood pressure 
(P for trend =.04) (Table 2). This trend was reflected in both systolic and diastolic 
blood pressures. Total vascular resistance in adulthood tended to decrease with 
increasing birth centile (P for trend=.09). We found no differences in cardiac 
performance between birth centile groups. Also physical activity levels did not differ 
between birth centile groups.
Insulin level, HOMA-ir and triglyceride level were higher in women born SGA compared 
to women born AGA-1 (Table 3). Metabolically we found no linear trends between 
birth centile and glucose metabolism or lipid concentrations. In contrast, glomerular 
filtration rate increased with birth weight centile (P for trend = .05). The 24-hour sodium 
output tended to increase with birth centile (P for trend = .08).  When the specific 
cardiovascular risk factors were clustered according to WHO criteria for the metabolic 
syndrome, women born SGA had the highest prevalence of Metabolic Syndrome 
(23 %). Estrogen and progesterone levels did not differ between groups. 
To explore possible confounding effects of the recent pregnancy, Table 4 summarizes 
the recent obstetric history of the included women. By inclusion, all women met 
the criteria for pregnancy-induced hypertension in previous pregnancy. In our study 
population 176 (63%) women additionally met the criteria for preeclampsia. As indicated 
Figure 2   Adult plasma volume (mL) plotted against women’s own birth weight centile, with 
regression line and corresponding 95% prediction interval.
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Table 2   Hemodynamic variables and current daily activity level at the time  
of plasma volume measurement of included women, stratified by birth 
weight centile group (N=280).
SGA
(<p10)
(n=40)
AGA-1
(p10-p50)
(n=112)
AGA-2
(p50-p90)
(n=84)
LGA
(>p90)
(n=44)
P for 
trend
Hemodynamic profile
Systolic blood pressure 
(mmHg)
119 ±11 116 ± 12 114 ± 9 113 ± 10 .04
Diastolic blood pressure 
(mmHg)
72 ± 8 71 ± 9 70 ± 6 68 ± 8 .04
Mean arterial pressure 
(mmHg)
86 ± 8 84 ± 9 83 ± 7 82 ± 8 .04
Resting heart rate  (bpm) 71 ± 12 71 ± 12 71 ± 10 71 ± 10 .95
Stroke volume (mL) 77 ± 17 78 ± 20 75 ± 19 82 ± 20 .70
Cardiac output (L/min) 5.2 ± 1.3 5.5 ± 1.5 5.4 ± 1.6 5.7 ± 1.4 .18
Cardiac index (L/min/m2) 2.9 ± 0.6 3.1 ± 0.8 3.0 ± 0.8 3.1 ± 0.7 .26
Total vascular resistance 
(dynes·s/cm5)
1331 
[1093-1655]
1242 
[1058-1553]
1239 
[1057-1526]
1149 
[915-1374] 
.09
Global vascular 
compliance  (mL/mmHg)
1.7 ± 0.4 1.8 ± 0.5 1.7 ± 0.5 1.8 ± 0.5 .40
Total plasma volume (mL) 2389 ± 421 2714 ± 383 2796 ± 403 3096 ± 400 <.001
Normalized plasma 
volume (mL/m2)
1349 ± 200 1518 ± 156 1544 ± 137 1663 ± 229 <.001
Current daily activity level 
2-4 MET, light (min/day) 362 ± 54 355 ± 61 364 ± 68 355 ± 59 .81
4-6.5 MET, moderate 
(min/day)
58 ± 22 58 ± 34 62 ± 39 55 ± 30 .62
≥ 6.5 MET, vigorous  
(min/day)
4 [1-10] 5 [1-9] 3 [0-9] 4 [1-10] .77
Total daily activity level 
(min/day)
336 ± 84 354 ± 100 349 ± 102 363 ± 96 .40
SGA, small for gestational age; AGA, appropriate for gestational age; LGA, large for gestational age; MET, 
metabolic equivalent of task. Data are mean (±standard deviation) or median [range] unless otherwise 
noted. P-value indicates linear trend based on regression analysis with birth weight centile used as a 
continuous variable.
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Table 3   Metabolic profile, kidney function and sex hormone status at the time  
of plasma volume measurement, stratified by birth weight centile group 
(N=280).  
SGA
(<p10)
(n=40)
AGA-1
(p10-p50)
(n=112)
AGA-2
(p50-p90)
(n=84)
LGA
(>p90)
(n=44)
P for 
trend
Metabolic profile
Glucose (mmol/L) 5.0 ± 0.5 4.9 ± 0.5 5.0 ± 0.5 4.8 ± 0.5 .52
Insulin (Umol/L) 13.3  
[10.0-18.8]
9.9 
[7.2-13.0]
11.0 
[7.9-14.8]
10.0 
[8.0-14.4]
.60
HOMA-ir 2.8
[1.8-3.9]
2.1
[1.5-2.9]
2.3
[1.7-3.6]
2.2
[1.6-3.1]
.62
Total cholesterol (mmol/L) 4.8 ± 0.8 4.7 ± 0.8 4.8 ± 0.9 4.5 ± 0.8 .67
LDL-c (mmol/L) 2.8 ± 0.8 2.9 ± 0.7 3.0 ± 0.8 2.8 ± 0.6 .59
HDL-c (mmol/L) 1.2 ± 0.3 1.3 ± 0.3 1.4 ± 0.3 1.2 ± 0.3 .85
Triglycerides (mmol/L) 1.1
[0.8-2.0]
0.9
[0.7-1.2]
0.9
[0.7-1.3]
0.9
[0.7-1.3]
.12
Kidney function 
Creatinine (µmol/L) 68 ± 12 65 ± 9 65 ± 10 64 ± 10 .35
GFR (mL/min/1.73m2) 106 ± 17 109 ± 24 114 ± 30 116 ± 24 .05
24-hours sodium output 
(mmol/24 hour)
129 ± 55 130 ± 55 140 ± 56 147 ± 57 .08
Microalbuminuria 
(gram/mol creatinine)
0.9 
[0.4-2.0]
0.8 
[0.5-1.4]
0.6 
[0.4-1.3]
0.7 
[0.4-1.4]
.10
Metabolic Syndrome
According WHO criteria (%) 23 10 11 14 .91
Hormonal status
Progesterone (nmol/L) 2.4
[1.3-7.4]
2.1
[1.3-18]
2.1
[1.3-14]
2.5
[1.3-16}
.56
Oestradiol (pmol/L) 250
[144-530]
300
[160-510]
255
[133-478]
290
[130-590]
.93
SGA, small for gestational age; AGA, appropriate for gestational age; LGA, large for gestational age; 
HOMA: Homeostasis Model of Assessment- Insulin Resistance (HOMA-ir); LDL, low-density lipoprotein; 
HDL, high-density lipoprotein; GFR; Glomerular Filtration Rate; WHO, World Health Organization.Data 
are mean (±standard deviation) or median [range] unless otherwise noted. P-value indicates linear trend 
based on regression analysis with birth weight centile used as a continuous variable.
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in Table 4, the obstetric outcomes did not differ between birth centile groups. Also, time 
interval between delivery and plasma volume measurements was the same in all birth 
centile groups. 
When the relation between birth centile and total adult plasma volume (mL) was 
adjusted for current body surface area, mean arterial pressure, total vascular 
resistance, glomerular filtration rate, and total 24-hour sodium output, each 10 centile 
change in birth weight is associated with an average change of 32.1 mL [95%CI: 
19.6-44.6] in adult plasma volume.
To identify predictors of adult plasma volume, we firstly explored univariably, which 
factors correlated with adult plasma volume (mL). Plasma volume correlated with BMI 
(r=0.44; P<.01), birth weight centile (r=0.36; P<.01), glomerular filtration rate (r=0.29; 
P<.01), total vascular resistance (r=-0.23; P<.01), daily activity level (r=0.23; P<.01), 
Table 4   Outcomes of recent pregnancy of the included women stratified by  
birth weight centile group (N=280).
SGA
(<p10)
(n=40)
AGA-1
(p10-p50)
(n=112)
AGA-2
(p50-p90)
(n=84)
LGA
(>p90)
(n=44)
P for 
trend
Recent obstetric history
Birth weight (grams) 1860 
[977-2978]
2350 
[1350-2985]
1907 
[1139-2987]
1797 
[1019-2953]
.73
Gestational age at delivery 
(days)
239 
[207-267]
252 
[223-270]
241 
[206-266]
234 
[209-267]
.29
Birth centile 25 [7-50] 23 [9-50] 25 [8-64] 26 [9-52] .75
Interval delivery and 
measurement (months)
9 [6-11] 8 [6-11] 9 [7-12] 8 [6-11] .72
Preeclampsia (%) 67 63 66 60 .73
HELLP (%) 58 51 57 44 .52
IUGR (%) 40 30 36 20 .50
Eclampsia (%) 2 2 3 2 .51
Placental abruption (%) 2 2 3 2 .69
Fetal death (%) 9 11 14 2 .75
SGA, small for gestational age; AGA, appropriate for gestational age; LGA, large for gestational age; 
HELLP, hemolysis, elevated liver enzymes, low platelets; IUGR, intrauterine growth restriction. Data are 
mean (±standard deviation) or median [range] unless otherwise noted. P-value indicates linear trend 
based on regression analysis with birth weight centile used as a continuous variable.
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global vascular compliance (r=0.23; P<.01), 24-hour sodium output (r=0.21; P=.01) 
and mean arterial pressure (r=-0.13; P<.01). Subsequent multivariable backward 
regression analysis revealed that only BMI, birth weight centile, daily activity level and 
glomerular filtration rate contributed independently to the adult plasma volume (R2 
final model=0.48). Quantitatively, BMI was the most important determinant in our 
model for total adult plasma volume, as indicated by the largest drop in explained 
variance (-0.17) after removal of the factor BMI from our final model (Table 5). 
Subsequent removal of birth centile indicates that the birth centile contributes for an 
additional 14% of the explained variance in total adult plasma volume. Similarly, daily 
exercise level and glomerular filtration rate accounted for 10% and 7% of the variance, 
respectively. Fifty two percent of the variance in total plasma volume remains 
unexplained by our model. 
Table 5   Predictors of the adult plasma volume (mL) (N=280).
Explained 
variance 
(R2)
Change 
in R2 after 
removal
Final model  
( BMI, birth centile, total daily exercise level, glomerular  
filtration rate)
0.48
-  Final model minus BMI 0.31 -0.17
-  Final model minus BMI and birth weight centile 0.17 - 0.14
-   Final model minus BMI, birth weight centile,  
and total daily exercise level 
0.07 - 0.10
BMI: body mass index
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Discussion
Our study demonstrates that women with a history of hypertension in pregnancy and 
who were born small for gestational age are predisposed for lower plasma volumes 
in adult life compared to counterparts who were born appropriate or large for 
gestational age. Low plasma volume is a condition known to precede chronic 
hypertension20,21. The association between birth weight centile and subsequent adult 
plasma volume is independent of current body composition, smoking, blood pressure, 
physical activity level, cardiac performance, glucose metabolism, lipid levels, kidney 
function, and levels of sex hormones. 
Formerly pre-eclamptic women have an increased risk of developing cardiovascular 
disease, suggesting a common risk profile22. Women who had gestational hypertension 
have a similar, but lower, risk of future hypertension and cardiovascular disease as 
those who had preeclampsia22. Previous studies also demonstrated associations 
between low plasma volume and preeclamptic pregnancies16,23,23,24. Etiology of this 
low plasma volume was largely unknown. This study identifies four independent 
determinants of the total adult plasma volume: body composition (BMI), birth weight 
centile, daily exercise level and the glomerular filtration rate. 
Reduced plasma volume could be an interesting factor linking, at least partially, 
intra-uterine development with hypertension in adulthood and remote cardiovascular 
disease. One process associated with fetal disproportionate growth is the 
redistribution of blood flow in favor of the brain, heart and adrenal glands, but away 
from other organs including splanchnic organs and the kidneys12,25,26. Interestingly, 
the size of splanchnic organs and kidneys is reduced in children born small for 
gestational age12. Our data suggest that reduced size of the splanchnic vascular bed 
may have long lasting impact on adult plasma volume status.  
Kidneys of individuals born small for gestational age are known to contain fewer 
nephrons, a condition that is thought to initiate hypertension27,28 Nephrogenesis is 
completed relatively late in gestation by 34-36 weeks, increasing the impact of fetal 
compromise on renal development27,28. People with fewer nephrons are likely to have 
a relatively high glomerular filtration rate in each available nephron. Over time, hyper-
filtration may cause glomerular injury and ultimately glomerular loss and the 
development of hypertension27. In our study the glomerular filtration rate correlated 
with adult plasma volume. However the relationship between birth weight centile and 
subsequent adult plasma volume was independent of glomerular filtration rate. This 
does not rule out single nephron hyperfiltration. 
51
BIRTH WEIGHT AND ADULT PLASMA VOLUME
3
Our data concerning hemodynamic and metabolic variables are consistent with 
earlier studies4,7,30. We confirm an inverse relationship between blood pressure and 
birth weight centile. Demonstrating this association in a young (younger than 40 
years) female population that is considered to be healthy is remarkable. Our data 
indicates that women who were born small for gestational age and who have a history 
of hypertension in pregnancy, have lower cardiovascular reserve capacity (i.e. lower 
plasma volume) at comparable arterial demands (i.e. cardiac index) when compared 
with women born normal or large for gestational age.  Insulin levels were evidently 
higher in women born small for gestational age. We observed that women born small 
for gestational age and with a history of hypertension in pregnancy have an almost 
23% risk of metabolic syndrome compared to 10% in women born appropriate for 
gestational age with a similar obstetric history. 
Our data are applicable to selected population of women with a history of hypertensive 
complications in pregnancy. This could potentially amplify certain associations 
between birth weight centile and current metabolic and hemodynamic variables. 
However, this does not per se limit generalization of our results to the common female 
population of comparable age without a history of hypertension in pregnancy, as a 
recent cohort study of formerly preeclamptic women indicates that at least 
hemodynamic variables resolve largely within 6 months after giving birth, although 
further recovery may be possible up to 2 years post partum35. Furthermore differences 
in recent obstetric outcome did not affect the relation between birth centile and adult 
plasma volume.
In this study we used self-reported birth weight that could have resulted in a recall 
bias. Nonetheless, numerous studies in women with a comparable age (30-40 years) 
demonstrated a high accuracy of self-reported of birth weight (Spearman’s correlation 
with state birth records varied between: r=0.74 and r=0.85)36,37. Therefore, we feel 
that recall bias has not substantially affected our observations. Because we did not 
observe differences between those who were able to recall their own birth weight and 
those who were not, we do not expect exclusion of this latter group affected our 
results. This study was unable to explore all potential mechanisms explaining the 
relationship between birth centile and subsequent adult plasma volume. We have no 
data directly evaluating the sympathetic system, the renin-aldosterone-angiotensin 
pathway, or potential effects of the glucocorticoid axis. Effects of these systems are 
considered to relate inversely to the plasma volume38.  Because we excluded women 
using medication against chronic hypertension, a condition likely to accompany 
alterations in these axes, we assume no substantial bias from these systems on our 
findings. Nevertheless, we were unable to quantify their contribution to the adult 
plasma volume status in this study. Unfortunately we had no data concerning 
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abdominal circumference at birth, which might have reflected size of the splanchnic 
organs even better.
A particular strength of this the study is the measurement of plasma volume in a large 
cohort of women in combination with the many important covariates that might 
determine adult plasma volume. Resultingly, we were able to analyze or exclude the 
potential confounding effects of these covariates and eventually weigh the contribution 
of predictors of adult plasma volume. 
In conclusion, birth weight centile relates linearly to adult plasma volume in women 
with a history of hypertension in pregnancy. Future studies will have to elucidate the 
effects of interventions aimed at modifying plasma volume on the recurrence of 
hypertension in pregnancy and future cardiovascular disease. 
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Abstract
The objective of this study was to estimate whether recurrence risks of preeclampsia, 
preterm birth and fetal growth restriction relate to prepregnancy plasma volume.
We conducted a retrospective cohort study in 580 formerly preeclamptic women and 
controls. In all women we measured plasma volume (125Iodine-human serum albumin 
indicator dilution method) in the nonpregnant state. 178 normotensive formerly 
preeclamptic women had a subsequent pregnancy within study period (1996-2008). 
Odds (OR’s) for recurrent preeclampsia, preterm birth and small for gestational age 
infant (SGA) were estimated, using multivariable logistic regression with adjustment 
for confounders.
Plasma volumes were lower in women who developed recurrent preeclampsia (1241 
± 158 mL/m2, 17% lower compared with women in control group) than in women 
without recurrent preeclampsia (1335 ± 167 mL/m2, 11% lower compared with women 
in control group). Logistic regression analysis demonstrated that each 100 mL/m2 
difference in plasma volume was associated with an odds ratio of 0.6 [95%CI: 0.5-0.8] 
to develop recurrent preeclampsia in subsequent pregnancy. Risk of preterm delivery 
(before 37 weeks of gestation) depended on preeclampsia in subsequent pregnancy; 
the adjusted hazard ratio for preterm birth was 0.9 [95%CI: 0.7-1.1] for each 100-mL/m2 
change in plasma volume. Risk of delivering an SGA neonate was independent of 
recurrent preeclampsia. Each 100-mL/m2 change in plasma volume was associated 
with an adjusted odds ratio of 0.8  [95%CI: 0.5-0.9] to deliver a SGA neonate in 
subsequent pregnancy.  
The risk of recurrent preeclampsia and fetal growth restriction in subsequent 
pregnancy relates inversely and linearly to prepregnancy plasma volume.
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Introduction
Preeclampsia, preterm birth and fetal growth restriction contribute to substantial 
maternal and perinatal morbidity and mortality. Strategies to identify those women at 
increased risk for recurrence of these conditions will be helpful not only to assess the 
individual risk but also to develop tailored preventative approaches. 
The recurrence rate of preeclampsia is approximately 15%1-5, but figures range from 
11% up to 65% depending on the population studied1. The risk of developing 
gestational hypertension in the pregnancy after a preeclamptic pregnancy is 1 in 36. 
In normotensive apparently healthy formerly preeclamptic women, no single biomarker 
has been found clinically useful to predict recurrent preeclampsia, leaving preeclampsia 
in the first pregnancy the strongest predictor for preeclampsia in a subsequent 
pregnancy1,4. In comparison with hypertensive women, normotensive formerly 
preeclamptic women are considered to be at low risk for recurrent preeclampsia1.
Low plasma volume relates both to the early phase of essential hypertension and to 
hypertensive complications in pregnancy7-10. Subnormal plasma volume before 
pregnancy predisposes to abnormal hemodynamic adaptation during pregnancy9. 
Whether prepregnancy plasma volume contributes in a volume-dependent manner to 
the risk of recurrent preeclampsia is currently unknown. Moreover, it is unknown 
whether low prepregnancy plasma volume additionally relates specifically to the fetal 
sequellae of preterm birth and fetal growth restriction. In this study we tested the 
hypothesis that the risk of preeclampsia, preterm birth and fetal growth restriction 
relate proportionately and independently to prepregnancy plasma volume. To this 
end, we studied the maternal and neonatal outcomes of pregnancy as a function of 
prepregnancy plasma volume in normotensive formerly preeclamptic women and 
healthy parous controls. 
Materials and methods
We conducted a hospital-based retrospective cohort study among primiparous 
women. Patients were recruited from the postpartum outpatient clinic as well as from 
referrals to the tertiary center for preconceptional counseling (1996-2008). Healthy 
primiparous controls with an uneventful previous pregnancy were recruited by 
advertisement and measured within the timeframe of all measurements in patients 
(1998-2007). Women in the control group were included when previous pregnancy 
had no hypertensive complications, when women delivered at term and gave birth to 
a normal weight neonate. The same exclusion criteria were used in both the control 
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and case groups. Participants did not use hormonal contraceptives and had 
discontinued breastfeeding. In the analysis we included women who were normotensive 
and non-diabetic at the interpregnancy evaluation and whose next pregnancy was 
singleton. We excluded women with chronic hypertension, when either using antihy-
pertensive medication or having blood pressures exceeding 140 mmHg systolic or 
90 mmHg diastolic or both at the interpregnancy evaluation11. We excluded women 
with diabetes based on a nonpregnant fasting glucose level above 6.1 mmol/L at two 
separate occasions or the use of antidiabetic medication12. Finally, women who did 
not complete a next pregnancy within the study period were excluded (1996-2008). 
The study was approved by the hospital medical ethical committee (CMO2007/252).
All measurements in both patients and women in the control group were performed 
6 to 12 months after the first pregnancy in the nonpregnant state. Blood pressure was 
measured oscillometrically (Dinamap, Vital Signs Monitor) at the right-upper arm. 
We used the median values of 9 consecutive recordings at 3-minute intervals starting 
after 5 minutes at rest in supine position. Thereafter Plasma Volume (PV) was 
measured in the nonpregnant state using the Iodine125-human serum albumin 
(125I-HSA) indicator dilution method9, normalized for body surface area (mL/m2). 
During this measurement, participants lay in a semi-supine position on a comfortable 
bed. Subsequently a standardized dose 0.2 MBq of 125I-HSA was injected intravenously 
in the right antecubital vein. Each 10 minutes a venous blood sample was taken from 
the contralateral intravenous catheter until 40 minutes after administration of the 
125I-HSA. The person drawing blood for the plasma volume measurement was blinded 
to the blood pressures obtained in advance of the procedure. Blood samples were 
analyzed in specialized laboratory. Plasma volume was obtained by dividing the total 
injected radioactivity by the virtual volume-specific radioactivity at time zero. Data of 
previous and first subsequent pregnancies were extracted from the medical records. 
All formerly preeclamptic patients received acetylsalicylic acid (80mg/day) in their 
next pregnancy (12-36 weeks). We defined (gestational) hypertension and preeclampsia 
according to ACOG criteria11. Fetal growth restriction was defined as a birth weight 
below the 10th centile of the national birth weight chart13. We defined the interbirth 
interval as the time between the two delivery dates. 
Statistical analysis
Data are expressed as means ± SD or as medians with interquartile ranges for 
normally and nonnormally distributed data, respectively. Normality of each variable 
was evaluated using Kolmogorov-Smirnov tests. Comparisons between groups were 
assessed using unpaired Student t-test for normally distributed data, Mann-Whitney 
U test for nonnormally distributed variables and Chi-square test for categorical 
parameters. P-value < 0.05 (two-sided) is considered statistically significant.
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Pre-pregnancy plasma volumes (mL/m2) in women with recurrent preeclampsia 
(RECUR) and those without recurrent preeclampsia (NON-RECUR) were compared 
with the control group (CONTR) using analysis of variance along with post-hoc 
Bonferroni correction for multiple testing. 
To present our raw data, we categorized the formerly preeclamptic normotensive 
women into quintiles according to their prepregnancy normalized plasma volume. 
This illustrates in a simple way the risks of recurrent preeclampsia across the full 
range of prepregnancy plasma volumes. We used logistic regression to evaluate the 
relation between prepregnancy plasma volume and recurrent preeclampsia. 
Independent variables were plasma volume (mL/m2), history of recurrent miscarriage, 
history of the birth of a growth restricted neonate, the gestational age at previous 
delivery, the mean arterial blood pressure (at the interpregnancy evaluation), smoking 
and body mass index (BMI) at the inter-pregnancy measurement, maternal age at 
subsequent delivery and the interbirth interval. Independent variables were selected 
based on their known association with preeclampsia in parous women. Odds ratios 
are presented with their 95% confidence intervals [CIs].
Based on this analysis we calculated the odds ratio [±95%CI] of recurrent preeclampsia 
associated with each 100 mL/m2 change in prepregnancy plasma volume. Because 
all data were obtained over a long period (13 years), changes in medical management 
during pregnancy or otherwise could have had an effect on the outcome. Hence, we 
repeated the analysis with date of delivery in subsequent pregnancy as additional 
covariate and we evaluated whether the relation between the incidence of preeclampsia 
and the independent variables changed over time, that is, we evaluated the interaction 
between independent variables in the logistic regression model and year of delivery 
in subsequent pregnancy.
Analogous to the evaluation of the relation between plasma volume and subsequent 
recurrent preeclampsia we analyzed the risk of delivering a SGA neonate in 
subsequent pregnancy. The relation between pre-pregnancy plasma volume and the 
gestational age of delivery in subsequent pregnancy is illustrated with a Kaplan-Meier 
curve for each normalized plasma volume quintile. We used Cox regression analysis 
to analyze the duration of the subsequent pregnancy and calculated the hazard ratio, 
with 95% confidence intervals for preterm birth associated with each 100mL/m2 
change in plasma volume. The independent variables were the same as in the logistic 
regression model for recurrent preeclampsia. To explore whether the risks of 
delivering a SGA neonate or preterm birth or both were independent of preeclampsia 
in subsequent pregnancy, we introduced preeclampsia in subsequent pregnancy as 
an additional independent covariate into our models for SGA neonates and preterm 
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birth. The statistical analyses were performed using the statistical software package 
SPSS 16.0.
Results 
We measured plasma volume in 580 primiparous women with a history of preeclampsia 
during their first pregnancy. For the analysis we excluded 102 hypertensive patients 
(17.6%) and 4 women (0.7%) with diabetes mellitus. Sixteen patients (2.7%) could not 
be further analyzed as a result of missing values or uncertain diagnosis. Finally, we 
excluded 280 women (48%) who did not have a subsequent pregnancy within the 
study period or whose outcome for the next pregnancy was unknown at the time of 
analysis. A total of 178 normotensive, nondiabetic, formerly preeclamptic women 
(30.6%) were available for analysis. (Fig 1)
The demographic and obstetric data of normotensive formerly preeclamptic women 
with a subsequent pregnancy (n=178) compared with women without a subsequent 
pregnancy (n=280) are shown in Table 1. Compared with those without subsequent 
pregnancy, women with subsequent pregnancy were younger (30 ± 4 vs. 32 ± 5 years) 
and previously had delivered at a lower gestational age (median: 32 [29-35] vs. 34 
[31-36] weeks) of neonates with lower birth weight (1566 ± 855 vs. 1836 ± 872 g.). 
For all other variables, the groups were comparable.
Table 2 lists the demographic and obstetric variables in the normotensive formerly 
preeclamptic women with a subsequent pregnancy (FORMER PE) and healthy controls 
(CONTR). Compared with women in the control group, normotensive formerly 
preeclamptic women delivered in the previous pregnancy at a lower gestational age 
(32 ± 4 vs. 39 ± 1 weeks) of neonates with lower birth weight (1566 ± 855 vs. 3420 
±277 g.). At the interpregnancy measurements formerly preeclamptic women had 
higher body mass index (median: 24 [19-29] vs. 22 [18-26] kg/m2) and lower plasma 
volume (1307 ± 175 vs. 1503 ± 130 mL/m2). In the subsequent pregnancy, formerly 
preeclamptic women gave birth to neonates with lower birth weight compared with 
controls (3063 ± 730 vs. 3722 ± 600 g) and a higher rate of SGA neonates (12 vs. 0 %).
Thirty-four (19%; 95%CI: 13-25%) of the 178 normotensive formerly preeclamptic 
women developed recurrent preeclampsia (RECUR). The group without recurrent 
preeclampsia (NON-RECUR: 144 women, 81%) includes 55 women (31%; 95%CI: 
23-40%) who developed gestational hypertension without progressing to preeclampsia 
and 89 women (50%; 95%CI: 43-58%) who remained normotensive during their 
subsequent pregnancy. RECUR neither differed from NON-RECUR with respect 
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to gestational age of delivery and birth weight in previous pregnancy nor the 
interpregnancy body mass index, smoking and mean arterial pressure. RECUR only 
differed from NON-RECUR by lower plasma volume (1241 ± 158 mL/m2 versus 1335 
± 167 mL/m2) at the interpregnancy measurement. (Figure 2) Women in the RECUR 
group delivered in their subsequent pregnancy at an earlier gestational age (37 ± 3 
vs. 39 ± 2 weeks) and had a higher rate of SGA neonates (36% vs. 6 %). (Table 2)
 
Mean plasma volume is 17% lower in RECUR and 11% lower in NON-RECUR 
compared to controls. (1241 ± 158 vs. 1335 ± 167 vs. 1503 ± 130 mL/m2, respectively), 
as shown in Figure 2. Mean plasma volume in RECUR was significantly lower 
compared to NON-RECUR.  Within the NON-RECUR group, plasma volume was 
lower in women who developed gestational hypertension without progressing to 
preeclampsia compared with women who remained normotensive in subsequent 
pregnancy (1283± 154 vs. 1371 ± 170 mL/m2; P=0.002).
Figure 1  Schematic presentation of study population and excluded patients.
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Figure 3 presents the relation between the interpregnancy plasma volume and the 
risk of recurrent preeclampsia. Logistic regression analysis demonstrated that each 
100-mL/m2 change in plasma volume was associated with an odds ratio of 0.6 
[95%CI: 0.5-0.8] to develop recurrent preeclampsia in subsequent pregnancy. This 
indicates that as plasma volume increases, the recurrence risk of preeclampsia 
decreases proportionately (P<0.01). Inclusion of the date of delivery in the logistic 
regression model did not change the odds ratio. Neither did the interactions between 
Table 1   Demographic and clinical variables of the normotensive formerly 
preeclamptic women. 
 
Normotensive 
formerly 
preeclamptic 
women with 
subsequent 
pregnancy 
(n=178)
Normotensive 
formerly 
preeclamptic 
women without 
subsequent 
pregnancy 
(n=280)
P-value
Obstetric history
Miscarriage ≥2 times (%) 4 5 .59
Gestational age at delivery (weeks) 32 [29-35] 34 [31-36] <.01*
Birth weight (g) 1566 ± 855 1836 ± 872 <.01*
Small for gestational age (%) 29 28 .78
General characteristics 
Age (years) 30 ± 4 32 ± 5 <.01*
Body Mass Index (kg/m2) 24 [19-29] 24.9 [18-32] .06
Smoking (%) 22 23 .76
Fasting glucose levels (mmol/L) 5.1 ± 0.5 5.2 ± 0.8 .20
Non-pregnant hemodynamic variables
Systolic blood pressure (mmHg) 117 ± 10 116 ± 11 .15
Diastolic blood pressure (mmHg) 72 ± 8 71 ± 9 .42
Mean arterial pressure (mmHg) 89 ± 8 88 ± 9 .38
Heart rate (bpm) 70 ± 10 71 ± 9 .36
Plasma volume (mL/m2) 1317 ± 175 1338 ± 169 .19
Data are women with subsequent pregnancy (n=178) compared with women without subsequent 
pregnancy (n=280) within the study period. Normally distributed data is expressed as mean (± SD), 
non-normally distributed is indicated as medians [inter-quartile range]. Comparisons between groups 
based on unpaired Student t-test for normally distributed data, Mann-Whitney U test for non-normally 
distributed variables and Chi-square test for categorical parameters. (*P < 0.05).
65
PLASMA VOLUME AND RECURRENT PREECLAMPSIA
4
Ta
b
le
 2
   D
em
og
ra
ph
ic
 a
nd
 c
lin
ic
al
 v
ar
ia
bl
es
 fo
r c
on
tro
ls
 (C
O
N
TR
) a
nd
 n
or
m
ot
en
si
ve
 fo
rm
er
ly
 p
re
ec
la
m
pt
ic
 w
om
en
  
(F
O
R
M
E
R
 P
E
). 
P
E
 is
 s
ub
 g
ro
up
ed
 in
to
 w
om
en
 w
ith
ou
t r
ec
ur
re
nt
 p
re
ec
la
m
ps
ia
 (N
O
N
-R
EC
U
R
) v
s.
 w
om
en
 w
ith
  
re
cu
rr
en
t p
re
ec
la
m
ps
ia
 (R
EC
U
R
)
FO
R
M
ER
 P
E 
(n
=
17
8)
P
-v
al
ue
C
O
N
TR
 
(n
=
17
)
N
O
N
-R
E
C
U
R
 
(n
=
14
4)
R
E
C
U
R
 
(n
=
34
)
FO
R
M
E
R
 P
E
 v
s.
 
C
O
N
TR
R
E
C
U
R
 v
s.
  
N
O
N
-R
E
C
U
R
O
b
st
et
ric
 H
is
to
ry
M
is
ca
rr
ia
ge
 ≥
2 
tim
es
 (%
)
0
4
6
.2
8
.5
2
G
es
ta
tio
na
l a
ge
 a
t d
el
iv
er
y 
(w
ee
ks
)
40
[3
8-
41
]
32
[2
9-
36
]
31
[2
9-
36
]
<
.0
01
*
.1
7
B
irt
h 
w
ei
gh
t (
g)
34
20
±
27
7
15
98
±
88
6
14
41
±
71
8
.0
03
*
.3
3
S
m
al
l f
or
 g
es
ta
tio
na
l a
ge
 (%
) 
0
24
31
.0
09
*
.4
1
M
at
er
na
l C
ha
ra
ct
er
is
tic
s 
A
ge
 (y
ea
rs
)
32
±
2
30
±
4
30
±
4
.2
0
.8
2
B
od
y 
M
as
s 
In
de
x 
 (k
g/
m
2)
22
[1
8-
26
]
24
[1
9-
29
]
25
[1
7-
32
]
.0
03
*
.0
7
S
m
ok
in
g 
(%
)
13
24
15
.4
4
.2
5
N
on
-p
re
g
na
nt
 h
em
od
yn
am
ic
 v
ar
ia
b
le
s 
S
ys
to
lic
 b
lo
od
 p
re
ss
ur
e 
(m
m
H
g)
11
4±
10
11
7±
10
11
7±
10
.2
8
.5
8
D
ia
st
ol
ic
 b
lo
od
 p
re
ss
ur
e 
(m
m
H
g)
70
±
7
72
±
8
74
±
8
.5
4
.0
9
M
ea
n 
ar
te
ria
l p
re
ss
ur
e 
(m
m
H
g)
84
±
8
88
±
8
91
±
8
.0
7
.0
6
H
ea
rt 
ra
te
 (b
pm
)
68
[5
4-
82
]
71
[5
7-
85
]
72
[6
2-
82
]
.4
6
.2
6
P
la
sm
a 
vo
lu
m
e 
(m
L/
m
2 )
15
03
±
13
0
13
35
±
16
7
12
41
±
15
8
<
0.
00
1*
.0
03
*
C
ha
ra
ct
er
is
tic
s 
of
 s
ub
se
q
ue
nt
 p
re
g
na
nc
y
In
te
rb
irt
h 
in
te
rv
al
 (y
ea
rs
)
2[
1-
3]
3[
1-
5]
3[
1-
5]
.4
1
.3
2
G
es
ta
tio
na
l a
ge
 (w
ee
ks
)
41
±
2
39
±
2 
37
±
3
.1
.0
02
*
B
irt
h 
w
ei
gh
t (
g)
37
22
±
60
0
31
47
±
68
4
27
36
±
82
1
.0
04
*
.0
02
*
S
m
al
l f
or
 g
es
ta
tio
na
l a
ge
 (%
)
0
6
36
.0
4*
<
.0
01
*
N
or
m
al
ly
 d
is
tri
bu
te
d 
da
ta
 is
 e
xp
re
ss
ed
 a
s 
m
ea
n 
(±
 S
D
), 
no
n-
no
rm
al
ly
 d
is
tri
bu
te
d 
is
 in
di
ca
te
d 
as
 m
ed
ia
ns
 [
in
te
r-q
ua
rti
le
 r
an
ge
]. 
 C
om
pa
ris
on
s 
be
tw
ee
n 
gr
ou
ps
 b
as
ed
 o
n 
un
pa
ire
d 
S
tu
de
nt
 t-
te
st
 fo
r n
or
m
al
ly
 d
is
tri
bu
te
d 
da
ta
, M
an
n-
W
hi
tn
ey
 U
 te
st
 fo
r n
on
-n
or
m
al
ly
 d
is
tri
bu
te
d 
va
ria
bl
es
 a
nd
 C
hi
-s
qu
ar
e 
te
st
 fo
r c
at
eg
or
ic
al
 p
ar
am
et
er
s.
 (*
P 
<
 0
.0
5)
.
66
CHAPTER 4
Figure 2  Plasma volume (PV, mL/m2, ± 1SD) for nonpregnant women in the control group 
(CONTR) and normotensive formerly preeclamptic women who develop recurrent preeclampsia 
(RECUR) or those who do not develop recurrent preeclampsia (NON-RECUR). ANOVA with 
Bonferoni: * P<0.01
Figure 3  Risk of recurrent preeclampsia (percentage ± 1SEM) for each quintile of nonpregnant 
normalized plasma volume (mL/m2). The dashed line represents mean plasma volume in 
healthy controls (1503 mL/m2). The shaded area corresponds with one standard deviation of 
mean plasma volume in controls (130 mL/m2).
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the date of delivery in subsequent pregnancy and the risk factors in the model show 
an association with the incidence of recurrent preeclampsia. The decrease in the log 
likelihood that resulted from including the nine interactions in the model was 3.9 
(p=0.92). 
In our study, 111 normotensive formerly preeclamptic women (62.4%) had normal 
weight (BMI 25 or lower) at the interpregnancy evaluation, whereas 50 women (28.1 %) 
were overweight (BMI: 25-30), 13 women (7.3%) were obese (BMI 30-35) and 4 
women (2.2%) morbidly obese (BMI more than 35). Recurrence rates of preeclampsia 
were 15.3 % in normal weight, normotensive formerly preeclamptic women, 26% in 
overweight women (OR1.9; 95%CI 0.9-4.4) and 30.8% in obese women (OR2.5; 
95%CI 0.8-8.9). There was no recurrent preeclampsia in the 4 women who were 
morbidly obese at the interpregnancy evaluation.
Kaplan Meier curves illustrate the relation between plasma volume quintiles and 
gestational age of delivery in next pregnancy (Figure 4). Cox regression analysis 
demonstrated that each 100-mL/m2 change in plasma volume is associated with a 
hazard ratio of 0.9 (95%CI: 0.7-1.1) of preterm delivery (<37 weeks gestation) in 
subsequent pregnancy. Regression analysis demonstrated a confounding effect of 
Figure 4  Kaplan-Meier curves illustrating the relation between quintiles of pre-pregnancy 
plasma volume (mL/m2) and gestational age of delivery in subsequent pregnancy. The vertical 
line represents the gestational age of 37 weeks.
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preeclampsia in subsequent pregnancy on the risk of preterm birth. Casewise 
analysis of the nature of preterm delivery in the subsequent pregnancy in formerly 
preeclamptic women demonstrated that only 8.6% of the preterm births were 
spontaneous. The remaining 91.4% were all indicated preterm births due to either 
gestational hypertensive disease or fetal growth restriction or both, explaining the 
large confounding effect of preeclampsia in subsequent pregnancy on the relation 
between prepregnancy plasma volume and risk of preterm birth. 
Logistic regression analysis demonstrates that each 100-mL/m2 change in plasma 
volume is associated with an adjusted OR of 0.8 (95%CI: 0.5-0.9) to deliver a neonate 
small for gestational age in subsequent pregnancy. This indicates that as plasma 
volume increases, the risk of a growth restricted neonate decreases proportionately 
(P<0.01) independent of preeclampsia in subsequent pregnancy. 
Discussion
This study indicates that in apparently healthy normotensive formerly preeclamptic 
women, the risk of recurrent preeclampsia and fetal growth restriction in the 
subsequent pregnancy inversely and linearly relates to prepregnancy plasma volume. 
In our study, 1 out of 5 normotensive women developed recurrent disease, whereas 
preeclampsia is reported to recur in approximately 1 out of 7 pregnancies1-5. The 
magnitude of recurrence risk is considered to be dependent on prior gestational age 
at time of previous disease onset, severity of disease, previous fetal growth restriction, 
and presence or absence of pre-existing hypertension and other medical disorders. 
This makes individual counseling difficult because the recurrence rate may vary 
between 1 of 9 and 2 of 31,3-6. Numerous factors can explain the relatively higher 
recurrence rate in our study group, despite the fact that all women were normotensive. The 
concept of a higher recurrence risk in women who delivered at an earlier gestational 
age in a previous pregnancy complicated by preeclampsia is well established4,5. 
Reported recurrence rates decrease from 39% in those who deliver before 28 weeks 
gestation to 13% in women delivering at term5. Also previous birth of an SGA neonate 
is associated with an increased recurrence risk of preeclampsia (aOR1.7; 95%CI 
1.4-2.1) compared witht women who gave birth to an appropriate sized neonate for 
gestational age4. Because we included primarily early-onset preeclamptic women, 
with 29% of the women giving birth to an SGA neonate in an earlier pregnancy, 
recurrence rate of preeclampsia is likely to be high in our studied group.  
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Our study demonstrates a gradient in plasma volume per body surface area between 
NON-RECUR who remain normotensive in subsequent pregnancy, NON-RECUR 
who develop gestational hypertension without progressing to preeclampsia in 
subsequent pregnancy and women who develop recurrent preeclampsia (RECUR). 
This suggests a certain continuum in the pathophysiological development of 
hypertensive disease during pregnancy depending on plasma volume status.  
    
In healthy persons, plasma volume remains relatively constant as a result of tight 
regulation by the complex interaction between neurohormonal systems involved in 
sodium and water homeostasis. Important mechanisms involved in the plasma 
volume regulation are the sodium- and water-retaining effects of the renin angiotensin 
aldosterone system (RAAS), the diuretic effects of natriuretic peptides in response to 
atrial and ventricular wall stretch and actions of the sympathetic nervous system. The 
sympathetic system acts on plasma volume through a range of effects on both 
kidneys and vasculature,14 the latter in particular by acting on the functional venous 
capacitance. In our study, the plasma volumes measured in the healthy controls (PV: 
1503 ± 130 mL/m2) compares well with plasma volumes (PV:1521 ± 180 mL/m2) 
measured by Bernstein et al in healthy women of comparable age and BMI15. 
Plasma volume relates to BMI16. Although recurrence risk of preeclampsia may vary 
with higher BMI, we were unable to demonstrate such correlation4. This could be the 
result of a type 2 error. Others proposed a pathophysiologic connection between 
obesity, insulin resistance and preeclampsia, with a central role of increased activity 
of the sympathetic nervous system17. Increased sympathetic tone decreases plasma 
volume by reducing the vascular capacitance15. In turn, this may link low plasma 
volume to obesity and in particular the metabolic syndrome. In our study, plasma 
volume related to recurrent preeclampsia even after adjustment of prepregnancy 
BMI, indicating that the relationship between plasma volume and recurrent 
preeclampsia is independent of prepregnant BMI. There are several possible 
explanations for this observation. First, increased sympathetic tone is particularly 
associated with central obesity in contrast to peripheral obesity18. This is not always 
well reflected in the BMI. Unfortunately, we did not record data that could discriminate 
between central and peripheral obesity. Second, also other factors, not necessarily 
linked to the metabolic syndrome, may relate to low plasma volume. A fundamentally 
small vascular system, in line with the Barker hypothesis19, might also account for low 
plasma volume. Future studies will have to elucidate the exact mechanisms resulting 
in low plasma volume. 
Few studies have investigated the pathophysiologic connection between plasma 
volume and preeclampsia. At normal cardiac functioning, the plasma volume reflects 
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the cardiovascular reserve capacity. Healthy maternal vascular adaptation in the first 
trimester of pregnancy includes adequate plasma volume expansion to meet the 
increased demands of advanced pregnancy20,21. Early pregnancy plasma volume 
expansion is triggered by a primary fall in systemic vascular tone9, 21. Women with low 
prepregnancy plasma volume show, as a consequence of venous overfill, little rise in 
plasma volume during the early phases of pregnancy compared with women with 
normal prepregnancy plasma volume9,22. Inherent to this low-volume condition is the 
necessity for more sympathetic activity to preserve venous return, restricting the 
reserve capacities even more and leading to arterial vasoconstriction, circulatory 
redistribution, increased vascular shear and with it endothelial dysfunction2,8,9,15,23. 
Low plasma volume therefore precedes vascular complicated pregnancy. This 
circulatory condition extents even to the nonpregnant state7,9, making plasma volume 
a potentially valuable tool in assessing individual risk in advance of the next 
pregnancy. This pathophysiologic link is strengthened by the observation of 
circulatory redistribution in nonpregnant women with reduced plasma volume at the 
expense of uterine perfusion24. This circulatory redistribution, in turn, may negatively 
affect fetal growth. Our study demonstrates both maternal and fetal consequences of 
low pre-pregnant plasma volume. 
In contrast to many other factors associated with increased recurrence risk of 
preeclampsia, prepregnancy plasma volume is particularly interesting since it is 
potentially modifiable in advance of the next pregnancy. Aerobic exercise is well 
known for its plasma volume expanding effect. This effect is initially established 
mainly through activation of the Renin-Angiotensin-Aldosterone system resulting in 
sodium retention25,26, and if training is continued through de novo protein synthesis, 
increasing oncotic intravascular pressure25,26, and at sustained training also by 
lowering sympathetic tone27 and increasing venous compliance28. Individuals who 
perform regular physical activity can increase their plasma volume approximately 
10%25,26. In our study group the difference in prepregnancy plasma volume between 
RECUR and NON-RECUR is about 8%. Future research may demonstrate whether a 
training program with regular aerobic exercise, aimed at increasing plasma volume, 
reduces recurrence risk of preeclampsia in formerly preeclamptic women with low 
plasma volume.
Besides the observational hospital based design, this study has several limitations. 
First, the study is restricted to a specific group of normotensive formerly preeclamptic 
women with two successive pregnancies within our study period. The largest 
excluded group (women without a subsequent pregnancy within the study period) 
only differed from the included group by the maternal age, the gestational age of 
delivery and neonatal birth weight in previous pregnancy. Therefore, our study 
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population forms a reasonable representation of the initial population of normotensive 
formerly preeclamptic women. Second, the control group is small, therefore discrete 
differences between controls and other groups could have been missed. The controls 
however, are only used to illustrate the normal spectrum of plasma volume, and were 
not used for the main study outcome describing the relation between prepregnant 
plasma volume and recurrence risk of preeclampsia. Third, we have no data 
concerning change of paternity. Change of paternity may be a modifier of the risk of 
preeclampsia in parous women, but also relates to larger interpregnancy interval1,3-6. 
Since the mean interbirth interval in our study is only 3 years, we don’t expect that 
possible change of paternity has contributed to our observations. Last, in this study 
we included women who were referred to a tertiary center. This may have led to over-
representation of more severely complicated pregnancies. However, the strongest 
denominator of severity, gestational age at delivery in previous preeclamptic 
pregnancy, did not affect the relation between plasma volume and subsequent 
pregnancy outcomes. Therefore, we assume our data represent formerly preeclamptic 
women in general, independent of onset of disease in previous pregnancy. 
In summary, our results demonstrate that in normotensive formerly preeclamptic 
women, the risk of recurrent preeclampsia and fetal growth restriction in subsequent 
pregnancy independently increase with lower prepregnant plasma volumes.
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Abstract
Formerly preeclamptic women are at risk for cardiovascular disease. Low plasma 
volume may reflect latent hypertension and potentially links preeclampsia with chronic 
cardiovascular disease. We hypothesized that low plasma volume in normotensive 
formerly preeclamptic women predisposes to hypertension. 
We longitudinally studied n=104 formerly preeclamptic women in whom plasma volume 
was measured 3 to 30 months after the preeclamptic pregnancy. Cardiovascular 
variables were assessed at two points in time (3 to 30 months postpartum and 2-5 
years thereafter). Study population was divided into low plasma volume (≤1373mL/
m2) and normal plasma volume (>1373mL/m2). Primary endpoint was hypertension 
at the second visit; defined as ≥140 mmHg systolic or ≥90 mmHg diastolic. Secondary 
outcome of this study was change in traditional cardiovascular risk profile between 
visits. Variables correlating univariately with change in blood pressure between visits 
were introduced in regression analysis.
 
Eighteen of 104(17%) formerly preeclamptic women who were normotensive at first 
visit had hypertension at second evaluation 2 to 5 years later. Hypertension developed 
more often in women with low plasma volume (10/35(29%)) than in women with 
normal plasma volume (8/69(12%); OR: 3.2 [95%CI: 1.4-8.6]). After adjustments, 
relationship between plasma volume status and subsequent hypertension persisted 
(aOR: 3.0 [95%CI: 1.1-8.5]). Mean arterial pressure at second visit correlated inverse 
linearly with plasma volume (r=-0.49, P<.01). 
Initially normotensive formerly preeclamptic women have 17% chance to develop 
hypertension within five years. Women with low plasma volume have higher chance 
to develop hypertension than women with normal plasma volume. Clinically, follow-up 
of blood pressure seems warranted in women with history of preeclampsia, even 
when initially normotensive. 
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Introduction
Preeclampsia (PE) is a serious hypertensive pregnancy disorder complicating 2 to 
5% of all pregnancies. Preeclampsia is characterized by hypertension and proteinuria 
after 20 weeks gestation. Women with a history of preeclampsia are at increased risk 
to develop early onset cardiovascular disease (CVD) later in life compared to women 
who had an uneventful pregnancy1. Therefore, in 2011, the American Heart Association 
added preeclampsia to the list of risk factors for developing CVD2. The mechanistic 
explanation for the link between preeclampsia and later CVD remains to be 
elucidated3. 
Numerous studies demonstrated increased prevalence of cardiovascular risk factors 
after a pregnancy complicated by preeclampsia4-6. Most formerly preeclamptic women, 
however, do not demonstrate a traditional cardiovascular risk profile within the first 
years following preeclampsia6. Yet, when compared to healthy parous controls, the 
relative risk of developing chronic hypertension within 15 years after preeclampsia 
is estimated 3.7 [95% CI: 2.7-5.5]1. This observation indicates that a subset of 
normotensive formerly preeclamptic women is at risk to develop hypertension within the 
first years following the affected pregnancy. It is conceivable that these formerly 
preeclamptic women have subtle or latent abnormalities that could explain the 
increased cardiovascular risk after pregnancy.
Low plasma volume (PV) is considered to reflect latent hypertension7 and normotensive 
formerly preeclamptic women with low PV (LPV) are prone to develop recurrent 
hypertensive disease in subsequent pregnancy8. Whether PV status also relates to 
chronic hypertension after a pregnancy complicated by preeclampsia has never 
been studied before. We hypothesized that LPV status in normotensive formerly 
preeclamptic women predisposes to the development of hypertension. In this 
longitudinal study, we additionally studied how the traditional cardiovascular and 
metabolic risk profiles evolve over time after a preeclamptic pregnancy.
Marterials and methods
In this study we used a database of women with a history of preeclampsia (n=386) 
who had been tested twice in the years following their preeclamptic pregnancy. We 
selected women who were normotensive and apparently healthy at their first 
assessment 3 to 30 months post partum. Reassessment of the cardiovascular and 
metabolic risk profile took place prospectively 2 to 5 years after the initial assessment.
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Preeclampsia was defined according the criteria set by the International Society for 
the Study of Hypertension in Pregnancy (ISSHP)9 (systolic blood pressure (SBP) 
≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg, measured twice, 
> 6 hours apart, plus consistent proteinuria of ≥ 300 mg in 24 hours or protein to 
creatinine ratio > 30 g/mol after gestational week 20 in previously normotensive 
women. All formerly preeclamptic women included in the database were of Northern 
European Ancestry and completed a cardiovascular evaluation 3 to 30 months after 
their complicated pregnancy (visit 1) in the period January 2008 - December 2010. 
A follow-up program was started in 2011 and all women were invited for reassessment 
of their cardiovascular risk profile (visit 2) at 2 to 5 years after the first visit. For this 
study we compared data from both assessments. 
Both cardiovascular evaluations were performed in the nonpregnant state at least 
three months postpartum and all women had discontinued breastfeeding for at least 
4 weeks. Women who were hypertensive at the first assessment were excluded. 
Hypertension was defined as SBP ≥ 140 mmHg and/ DBP ≥ 90 mmHg, or when 
taking antihypertensive drugs. Also excluded from analysis were women diagnosed 
with diabetes mellitus (type 1 or 2), or autoimmune diseases at the first visit. Women 
were only invited for the second cardiovascular assessment when at least 2 years 
after the initial evaluation.
The study was approved by the Medical Ethics Committee of the Radboud University 
Medical Centre Nijmegen (CMO 2010/245) All women gave written informed consent. 
This study adhered to the principles of the declaration of Helsinki. 
Experimental procedures
PV was measured only during visit 1, and not during visit 2. All other measurements 
were performed at both visits according identical protocol. 
The plasma volume (PV, mL) indicates the total blood volume minus the cellular 
volume and was measured using the golden standard method:  the iodine125 albumin 
indicator dilution technique (125I-HSA). During the measurement, women were in 
semi-supine position on a comfortable bed. An 18-gauge intravenous catheter was 
inserted in the left antecubital vein for repetitive blood sampling. A standardized dose 
(0.2 MBq) of 125I-HSA was injected intravenously in the right antecubital vein. Every 10 
minutes a venous blood sample was taken from the contra lateral intravenous catheter 
until 40 minutes after administration of the 125I-HSA. Blood samples were analyzed 
using a gamma counter. PV was calculated by dividing the total injected radioactivity 
by the virtual volume specific radioactivity at time zero, as described elsewhere8. PV 
was normalized for body surface area (mL/m2). Plasma volume was categorized into 
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2 groups based on measurements in control group: low plasma volume (LPV): ≤ 1373 
mL/m2 corresponding with ≤ -1SD below mean plasma volume in control subjects; 
and normal plasma volume (NPV): >1373 mL/m2 equivalent to > -1SD of controls.  
At each visit a detailed history of complaints including family history was taken. A positive 
family history of CVD, hypertension or diabetes was defined as having at least one 
first-degree relative who was diagnosed with any of these conditions before the age 
of 65 years. All measurements were performed after an overnight fast and scheduled 
between day 3 and 11 of the menstrual cycle to minimize possible endocrine influences 
of the sex hormones on the cardiovascular system.10 The measurements started at 
8.00 AM to prevent diurnal variations between measurements in a temperature 
controlled room (≈22 ºC) with external disturbances kept to a minimum. Participants 
were instructed to abstain from strenuous physical activity in the 24 hours prior to 
testing. Participants collected urine for 24 hours preceding the measurements. The 
24 hours urine sample was assayed for albumin, protein and creatinine to establish 
(micro-) albuminuria corrected for creatinine output (g/mol creatinine) and total protein 
concentration (g/24hrs) (Aeroset, Abbot Laboratories, Illinois USA). Body weight and 
height were measured. Body mass index (BMI, kg/m2) was calculated as body weight 
(kg) divided by squared height (m2), body surface area (BSA, m2) as 0.007184·height 
(cm)0.725·weight (kg)0.425.11 
After 30 minutes of rest in semisupine position, blood pressure and HR were 
measured oscillometrically (Dinamap, Vital Signs Monitor 1846, Critikon, Tampa, 
Florida) in this half-sitting position, with the cuff at the right upper arm at heart level at 
3-minute intervals for a period 30 minutes with a cuff size recommended for the arm 
circumference (13.5x30.7cm if arm circumference ranged between 27.5 and 36.5cm 
or 17x38.6cm if arm circumference ranged between 35.5 and 46cm). We recorded 
systolic (SBP,mmHg), diastolic (DBP,mmHg) and mean blood pressure (MBP, mmHg) 
and heart rate (HR,bpm), and used the median values of 9 consecutive measurements 
for analysis. Hypertension was defined as SBP ≥140mmHg and DBP ≥ 90mmHg. 
Venous blood samples were taken from an antecubital vein and analyzed for glucose, 
insulin, lipid profile, and creatinine concentration (Aeroset, Abbot Laboratories, Illinois 
USA). The Homeostatic Model Assessment (HOMA) score was used to calculate the level 
of insulin resistance with the following equation: (fasting glucose x fasting insulin)/22.5. 
Statistical analysis
Normally distributed data are presented as means ± SD, non-normally distributed 
data as medians with interquartile range. Differences between groups were tested 
using ANOVA statistics, Wilcoxon ranks sum or Chi-square tests where appropriate. 
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Associations of variables with change in mean blood pressure between assessments 
were explored using univariate analysis (Spearman-Rho). All variables with significant 
association (p<0.05) with change in blood pressure between two assessments were 
subsequently included in a multivariate regression model. For the multivariate 
analyses, we used stepwise backward elimination on the basis of Wald’s test, using 
a p-value of 0.05 for elimination of variables. The NPV group was used as statistical 
reference group. Group-size calculation was estimated based on combining the 
observed occurrence of hypertension within 12 months (25%)9 and within 15 years 
(52%)1 after preeclampsia. It was estimated that 12% of initially normotensive formerly 
preeclamptic women develop de novo hypertension within 5 years. To compensate 
for possible errors in the estimation we based our sample size calculation on a 
prevalence of only 10% chronic hypertension in women 2 to 5 years after a pregnancy 
complicated by preeclampsia. In the general Dutch population the prevalence of 
hypertension in women of similar age is: 3.7%. Using this percentage as a reference, 
than the study population would need at least 98 subjects to detect 10% chronic 
hypertension with a power of 80% and alpha of .05. All computations were performed 
using SPSS version 20.0. 
Results
From 386 formerly preeclamptic women who completed a cardiovascular evaluation 
after a preeclamptic pregnancy (visit 1), 104 (27%) women were eventually included 
in the final analysis. As shown in Figure 1, 183 women met the exclusion criteria 
(Figure 1). The remaining 203 normotensive apparently healthy formerly preeclamptic 
women were eligible and therefore invited for the second assessment (visit 2). At time 
of analysis, 99 out of the 203 (49%) eligible women were lost to follow-up. 
The first cardiovascular and metabolic assessment was at a median of 7 months 
after the index pregnancy (interquartile range: 6-11 months) and the median interval 
between visits was 47 months (interquartile range: 42-53 months). Consequently, 
the median interval between delivery and second assessment was 55 months 
(interquartile range: 50-65). 
The characteristics of the 104 women included in the final analysis are shown in 
Table 1. Women who were eligible, but not available at follow-up (n=99) were less 
often primiparous (79 vs. 94%), delivered at a later gestational age (35 vs. 33 weeks) 
of heavier infants (2149 vs. 1945 g) and had less often a positive first-degree family 
history for hypertension (54 vs. 63%) and/or cardiovascular disease (25 vs. 42 %). 
Thirty-five of the 104 included women (34%) had LPV at the first visit.
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Table 2 shows the characteristics of the 104 formerly preeclamptic women who were 
normotensive at the first visit and either stayed normotensive (n=86; 83%) or developed 
hypertension (n=18; 17%) 2 to 5 years later. Women who developed hypertension 
when compared with women who remained normotensive were comparable for all 
measured variables at the first visit except for a significantly lower mean plasma 
volume (1322 vs. 1509 mL/m2). In women who stayed normotensive 25/86 (29%) had 
LPV, in contrast to 10/18 (56%) women who developed hypertension (P=.03). Average 
systolic, mean and diastolic blood pressures were slightly, but not significantly, higher 
in women destined to develop hypertension (123 vs. 119; 92 vs. 88 and 75 vs. 72 mmHg, 
respectively). 
The majority of women in both groups had a second pregnancy between the two 
visits. Outcomes of these pregnancies were comparable, although gestational hyper- 
tension in the next pregnancy tended to occur more often in women who subsequently 
developed de novo hypertension (73 vs. 45%). 
Figure 1   Flowchart of women included and excluded from retrospective analysis.  
Exclusions are shown in gray boxes.
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Table 1   Characteristics of normotensive formerly preeclamptic women at 3 to  
30 months following a preeclamptic pregnancy (visit 1).
Characteristics Included in 
analysis (n=104)
Lost to follow-up 
(n=99)
P-value
Obstetric history
Primiparous (n/N (%)) 97/104 (94) 78/99 (79) <.01
Gestational age at delivery index 
pregnancy (weeks)
33 (30-38) 35 (32-40) <.01
Birth weight at index pregnancy (g) 1945 (1090-2795) 2149 (1602-3265) .01
Birth weight centile at index pregnancy 22 (5-37) 27 (9-44) .18
Baseline characteristics
Interval index pregnancy to visit 
1(months)
7 (6-11) 8 (6-12) .67
Age (years) 32±4 33±5 .49
Smoking (n/N (%)) 18/104 (17) 18/99 (18) .42
BMI (kg/m2) 24±6 25±6 .12
Systolic blood pressure (mmHg) 120±10 119±10 .18
Diastolic blood pressure (mmHg) 72±7 70±9 .28
Mean blood pressure (mmHg) 88±7 87±8 .32
Heart rate (bpm) 69±9 72±10 .10
Plasma volume (mL/m2) 1476±200 1492±171 .28
Low plasma volume (n/N (%)) 35/104 (34%) 32/99 (32%) .68
Cholesterol (mmol/L) 4.6±0.9 4.7±0.7 .44
HDL (mmol/L) 1.4±0.3 1.4±0.3 .68
LDL (mmol/L) 2.8±0.7 2.9±0.7 .57
Triglycerides (mmol/L) 1.0±0.5 1.1±0.3 .38
Creatinine (micromol/L) 67±7 67±7 .72
Microalbuminuria (gmol/creat) 1.6 (0.6-5.8) 1.5 (0.6-5.2) .37
Proteinuria (g/24 hrs) 0.09 (0.06-0.13) 0.09 (0.05-0.14) .46
Family history (1st degree)†
Hypertension (n/N (%)) 64/101 (63) 53/98(54) <.01
Cardiovascular disease (n/N (%)) 42/101 (42) 34/96 (35) .02
Diabetes (n/N (%)) 45/101 (45) 40/97 (41) .30
Data are n/N, mean ± standard deviation, or median (interquartile range). Statistics χ2, Student t, or Wilcoxon 
ranks sum test. BMI indicates body mass index, HDL: High density lipoprotein, LDL: Low density lipoprotein, 
PV: plasma volume. *Low Plasma Volume: PV≤1373 mL/m2.  †In 6 subjects, family history was missing or 
incomplete.
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Table 2   Characteristics of formerly preeclamptic women at 3 to 30 months 
post-partum (visit 1) and 2 to 5 years after the initial visit (visit 2), divided 
between persistently normotensive women and women who developed 
hypertension during follow-up. 
Characteristics Women 
persistently 
normotensive 
(n=86)
Women 
developing 
hypertension 
(n=18)
P-value
Obstetric history
Primiparous (n/N (%)) 82/86 (95%) 17/18 (94%) .76
Gestational age at delivery index 
pregnancy (weeks)
34 (30-39) 33 (29-38) .80
Birth weight at index pregnancy (g) 1845 (1570-2500) 1420 (1030-2775) .27
Birth weight centile at index pregnancy 20 (7-42) 12 (5-33) .12
Characteristics at first follow-up visit
Interval index pregnancy and visit  
1 (months)
7 (6-11) 9(7-15) .34
Age (years) 32±4 33±3 .48
 Smoking (n/N (%)) 14/86 (16) 3/18 (17) .62
BMI (kg/m2) 24±6 24±4 .90
Systolic blood pressure (mmHg) 119±10 123±10 .13
Diastolic blood pressure (mmHg) 72±7 75±6 .03
Mean blood pressure (mmHg) 88±7 92±5 .02
Heart rate (bpm) 68±9 69±11 .72
Plasma volume (mL/m2) 1509±191 1322±176 <.01
Low plasma volume (n/N (%) 25/86 (29) 10/18 (56) .03
Fasting insulin (mU/L) 9.2±3.9 10.7±3.8 .16
HOMA-IR 2.0±0.9 2.4±1.0 .07
Cholesterol (mmol/L) 4.7±0.9 4.6±0.8 .79
HDL (mmol/L) 1.4±0.3 1.4±0.3 .87
LDL (mmol/L) 2.9±0.7 2.6±0.5 .22
Triglycerides (mmol/L) 1.0±0.5 1.1±0.4 .41
Creatinine (micromol/L) 67±8 66±6 .64
Microalbuminuria (gmol/creat) 1.5 (0.6-4.1) 1.8 (0.8-5.4) .14
Proteinuria (g/24 hrs) 0.09 (0.06-0.12) 0.09 (0.07-0.14) .22
Family history (1st degree)†
Hypertension (n/N (%)) 63/84 (62) 12/17 (71) .43
Cardiovascular disease (n/N (%)) 44/84 (43) 7/17 (41) .77
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Table 2   Continued. 
Characteristics Women 
persistently 
normotensive 
(n=86)
Women 
developing 
hypertension 
(n=18)
P-value
Family history (1st degree)†
Diabetes (n/N (%)) 45/84 (44) 8/17 (47) .45
Pregnancy after first follow-up visit?
No pregnancy (n/N (%)) 20/86 (23) 3/18 (17) .33
Normotensive pregnancy (n/N (%)) 36/66 (55) 4/15 (27) .08
Gestational hypertension (n/N (%)) 30/66 (45) 11/15 (73) .08
Preeclampsia (n/N (%)) 13/66(20) 5/15 (33) .30
Characteristics at second follow-up visit
Interval index pregnancy to visit  
2 (months)
54 (48-64) 60 (55-73) .02
Interval between visits (months) 46 (42-52) 50(48-55) .02
Age (years) 35±3 36±3 .27
BMI (kg/m2) 25±6 26±6 .48
Systolic blood pressure (mmHg) 115±11 141±5 <.01
Diastolic blood pressure (mmHg) 71±8 89±8 <.01
Mean blood pressure (mmHg) 85±7 106±6 <.01
Heart rate (bpm) 67±11 68±10 .63
Fasting glucose (mmol/L) 4.7±0.4 5.1±0.8 <.01
Fasting insulin (mU/L) 9.8±5.3 11.3±4.7 .26
HOMA-IR 2.1±1.2 2.6±1.3 .07
Cholesterol (mmol/L) 4.6±0.7 4.5±0.7 .50
HDL (mmol/L) 1.3±0.3 1.3±0.2 .29
LDL (mmol/L) 2.9±0.7 3.0±0.5 .73
Triglycerides (mmol/L) 0.9±0.5 1.0±0.4 .65
Creatinine (micromol/L) 65±9 67±6 .62
Microalbuminuria (gmol/creat) 1.5 (0.4-5.2) 1.9 (0.7-6.6) .87
Proteinuria (g/24 hrs) 0.07 (0.04-0.15) 0.11 (0.07-0.18) .80
Data are n/N, mean ± standard deviation, or median (interquartile range). Statistics χ2, Student t, or 
Wilcoxon ranks sum test. BMI indicates body mass index, BP: blood pressure, HDL: High density 
lipoprotein, LDL: Low density lipoprotein, PV: plasma volume. *Low Plasma Volume: PV≤1373 mL/m2. 
†In 3 subjects, family history was unavailable.
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At the second cardiovascular evaluation most women who qualified as hypertensive 
had blood pressures just above the cutoff values for hypertension. Average systolic 
blood pressure in the hypertensive group was 141±4 mmHg, mean blood pressure 
106±6mmHg and diastolic blood pressure 89±8 mmHg. In the persistently normo- 
tensive women average values were systolic 115±11mmHg, mean 85±7 and diastolic 
71±8 mmHg. Women who developed hypertension had higher mean blood glucose 
levels at the second visit than women who remained normotensive (5.1±0.8 vs. 
4.7±0.4 mmol/L; P<.01). Otherwise groups were metabolically comparable.
Mean arterial blood pressure at the second cardiovascular visit related inverse linearly 
to normalized plasma volume measured at the first visit (mL/m2) (r=-0.49, P<.01). 
Women with lowest PV at the first follow-up visit had highest mean arterial blood 
pressure at the second follow-up 2 to 5 years thereafter (Figure 2). Change in mean 
arterial blood pressure between the two visits did not only correlate with PV, but also 
with positive first-degree family history for hypertension (r=0.23; P=0.02) and diastolic 
blood pressure at the first visit (r=0.21; P=0.03) (Table 3).
Figure 2  Inverse linear relationship of mean arterial pressure at visit 2 as a function of normalized 
plasma volume at visit 1 in formerly preeclamptic women. All women by selection were normotensive 
at the time of plasma volume measurement.
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Table 3   Correlation coefficients of co-variables with change in mean  
blood pressure between the two assessments in initially normotensive 
formerly preeclamptic women.
Characteristics Correlation 
coefficient (r)
P-value
General characteristics at first visit
Age (years) 0.10 .33
Smoking (yes/no) 0.13 .14
BMI (kg/m2) 0.07 .45
Change in weight (kg) between visits
First degree relative with hypertension (yes/no)
0.14
0.23
.10
.02 
Hemodynamic characteristics at first visit
Systolic blood pressure (mmHg) 0.03 .75
Diastolic blood pressure (mmHg) 0.21 .03
Mean blood pressure (mmHg) 0.12 .21
Heart rate (bpm)
Plasma volume (mL)
Plasma volume (mL/m2)
0.05
-0.26
-0.32
.60
<.01
<.01
Metabolic characteristics at first visit
Fasting glucose (mmol/L) 0.10 .31
Fasting insulin (mU/L) 0.12 .24
Cholesterol (mmol/L) -0.02 .84
HDL (mmol/L) 0.04 .70
LDL (mmol/L) -0.11 .25
Triglycerides (mmol/L) 0.03 .80
Time interval
Interval index-pregnancy to visit 1 (months)
Interval between visits (months)
0.13
0.11
.18
.27
Interval index-pregnancy to visit 2 (months) 0.11 .25
BMI indicates body mass index, BP: blood pressure, HDL: High density lipoprotein, LDL: Low density 
lipoprotein
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When study group was divided based on PV status, chance of developing 
hypertension after preeclampsia was 10 of 35 (29%) in women with LPV status and 8 
of 96 (12%) in women with NPV status (OR: 3.2 [95%CI: 1.4-8.6]) (Table 4). When 
adjusted for possible confounders like family history for hypertension and diastolic 
blood pressure at first visit the relationship between PV and developing hypertension 
after preeclamptic pregnancy persisted (aOR: 3.0 [95%CI: 1.1-8.5]). 
Discussion
This study demonstrates that 1 out of 6 (17%) formerly PE women who are 
normotensive at 3 to 30 months post-partum develop overt hypertension within the 
subsequent 2 to 5 years. Women with low plasma volume were more prone to develop 
hypertension than women with normal plasma volume. Low plasma volume may 
therefore reflect a latent hypertensive profile that can become manifest within a few 
years after the preeclamptic pregnancy. 
It has been well established that formerly preeclamptic women are at increased risk 
of developing cardiovascular disease later in life1. It is hypothesized that preeclampsia 
and CVD share several common risk factors that may lead to expression of these 
disease entities at different times in a woman’s life5,6,12-14. An alternative hypothesis is 
that preeclampsia itself may induce subclinical vascular and metabolic changes that 
in time increase the risk for overt hypertension and CVD later in life. Our study does 
not differentiate between these possible mechanisms. Irrespective of the underlying 
mechanism, a history of preeclampsia may identify women at risk for CVD early in life, 
thus offering a unique opportunity for timely screening and preventative strategies15.
Table 4   Absolute and relative risk and odds ratios of developing hypertension in 
initially normotensive formerly preeclamptic women. 
Characteristics Low plasma volume (n=35) Normal plasma volume (n=69)
Prevalence (n/N (%)) 10/35 (29) 8/69 (12)
Crude OR [95%CI] 3.2 [1.4-8.6] Reference
Adjusted OR [95%CI] * 3.0 [1.1-8.5] Reference
Prevalence (n/N (%)) and odds ratios of de novo hypertension at the second visit in women with a history 
of preeclampsia. Study population classified in 2 groups according plasma volume. Low plasma volume 
defined as < 1373 mL/m2; normal plasma volume as ≥ 1373 mL/m2. OR indicates Odds Ratio, CI: 
confidence interval. *Adjustments for family history of hypertension (yes/no) and diastolic blood pressure 
(mmHg) at the first visit were performed using backward multivariate regression analysis.
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The prevalence of 17% hypertension in our study is markedly higher than the 3.7% 
prevalence of hypertension in the general population of Dutch women between 30 
and 39 years16. Adding the excluded women who remained hypertensive after the 
preeclamptic index pregnancy (47/386 (12%)), the overall prevalence of hypertension 
after preeclampsia is comparable with the mean prevalence of 30 to 40% found in 
other studies in formerly preeclamptic women6,17-20. Our data show that a substantial 
proportion of women progressed within a few years from normotension to hyper- 
tension.
The exact cause of the phenotype low plasma volume is currently unknown, but 
several explanations have been hypothesized. With twothirds of resting blood volume 
in the venous compartment, an actively constricted venous system might chronically 
reduces venous dimensions and (resting) elastic properties of the venous wall and 
thereby reducing its capacitance.  An intrinsically small venous system, in line with 
the Barker hypothesis might also account for the observed plasma volume. Lastly, 
plasma volume may be functionally reduced as a result of hormonal misbalance. 
Recent studies have suggested a pathophysiological role of increased vasopressin 
levels in preeclampsia21. If vasopressin increases one would expect higher plasma 
volume levels unless the vasopressin is increased secondary to low plasma volume 
status. In pregnancy however women who develop preeclampsia are not chronically 
underfilled, since compensatory neuro-humoral changes such as elevated renin, 
angiotensin and aldosterone levels are lacking23. Whether neurohumoral changes 
contribute, either by cause or effect, to low plasma volume status in the nonpregnant 
situation of formerly preeclamptic women is currently unknown. Therefore neurohumoral 
explanations for low plasma volume cannot be completely excluded. 
The mechanistic explanation for the relationship between low plasma volume and the 
development of hypertension is hypothetical. One possible pathophysiological 
explanation could be that low plasma volume status negatively affects cardiac 
preload, driving the sympathetic nervous system to compensate the reduced venous 
reserve. The resultant reduction in circulation time of the blood to pass the heart at 
each rotation will increase shear forces on the vascular endothelium, setting the 
stage for chronic hypertension7,14,22.
Formerly preeclamptic women who developed hypertension gained more weight 
between the two visits and had higher fasting glucose levels at the second visit. This 
suggests a less healthy lifestyle in formerly preeclamptic women destined to develop 
hypertension. Lipid profile and microalbuminuria remained relatively stable in the first 
5 years following the preeclamptic pregnancy, independent if women developed 
hypertension or not. This may indicate that short-term cardiovascular follow-up in 
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normotensive formerly preeclamptic women should focus on aberrations in blood 
pressure, body weight and glucose metabolism and less on dyslipidemia or 
albuminuria.   
Generalizability of the study is limited because of several reasons. First, women 
with a positive family history of hypertension or cardiovascular disease may have had 
an incentive to participate in our follow-up study. This may have resulted in an 
 overrepresentation of women who are genetically more susceptible to develop 
hypertension at a young age. Also women lost to follow-up were more often 
multiparous and delivered at a later gestational age. Therefore women with earlier 
onset preeclampsia, an indicator of more severe forms of preeclampsia, might be 
overrepresented in our study group. Second, there was a considerable loss to 
follow-up, mainly because interval after the first assessment was not yet more than 
2 years. Because group characteristics of included women were generally comparable 
with women lost to follow-up, we do not expect a large selection bias. Third, women 
who developed hypertension had more often a hypertensive pregnancy between the 
two assessments compared to women who remained normotensive. Although the 
second assessment was at least 3 months post partum to allow for hemodynamic 
recovery, we cannot rule out a possible overestimation of the blood pressure as 
recovery may still continue thereafter. Pregnancy outcome however did not correlate 
with change in blood pressure between visits, suggesting a nonsignificant impact on 
outcome. Follow-up period of maximally 5 years is relatively short for developing 
hypertension. Longer follow-up would likely influence the reported occurrence of 
hypertension in formerly preeclamptic women. 
Perspectives
Monitoring of blood pressure seems warranted in women with a history of 
preeclampsia, even in absence of hypertension in the first two years after pregnancy. 
It should be noted that the effects of structural cardiovascular and metabolic follow-up 
on clinical cardiovascular outcomes in this specific population are unknown. 
Nevertheless, based on the strong association between preeclampsia and future 
cardiovascular disease, structured follow-up is often recommended. This may vary 
from follow-up in primary care or in more specialized cardiovascular risk management 
collaborations of care takers including perinatology, cardiology and vascular internal 
medicine specialists7. Structured follow-up more likely secures regular surveillance of 
CVD risk factors, and hypertension in particular, with treatment according to national 
guidelines for CVD prevention in these women. Ideally this should be coupled to 
primary prevention strategies focusing at lifestyle modifications (physical exercise, 
healthy diet, weight loss and smoking cessation) in order to optimize maternal 
cardiovascular health. Lifestyle interventions have demonstrated to reduce cardio-
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vascular risks substantially in various populations at risk for cardiovascular disease24,25. 
Aerobic exercise and diet prevent hypertension, excessive weight gain and reduce 
insulin resistance24. Interestingly, women are particularly motivated to change their 
lifestyle habits during pregnancy or the postpartum period in order to optimize 
outcomes of mother and child and it is therefore considered an ideal timing to 
encourage primary prevention strategies26,27.
Conclusion
One in six initially normotensive formerly preeclamptic women develop hypertension 
within the next 2 to 5 years. In these apparently healthy women low plasma volume 
correlates with increased risk to develop hypertension. Clinically, follow-up of blood 
pressure seems warranted after a pregnancy complicated by preeclampsia, even in 
women who are initially normotensive.
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Abstract
In women with a history of preeclampsia, low plasma volume (≤1373 mL/m2) is 
associated with recurrent preeclampsia and chronic hypertension. Interventions that 
improve volume reserve may reduce these risks in formerly preeclamptic women. In 
this study we examined the effects of aerobic exercise training on venous reserves in 
24 normotensive formerly preeclamptic women and 20 controls. 
Before and after 12-week aerobic exercise training, we measured plasma volume with 
albumin indicator dilution technique and venous compliance with venous occlusion 
plethysmography. Venous compliance and hemodynamic responses were assessed 
dynamically during graded head-up tilt (HUT). Formerly preeclamptic women had 
lower pretraining plasma volume and venous compliance than controls (1348±78 
vs.1529±112mL/m2; (P<.01) and 0.04±0.02 vs. 0.07±0.01 mL/dL/mmHg; (P<.01) 
respectively). Blood pressure decreased comparably between groups in response to 
HUT (P=0.11); the increase in heart rate in response to HUT was however more 
pronounced in formerly preeclamptic women than in controls (P=0.01). Training 
increased plasma volume comparably in both groups (+180 vs.+135mL/m2; P=0.22; 
and similarly physical fitness +3.4 and +3.7mL/min/kg; P=.43). Venous compliance 
increased twice as much in formerly preeclamptic women than in controls (supine 
+0.02 vs. +0.01mL/dL/mmHg; P<.01). After training, HUT decreased mean blood 
pressure comparable with pre-training responses in both groups, whereas both 
groups fulfilled the HUT testing at a persistently lower heart rate. 
These results demonstrate that 12 weeks of aerobic exercise training improves venous 
reserve in postpartum women. Training normalized plasma volume and venous 
compliance in formerly preeclamptic women to pretraining levels of controls. 
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Introduction
Women with a history of preeclampsia are at increased risk for recurrent gestational 
hypertensive disease and cardiovascular disease later in life1,2. Fifty percent of 
formerly preeclamptic women have low plasma volume (PV)3 and the recurrence risk 
of preeclampsia varies inversely with PV4. In pregnancy, a marked PV expansion (+30 
to 60%) is required to meet the physiological demands of advanced pregnancy5,6. 
Formerly preeclamptic women with low PV show reduced PV expansion in pregnancy, 
which suggests that the adaptive capacity of the venous system in these women is 
limited7. When PV expansion cannot meet the physiological demands, the circulation 
may compensate for it by an increase in sympathetic activity7. The resulting low-volume 
high-output circulation will exert extra shear stress upon the endothelium3,7. This may 
set the stage for endothelial dysfunction, vascular damage, and hypertensive disease 
in pregnancy and later in life. 
The venous compartment is the most prominent blood volume reservoir of the body. 
Allthough at rest two-thirds of PV is localized in the venous system, it can be rapidly 
mobilized by sympathetic mediated venoconstriction in times of increased arterial 
demands, including pregnancy and exercise8,9. Venous capacity is largely determined 
by venous compliance (VeC), and varies dynamically with sympathetic tone 
predominantly controlled by the baroreflex system8. Dynamic changes in venous 
compliance can be tested through orthostatic stress testing. Previous studies 
demonstrated that formerly preeclamptic women at rest have low venous reserve, 
characterized by low PV, low venous compliance and high sympathetic tone10.
Aerobic exercise is perhaps the best intervention to improve venous reserve. It increases 
PV and reduces sympathetic tone in healthy individuals11,12. In formerly preeclamptic 
women with low PV, aerobic exercise training could help to normalize venous reserve 
and thereby reduce the risk of hypertensive disease in future pregnancy and later in life. 
The extent to which formerly preeclamptic women are able to improve their venous 
reserve by exercise training is unknown. Our study addresses the question to what 
extent an aerobic exercise training program (12 weeks of cycling at 70-80% VO2max, 
2-3 times per week) can improve venous reserve in formerly preeclamptic women 
compared to parous controls. Based on the observation that formerly preeclamptic 
women demonstrate reduced PV expansion in pregnancy, we hypothesized that 
formerly preeclamptic women may be less able to increase venous reserve in 
response to exercise training compared with parous controls. 
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Materials and methods
We recruited 25 normotensive formerly PE women and 22 controls. Primiparous 
formerly preeclamptic women were recruited during their postpartum checkup at the 
Radboudumc, controls from the community by advertisement. Preeclampsia in prior 
pregnancy was defined by the combination of gestational hypertension (≥140/90 
mmHg, measured twice, six hours or more apart), and proteinuria (consistently ≥300 
mg/24 hours) after 20 weeks of pregnancy in previously normotensive women13. 
Controls were healthy primiparous women; their pregnancy charts were checked to 
ensure that the preceding pregnancy had been normal. 
 
All participants were white women, healthy and normotensive at the time of 
measurements. None had diabetes mellitus, autoimmune disease or overt cardio- 
vascular disease. None of the women smoked or used medication or supplements 
that might affect the cardiovascular system and none of the women included were 
pregnant, breastfeeding, or using hormonal contraceptives. Excluded from analysis 
were women who became pregnant during the course of training and women who 
did not finish the exercise protocol. The study was approved by the Medical Ethics 
Committee of the Radboudumc (CMO: 2008/226) All participants gave written informed 
consent before entering the study. The study was registered at clinicaltrials.gov 
(id: NCT00900458).
Experimental design
Measurements and training were performed in the non-pregnant state, 6 to 12 months 
after pregnancy to allow for cardiovascular recovery after pregnancy14. Subjects were 
tested before and after 12 weeks of the exercise training. All measurements, except 
VO2max testing, were performed during the same visit. VO2max was tested 1 to 
5 days from the other visit. In sequential order, we measured body characteristics, 
resting blood pressure, cardiac output, PV and venous and hemodynamic 
responsiveness during head-up tilt (HUT). This study protocol is part of a more 
extensive protocol that also involves functional arterial measurements. Results of the 
arterial measurements are published elsewhere15,16. 
Experimental procedures
Tests and measurements were performed between day 3 and 11 of the menstrual 
cycle to minimize possible endocrine influences of the sex hormones on the 
cardiovascular- and autonomic nervous system17. All measurements except VO2max 
were performed following an overnight fast. Participants were instructed to abstain 
from strenuous physical activity in the 24 hours prior to testing. Participants collected 
urine in the 24 hours preceding the measurements. The 24-hour urine sample was 
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assayed for albumin, protein and creatinine to define the (micro) albuminuria corrected 
for creatinine output (g/mol creatinine) and total protein level (g/24 hrs) (Aeroset, 
Abbot Laboratories, Illinois USA).  
Tests were performed under standardized conditions in a temperature-controlled 
room (22±0.5ºC). Measurements were performed at the same time in the morning to 
prevent diurnal variation. After 30-minute rest in supine position, blood pressure and 
heart rate (HR) were measured oscillometrically (Dinamap, Vital Signs Monitor 1846, 
Critikon, Tampa, Florida) in the upright sitting position, at the right upper arm, with the 
cuff size recommended for the arm circumference, at 3-minute intervals for 30 
minutes.18 We recorded systolic (SAP, mmHg), diastolic (DAP, mmHg) and mean 
(MAP, mmHg) arterial pressures and heart rate (HR; bpm) and used the median 
values of 9 consecutive measurements for analysis. Cardiac output (CO; L/min) was 
measured in the left-lateral position, using a validated, non-invasive, inert gas 
rebreathing method (Innocor, Innovision, Copenhagen) as detailed elsewhere19. 
Stroke volume (SV, mL) was calculated as CO/HR. Venous blood samples were taken 
from the antecubital vein and analyzed for creatinine concentration (Aeroset, Abbot 
Laboratories, Illinois USA).
Plasma volume
Plasma volume (PV, mL) was measured using the iodine125 albumin indicator dilution 
technique (125I-HSA). During the measurement, women were in semi-supine position 
on a comfortable bed. An 18-gauge intravenous catheter was inserted in the left 
antecubital vein for repetitive blood sampling. A standardized dose (0.2 MBq) of 
125I-human serum albumin was injected intravenously in the right antecubital vein. 
Every 10 minutes a venous blood sample was taken from the contra lateral intravenous 
catheter until 40 minutes after administration of the 125I-HSA. Blood samples were 
analyzed using a gamma counter. PV was calculated by dividing the total injected 
radioactivity by the virtual volume specific radioactivity at time zero, as described 
elsewhere20. PV was normalized for body surface area (PV, mL/m2). Low plasma 
volume was defined as PV ≤1373 mL/m2 4. The technician who measured PV was 
unaware of the medical history of participants.
Head-up tilt test
Head-up tilt (HUT) was performed after voiding the bladder, and executed under 
standardized environmental conditions in a quiet and partially darkened room. 
Subjects were positioned on the tilt table on a comfortable mattress to minimize 
muscular activity and both arms were positioned at heart level. Participants remained 
supine for 20 minutes; thereafter head-up tilt was imposed by passively changing the 
body posture from 20 degrees head-down tilt (-20º) to 60 degrees head-up tilt (+60º), 
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in steps of 20º at 8-minute interval. Some women experienced presyncope and could 
not complete the whole test. Presyncope was defined by a precipitous fall in systolic 
arterial pressure > 15 mmHg concurrent with symptoms such as bradycardia, 
light-headedness, blurred vision, sweating and/or nausea. Women who experienced 
pre-syncope were returned to supine position.
Venous compliance during HUT
Venous compliance (VeC, mL/dL/mmHg) was measured on the forearm using strain 
gauge venous occlusion plethysmography with direct intravenous pressure 
measurement21. Venous pressure was directly measured through a catheter in the left 
antecubital vein connected to a pressure transducer system at atrial height. Changes 
in forearm volume were measured by a mercury-in-silastic strain gauge 5 cm distal to 
the antecubital crease. A venous collective cuff was placed 5 cm proximal to the 
antecubital crease. The pressure cuff was connected to a rapid cuff inflator (Hokanson 
E20, Denmark) to ensure rapid and accurate filling and deflation of the cuff. Data 
signals were recorded by computer at a sampling rate of 100Hz and stored for further 
analysis (MIDAC, Biomedical Engineering Department, Radboudumc, Nijmegen, 
The  Netherlands). Cuff pressure was gradually increased from 0 to 40 mmHg in 60 
seconds. Changes in forearm volume and intravenous pressure were recorded at the 
end of each rotational step. VeC was defined as the ratio of the slope of the 
volume-time curve and the slope of the pressure-time curve:
 Δ volume / Δ time
VeC =
 Δ pressure/ Δ time
Only the data of the linear part of the relationship were used.
Hemodynamic responses during HUT
During the HUT, HR and arterial blood pressure were measured continuously using a 
monitoring device attached to the 3rd finger of the right hand and a sampling rate of 
100Hz (Finometer, Finapres BV, the Netherlands). We used the hemodynamic data 
only to study heart rate and relative changes of blood pressure in response to 
orthostatic stress. It is known that absolute values of blood pressure acquired from 
Finometer are not reliable enough as these values are reconstructed from waveform 
transformation. Changes in blood pressure can however be measured accurately.22 
We excluded data of the first minute after postural change because we have shown 
in previous experiments that a new steady state is reached within 60 seconds after 
postural change23. Head-down tilt was performed to test the responses with 
maximized venous return. Post hoc, the recordings were analyzed by calculating 
mean heart rate and mean blood pressure over five minutes starting 60 seconds after 
postural changes at each rotational step.
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Physical Fitness  
Physical fitness was measured before and after a 12-week aerobic training program. 
Fitness was defined as the peak oxygen uptake (VO2max, mL/min/kg) during a 
maximal test on a cycle ergometer (Excalibur Sport, Lode BV, Groningen NL). Tests 
were performed in the afternoon after a light lunch ad libitum. The initial workload was 
set at 10W for 1 minute and followed by 10W increments every minute until exhaustion. 
Breath by breath oxygen uptake was measured using spiro-ergometric equipment 
(Quark CPET, Cosmed, Italy). A 3-lead ECG continuously recorded HR and rhythm. 
Maximal workload (Workmax) was defined as the last completed workload before 
exhaustion. Test performance was considered to be adequate when (1) The increase 
in VO2 during Workmax was <150mL compared to the previous workload, indicating 
plateau formation in oxygen uptake (2) HR at Workmax was <10 bpm from estimated 
maximal HR (220-age) (3) Respiratory Exchange Ratio (RER, CO2/O2) during 
Workmax was consistently >1.1 and (4) Capillary lactate level was >8mmol/L, 90 
seconds after exhaustion. If the test failed to achieve these 4 qualifications the test 
was repeated 2-3 days later. In three cases (2 formerly PE women, 1 control) the test 
had to be repeated, all tests eventually fulfilled the criteria.
Exercise training
Exercise training consisted of 12 weeks of HR controlled, supervised cycle training 
(cycle ergometer, Corival, Lode BV, Groningen Netherlands) at 70-80% of VO2max. 
Participants trained twice a week during the first 6 weeks and 3 times a week during 
the last 6 weeks. Each training session was supervised and executed in the 
gymnasium of our laboratory. Care was taken that each training session had at least 
one day in between to allow adequate recovery. Participants were instructed not to 
exercise in addition to the exercise protocol given. During each training session, HR 
was continuously monitored and recorded (RS800CX, Polar Electro Inc, NY USA). 
Each training session started with 10 minutes warming-up at 50% of the HR reserve 
(HRR) above resting HR. HRR was calculated as HRR=HRmax-HRrest in which HRmax is 
maximal HR during the fitness test at study entry and HRrest is the HR determined at 
rest. Training consisted of 40 minutes of cycling at 70-80% of the individual HRR. 
Within their target HR zone, participants were free to choose the number of revolutions 
per minute (RPM). Cooling down for 5 minutes at warming-up workload completed 
the training.
Statistical analysis
Statistical analyses were performed using SPSS 17.0 (SPSS, Chicago, IL) software. 
All normally distributed data are reported as mean ± SD; other data are presented as 
median [interquartile range].  Normality of data was tested with a Kolmogorov-Smirn-
ov test. Two-way repeated-measures ANOVA was used to examine differences 
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between formerly PE women and controls groups, to assess the effects of training 
(intervention) and to determine if training effects differed between formerly PE women 
and controls (training x group). A mixed linear model for repeated measures was 
performed to test differences between groups and effects of training on the response 
curves of venous and hemodynamic variables to HUT. When significant effects were 
found, Bonferroni posthoc comparison tests were used. Statistical significance was 
assumed at P<.05. We based our group-size calculation for the intervention part of 
our study on an anticipated difference in exercise induced PV expansion (primary 
outcome measure) of 4% between groups, a power of 90% and an alpha of .05. 
Assumed standard deviation of the exercise induced plasma volume expansion was 
based on a pilot study in 9 formerly PE women (4%)24. Based on these assumptions, 
18 subjects were required per group. To anticipate possible dropout we decided to 
include at least 20 subjects per group.
Results
Included in the analysis were 24 formerly preeclamptic women and 20 controls, after 
exclusion of 1 formerly preeclamptic woman (who became pregnant) and 2 controls 
(one who became pregnant and one who did not finish the training protocol). 
Mean age and interval from delivery to test were comparable between groups (32±4 
vs. 32±4 years, P=.62 and 7±2 vs.7±1 months, P=.88, respectively). Formerly 
preeclamptic women had delivered at an earlier gestational age compared with controls 
(32 [29-37] vs. 40 [38-41] weeks, P<0.01), of children with a lower birth weight 
(1571±675 vs. 3532±311 grams, P<.01).
Prior to training
Physical and hemodynamic characteristics of formerly preeclamptic women and 
controls are shown in Table 1.  Prior to training, mean physical fitness was comparable 
between both groups (VO2max: 27.0±4.0 and 28.2±3.7 mL/min/kg, P=.32) as were 
body mass index, stroke volume, cardiac output and serum creatinine concentration. 
All subjects were normotensive (by inclusion). In formerly preeclamptic women, 
average values of HR, systolic arterial pressure, diastolic arterial pressure, MAP, 
creatinine clearance and albuminuria were higher than in controls. PV was 13% lower 
in formerly preeclamptic women than in controls (1348±78 vs. 1529±112 mL/m2, 
P<.01), as shown in Figure 1. 
The venous response curves to graded HUT are shown in Figure 2. Before training, 
VeC was lower in formerly preeclamptic women than in controls (supine: 0.04±0.02 
vs. 0.07±0.01 mL/dL/mmHg, P<.01). Formerly preeclamptic women had lower VeC 
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at all levels of HUT and a more gradual slope of the VeC response to progressive HUT 
than controls (P=.004), indicating a relatively poor venous response to orthostatic 
stress. 
Blood pressure decreases significantly secondary to orthostatic stress (P<.01). The 
response curves of mean blood pressure to graded HUT show that prior to exercise 
training blood pressure drops comparably between formerly preeclamptic women 
and controls in response to HUT (P=.11)(Figure 3). The increase in heart rate in 
response to HUT was however more pronounced in preeclamptic women than in 
controls (P=.01). With progressive HUT mean heart rate increased. From 20 degrees 
HUT onward, the slope of the orthostatically induced increase in heart rate was steeper 
in formerly preeclamptic women than in controls (P=.01) (Figure 4). Presyncope at 
60 degrees HUT tended to occur more frequently in formerly preeclamptic women 
than in controls (6/24 (25%) vs. 1/20 (5%), P=.07). 
Figure 1  Effects of 12 weeks aerobic exercise training on plasma volume (mL/m2) in formerly 
preeclamptic women (n=24) and controls (n=20). Grey lines represent individual data. Black 
lines represent means, error bars standard deviation, * indicates significant difference from 
healthy parous control women before training (P<0.05 ).
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Effects of training  
Twelve weeks of training improved physical fitness comparably in both groups, as 
mean VO2max increased by +3.4 and +3.7 mL/min/kg
 respectively. Training increased 
PV in both groups (+180 vs.+135 mL/m2; P=.22) (Figure 1) and it increased PV in 
formerly preeclamptic women up to pretraining values of controls (P=.84). 
As shown in Table 1, training reduced BMI, systolic arterial pressure, diastolic arterial 
pressure, and MAP comparably in both groups. Although training increased stroke 
volume, cardiac output was unaffected as the reduction in HR was more pronounced 
in formerly preeclamptic women than in controls (interaction: P=.03). Training abolished 
the differences in blood pressures between formerly preeclamptic women and controls, 
but did not affect serum creatinine levels and albuminuria, so that albuminuria 
remained higher in formerly preeclamptic women than in controls. 
Figure 2  Effects of orthostatic stress testing on venous compliance in formerly preeclamptic 
women and controls before and after 12 weeks aerobic exercise training. On x-axis degrees of 
head-up tilt, on y-axis venous compliance (mL/dL/mmHg). Error bars represent standard error.
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Training improved VeC (Figure 2). The improvement was significantly more pronounced 
in formerly preeclamptic women than in controls (supine VeC +0.02 vs. +0.01 mL/
dL/mmHg respectively; training x group: P<.01), and supine VeC in trained formerly 
preeclamptic women became comparable with that of untrained controls (P=.30). 
The slope of the VeC curve in response to HUT increased with training (HUT x training: 
p<.01), so that it became comparable for formerly preeclamptic women and controls 
(group x HUT: P=.78). 
After 12 weeks of training the average MAP over the 5 rotational steps (P=.55) and the 
slopes of the MAP curves in response to HUT (P=.54) were similar in formerly 
preeclamptic women and controls. Training shifted the heart rate response curve to 
HUT downwards in both groups. After 12-week exercise training, the slopes of the 
response curves of heart rate were comparable between formerly preeclamptic 
women and controls (P=.14) although formerly preeclamptic women still performed 
at a higher heart rate at each level of HUT (P=.05).
Figure 3  Effects of orthostatic stress testing on mean arterial pressure (MAP) in formerly 
preeclamptic women and controls before and after 12 weeks aerobic exercise training. On x-axis 
degrees of head-up tilt, on y-axis mean arterial pressure (mmHg). Error bars represent standard 
error.
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Training reduced the rate of pre-syncope in formerly preeclamptic women, albeit not 
significantly (from 6/24 (25%) to 3/24 (12.5%), P=.27). After training, none of the 
control women showed symptoms of presyncope.
Discussion
The major finding in this study is that a 12-week aerobic exercise program increases 
plasma volume and venous compliance in formerly preeclamptic women to pretraining 
levels of parous women without a history of preeclampsia. 
Preeclampsia is a multifactorial disorder. In this study, we focused on the link between 
preeclampsia and reduced venous reserve. Although it has been repeatedly shown 
that formerly preeclamptic women have low PV3,4,7,20, the exact cause for low PV is 
unknown. Formerly PE women had higher creatinine clearance and microalbumin-
uria, both characteristics of borderline hypertension25-26. Therefore, one could argue 
that hyperfiltration may have contributed to reduced PV in formerly preeclamptic 
Figure 4  Effects of orthostatic stress testing on heart rate in formerly preeclamptic women 
and controls before and after 12 weeks aerobic exercise training. On x-axis degrees of head-up 
tilt, on y-axis heart rate (bpm). Error bars represent standard error.
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women. However in pregnancy women with prepregnant low plasma volume 
demonstrate reduced plasma volume expansion with concurrent increased levels of 
atrial natriuretic peptide suggesting a restricted volume compartment rather than 
 hyperfiltration7. Therefore, other possible pathogenic factors for low PV may be more 
likely such as a constitutionally small venous compartment18 or a constricted venous 
system27,28  Both glomerular hyperfiltration and a constricted venous system are 
linked to sympathetic overactivity26,27. Our results are consistent with a constricted, 
but not necessarily constitutionally small, venous compartment29,30. A constitutionally 
small venous compartment most likely would have resulted in a small increase in PV 
with training in formerly preeclamptic women, yet our data show that PV increased at 
least as much in formerly preeclamptic women as in controls. The normal increase in 
PV and the larger increase in VeC in formerly preeclamptic women than in controls in 
response to training are consistent with a venous compartment that was initially 
constricted but was able to relax secondary to exercise-induced reduction of 
sympathetic tone. The magnitude of the exercise-induced plasma volume expansion 
in our study is comparable with first trimester PV expansion in normal pregnancy 
(~10%). If pregnancy proceeds normally, PV expands further to more than ±40%. 
It is conceivable that in pregnancy venous capacitance problems arise when >10% 
plasma volume expansion needs to be accommodated. The effects of the exercise- 
induced PV expansion in formerly preeclamptic women on the subsequent recurrence 
risk of preeclampsia have not yet been studied. 
Formerly preeclamptic women apparently have an increased venous tone and 
reduced venous compliance, similar to hypertensive subjects31-33. The VeC at rest 
was lower in formerly preeclamptic women than in controls prior to training and 
improved markedly by exercise training. VeC modulation during HUT was initially 
blunted in formerly preeclamptic women compared with controls, but training shifted 
the curve upward and increased the slope. This implies that the ability of the veins to 
mobilize venous volume through venoconstriction was initially limited but improved 
markedly with exercise training. Twelve weeks of aerobic training allowed formerly 
preeclamptic women to effectively improve VeC modulation up to the pretraining level 
of controls. We presume that an increase in venous compliance before a new 
pregnancy will likely allow better accommodation of the necessary PV expansion in 
pregnancy at a lower sympathetic activity level. 
We would like to address several methodological issues. First, a time control group 
could have strengthened our results to rule out effects of post-partum recovery 
resulting in an overestimation of our training effects. We studied our participants 6 to 
12 months postpartum, which may not have been enough for full recovery. Yet, our 
data probably approach full recovery as venous functions have been reported to 
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normalize within 3 months after delivery34, and hemodynamic and metabolic recovery 
is at least 80% complete within 6 months14. The postpartum interval was similar 
between groups; it is therefore unlikely that this has significantly impacted our 
comparisons.  Moreover, the fact that formerly preeclamptic women only improved 
up to a level that is comparable with that of untrained controls suggests that the 
observed training effects are not only reversion to the mean. Second, we measured 
venous compliance in a limb as a proxy for the whole body. One could argue that the 
splanchnic venous bed would have been more relevant because it contains the 
largest volume of venous blood and therefore plays a more important role in restoring 
venous return. However measuring splanchnic venous compliance is technically too 
challenging, especially during dynamic testing. Measuring limb venous compliance 
is a well-accepted method for studying the venous vascular bed. Finally, controls 
were recruited from the community; therefore women with subjectively poor fitness 
may have had an incentive to participate in the study, knowing that their cardiovascular 
health would be assessed and improved by training. 
Perspectives
Pregnancy represent a unique screening test in which preeclampsia indicates women 
at high risk for future gestational hypertension and/or cardiovascular disease in later life2,35. 
Women at risk for cardiovascular disease are likely to be detected at a young age, early 
enough to benefit from subsequent preventative strategies. Although the reported effect of 
exercise before and during pregnancy on the reduction of recurrence risk of preeclampsia 
is conflicting36,37, aerobic exercise training is a powerful nonpharmacological and low 
cost strategy to reduce blood pressure38. The protective effects of exercise are 
complex and go beyond the effects on traditional cardiovascular risk factors alone39. 
Our study has shown that formerly PE women can improve their venous reserve 
capacity through aerobic training to the level of that of untrained healthy control 
women who carried their pregnancy without developing hypertension. It is likely that 
if the active lifestyle is not maintained many of the exercise induced venous and 
autonomic changes will reverse. Further studies are needed to demonstrate the 
extent to which aerobic training prior to pregnancy is of clinical benefit to reduce 
recurrent hypertensive disease in pregnancy and cardiovascular disease later in life.
Conclusion
Normotensive formerly preeclamptic women have reduced plasma volume and lower 
venous compliance indicating reduced venous reserve capacity. Twelve weeks of 
aerobic training at 70-80% VO2max 2 to 3 times per week significantly improves the 
venous reserve capacity in postpartum women. In formerly preeclamptic women it 
restores these functions to the level of untrained healthy parous controls.
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Abstract 
Formerly preeclamptic women demonstrate higher prevalence of metabolic syndrome 
(MetS), impaired vascular function and increased sympathetic activity, and are at 
increased risk of cardiovascular disease. The aim of this study was to assess the effects 
of 12 weeks exercise training (70-80%VO2max) in formerly preeclamptic women on 
components of metabolic syndrome, vasculature and autonomic functions compared 
with healthy controls. 
Our prospective case-control study included 24 normotensive formerly preeclamptic 
women and 20 controls who were matched for age and postpartum interval (all 6 to 
12 months after delivery). Before and after training, we measured all components of 
MetS (i.e. blood pressure, lipids, glucose/insulin and albuminuria), carotid intima- 
media thickness (IMT) and brachial (BA) and superficial femoral artery (SFA) 
endothelial function using flow mediated dilation (FMD). Autonomic activity was 
quantified using power spectral analysis (Low Frequency/High Frequency power 
(LF/HF)-ratio). 
At baseline, formerly preeclamptic women demonstrated higher values of most 
components of MetS. Compared with control subjects, formerly preeclamptic women 
had increased IMT (580±92µm vs. 477±65 µm), impaired endothelial function (FMD 
BA: 5.3±2.2% vs. 10.8±3.5% and FMD SFA: 4.9±2.1% vs. 8.7±3.2%) and increased 
LF/HF-ratio (2.2±1.0 vs. 1.3±0.4, all p<0.05). In both groups exercise training decreased 
values of most components of MetS and IMT, improved FMD and concurrently 
reduced LF/HF. Despite these improvements, vascular and autonomic variables did 
not normalize by 12 weeks training in women with a history of preeclampsia. 
This study demonstrates that exercise training in formerly preeclamptic women and 
control subjects improves components of MetS, endothelial function, vascular wall 
thickness and autonomic control. Nonetheless, trained women with a history of 
preeclampsia only reached a cardiovascular status that is comparable to sedentary 
healthy control subjects.
115
CARDIOVASCULAR EFFECTS OF EXERCISE TRAINING 
7
Introduction
Women who have experienced preeclampsia during pregnancy are prone to 
cardiovascular disease later in life1. The cardiovascular stress test of pregnancy 
therefore may unmask a previously unrecognized cardiovascular risk profile in young 
women. Most likely the development of preeclampsia during pregnancy reflects their 
preexisting, often latent, cardiovascular risk condition2,3. Alternatively, the increased 
risk can be attributed to factors that originate from the complicated pregnancy itself4. 
In either case, formerly preeclamptic women may benefit from selective screening for 
cardiovascular risk markers5, assuming that targeted treatment alter these risk 
factors, and consequently effectively alter the risk for pregnancy-related vascular 
complications and future cardiovascular disease. 
 
Women with a history of preeclampsia demonstrate higher prevalence of traditional 
cardiovascular risk factors3,6-8 (e.g. hypertension, dyslipidemia and reduced insulin 
sensitivity), endothelial dysfunction9-11, increased arterial wall thickness12 and augmented 
sympathetic nervous system activity13-15 compared with healthy control subjects, 
which likely relates to the increased cardiovascular risks in these women. These 
dysfunctions are potentially amenable for improvement by exercise training16-18.  
Aerobic exercise training is a well-established potent physiological stimulus that 
reduces primary and secondary cardiovascular events19. The beneficial effects of 
exercise on cardiovascular risk are not only mediated through improvement of 
traditional cardiovascular risk factors20,21, but also through up-regulation of nitric 
oxide (NO)-derived endothelium mediated vasodilation16,17,22, reduction of arterial wall 
thickness23, and reduction of sympathetic tone24,25.  Although suggested in many 
articles26, no previous study examined the effects of exercise training in formerly 
preeclamptic women that could provide strong rationale for advising exercise training 
in women with increased cardiovascular risk.
This study therefore addressed the question to what extent an exercise training program 
(12 weeks of cycling at 70-80% VO2max, 2 to 3 times per week) in formerly preeclamptic 
women affects physical fitness, components of the metabolic syndrome, endothelial 
function, arterial wall thickness and autonomic function, and how these changes 
compare with control subjects. The primary outcome of this study was endothelial 
function, which was measured by flow-mediated dilation (FMD). Endothelial 
dysfunction is not only a key feature in preeclampsia, but also it has proven to be 
associated with cardiovascular disease burden and outcome. We hypothesize that 
exercise training improves vascular function and structure as well as autonomic control, 
we expect these vascular and autonomic changes to be related closely. The question 
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is, however, whether formerly preeclamptic women will respond adequately to the 
exercise stimulus, because these women maladapted to the cardiovascular stimulus 
of previous pregnancy. Based on the circulatory maladaptation to previous pregnancy, 
we hypothesized that formerly preeclamptic women are less able to improve vascular 
and autonomic characteristics with exercise training compared with healthy control 
subjects. We therefore performed an experimental intervention study in 24 formerly 
preeclamptic women and 20 control subjects.  
Materials and methods
We recruited 25 normotensive formerly preeclamptic women and 22 control subjects. 
Primiparous women with a history of preeclampsia were recruited from the Radboud 
University Nijmegen Medical Centre, and control subjects were recruited from 
the community by advertisement at day care centers. Preeclampsia in previous 
pregnancy was defined by the combination of gestational hypertension (≥140/90 
mmHg, measured twice, six or more hours apart), and proteinuria (consistently ≥300 
mg/24 hours) after 20 weeks of pregnancy in previously normotensive women27. 
In our hospital, women with a history of preeclampsia are invited for cardiovascular 
follow-up evaluation 6 to 12 months after pregnancy that was complicated by 
preeclampsia. At this follow-up visit, women who were eligible for our study were 
given written information about this study, and if interested these women contacted 
our laboratory for further information and inclusion. Control subjects contacted our 
laboratory after reading the advertisement. If interested, they received the same 
written information as formerly preeclamptic women. Control subjects were healthy 
primiparous women whose pregnancy charts were checked to ensure a normal 
pregnancy course that resulted in a term delivery. Participants were not compensated 
in this study.
All participants were white women, who were healthy and normotensive at the time of 
measurements. None of the women had diabetes mellitus, autoimmune disease or 
overt cardiovascular disease. None of the women smoked or used medication or 
supplements that might affect the cardiovascular system. None of the women who 
were included were pregnant, breastfeeding, or using hormonal contraceptives. 
Excluded from analysis were women who became pregnant during the course of the 
study and women who were unable to cope with physical exercise training. The study 
was approved by the Medical Ethics Committee of the Radboud University Nijmegen 
Medical Centre (CMO: 2008/226) All participants gave written informed consent 
before entering the study. The study adhered to the principles of the Declaration of 
Helsinki.  The study was registered at clinicaltrials.gov (id: NCT00900458).
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Experimental design
Measurements and training were performed in the nonpregnant state, 6 to 12 months 
after pregnancy. Subjects were tested before and after 12 weeks of exercise training. 
All measurements, except VO2max, were performed during the same visit. VO2max 
was tested 1 to 5 days from the other visit. In sequential order, we measured: body 
characteristics (weight, height, waist circumference), metabolic components (lipids, 
glucose and insulin concentrations), blood pressure (BP), heart rate (HR), autonomic 
function by spectral analysis of spontaneous fluctuations in heart rate and blood 
pressure and vascular ultrasound measurements: intima media thickness (IMT), 
flow-mediated dilatation (FMD) and vasodilation response to glyceryl trinitrate (GTN).
Experimental procedures
Tests and measurements were performed between day 3 and 11 of the menstrual 
cycle to minimize possible endocrine influences of the sex hormones on the 
cardiovascular- and autonomic nervous system. All measurements, except VO2max 
were performed following an overnight fast. Participants were instructed to abstain 
from strenuous physical activity in the 24 hours before testing. Participants collected 
urine in the 24 hours preceding the measurements. The 24-hour urine sample was 
assayed for albumin, protein and creatinine to define the microalbuminuria corrected 
for creatinine output (g/mol creatinine) and total protein level (g/24 hours) (Aeroset, 
Abbot Laboratories, Illinois USA).  
Height and body mass (Seca 888 scale, Hamburg, Germany), and waist circumference 
were measured. Venous blood samples were taken from the antecubital vein and 
analyzed for metabolic parameters: glucose, insulin, total cholesterol, high and low 
density lipoproteins and triglycerides (Aeroset, Abbot Laboratories, Illinois USA). The 
homeostasis model assessment index (HOMA) was calculated as fasting insulin 
[mU/L] x fasting glucose [mmol/L]/22.5 to estimate insulin resistance28.
Tests were performed under standardized conditions in a temperature-controlled 
room (22±0.5ºC). Measurements were performed at the same time in the morning to 
prevent diurnal variation in the vascular and autonomic responses.29 After 30 minutes 
rest in supine position, blood pressure and heart rate were measured oscillometrical-
ly (Dinamap, Vital Signs Monitor 1846, Critikon, Tampa, Florida), at the right upper 
arm, with the cuff size recommended for the arm circumference, at 3-minute intervals 
for 30 minutes. We recorded systolic (SAP) diastolic (DAP) and mean (MAP) arterial 
pressures and heart rate (HR; bpm) and used the median values of 9 consecutive 
measurements for analysis. This resting heart rate was used for the calculation of the 
training intensity. 
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Autonomic function 
Autonomic function was measured with subjects comfortably lying in supine position 
in a quiet, partially darkened room. Autonomic activity and baroreflex sensitivity were 
quantified by spectral analysis, from a 5 minute recording of spontaneous fluctuations 
in HR and BP.30 Heart rate and arterial blood pressure (ABP) were measured 
continuously using a finger arterial blood pressure monitoring device attached to the 
3rd digit of the right hand at a sampling rate of 100Hz (Finometer, Finapres BV, the 
Netherlands). Post hoc, these recordings were subdivided into data segments of 
100s, overlapping for 50% and resampled at 5.12 Hz. Each segment was then 
analyzed with Fast Fourier Transformation to search for rhythmic fluctuations in 
systolic arterial pressure (SAP) and pulse interval with a frequency range between 0 
and 2.56 Hz. The amplitude of each fluctuation determines the power at each 
frequency. The ratio (LF/HF) of absolute low frequency (LF) and high frequency (HF) 
powers of the pulse interval was used to represent the autonomic balance between 
the sympathetic and vagal system. The LF component is regarded a marker of mainly 
sympathetic modulation, HF components mainly reflect vagal activity. Therefore, a 
higher LF/HF can be interpreted as a sign of increased sympathetic dominance. 
Baroreflex sensitivity (BRS, ms/mmHg), was defined as the (low frequency) transfer 
gain from SAP to pulse interval, which provides information about the changes in the 
heart rate (output) in response to fluctuation in SAP (input).
Vascular measurements
All measurements were performed by the same sonographer (RS) according to 
recent guidelines for assessment of the Flow Mediated Dilation (FMD)29 using a 
10-MHz multifrequency linear array probe attached to a high resolution ultrasound 
machine (T3000, Terason, Burlington, MA). Ultrasound parameters were set to 
optimize longitudinal B-mode images of the lumen/arterial wall interface. Continuous 
Doppler velocity was assessed simultaneously using the lowest possible insonation 
angle (always<60º). For assessment of the FMD responses, a rapid inflation/deflation 
pneumatic cuff (Hokanson, Bellevue, WA) was positioned distal to the imaged artery 
and inflated for 5 minutes (220mmHg) to provide the stimulus for reactive hyperemia. 
FMD represents a predominantly nitric-oxide (NO)-mediated, endothelium dependent 
vasodilation. 
Carotid artery IMT. The intima-media thickness of the left common carotid artery (CA) 
was measured 2cm proximal to the bulbus. Perpendicular incidence of the B-mode 
imaging ultrasound beam in relation to the orientation of the vessel provided clearly 
demarcated intima medial boundaries, which were optimized using contrast controls. 
Wall thickness and diameter were measured continuously for 1 minute. The 
measurement was repeated once, from a different perpendicular plane (±90º 
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compared with previous measurement). From the 2 measurements, mean diameter 
and wall thickness were calculated and used for analysis31.
 
Brachial artery FMD. Brachial artery FMD was measured with subjects positioned 
supine with the right arm extended and immobilized with foam, supported at an angel 
of approximately 80 degrees from the torso. The pneumatic cuff was placed distal to 
the olecranon. The brachial artery (BA) was scanned 2-5 cm above the antecubital 
fossa. Before inflation, resting baseline diameter and blood flow velocity were 
recorded continuously for at least 1 minute. After cuff deflation, diameter and blood 
flow velocity were recorded continuously for 3 minutes. 
Superficial femoral artery FMD. Superficial femoral artery FMD was measured with 
subjects positioned supine with the lower leg slightly elevated (approximately 10 
degrees). The pneumatic cuff was placed 15 cm below the inguinal ligament. The 
superficial femoral artery (SFA) was scanned in the proximal one-third of the thigh, at 
least 5 cm distal from the bifurcation and above the cuff position. Before inflation, 
resting baseline diameter and blood flow velocity were recorded continuously for at 
least 1 minute. After cuff deflation, diameter and blood flow velocity were recorded 
continuously for 5 minutes.
 
Vasodilation after glyceryl trinitrate (GTN). GTN responses were measured after a 
resting period of 30 minutes to allow arterial diameter to return to baseline, another 
1-minute baseline recording of the superficial femoral artery was made. Endothelium 
independent dilation was examined using a single sublingual dose of GTN (400µgr; 
G-Pohl-Boskamp GmbH and Co KG, Hohenlockstedt, Germany), a NO donor, 
followed by ≥10 minutes recording of the arterial diameter. The maximal dilatation 
after administration of GTN represents the endothelium independent vasodilation.
Conduit artery diameter, wall thickness and blood flow analysis
Posttest analysis of diameter, velocity and wall thickness of the 3 conduit arteries 
(CA, BA and SFA) was performed using edge-detection and wall-tracking DICOM 
based software32 to minimize investigator bias29,32. The post-hoc analysis of the 
diameter, velocity and wall thickness was performed blinded (to subject and moment 
of assessment). FMD was calculated as the percentage of rise in peak diameter from 
the preceding baseline diameter. The post deflation shear rate data, derived from 
simultaneously acquired velocity and diameter measures at 30Hz, was used to 
calculate the area under the shear rate curve for data up to the point of maximal 
post-deflation diameter (FMD) for each measurement. Reproducibility of the brachial 
artery FMD using this semi-automated software has a coefficient of variance of 
6.7%32, the superficial femoral artery FMD has a coefficient of variance of 15%29.
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Physical Fitness 
Physical fitness was measured before and after a 12-week training program. Fitness 
was defined as the peak oxygen uptake (VO2max, mL min
-1 kg-1) during a maximal 
cycling test on a cycle ergometer (Excalibur Sport, Lode BV, Groningen NL). Tests 
were performed in the afternoon after a light lunch. The initial workload set at 10 Watt 
for 1 minute followed by 10-Watts increments every minute until complete exhaustion. 
Breath-by-breath oxygen uptake was measured using spiro-ergometric equipment 
(Quark CPET, Cosmed, Italy). Heart rate and rhythm were continuously recorded by 
3-lead ECG. Maximal workload (Workmax) was defined as the last completed 
workload before exhaustion. Test performance was considered to be adequate when: 
1. The increase in VO2 (ml) during Workmax was <150mL compared to the previous 
workload, indicating plateau formation in oxygen uptake 2. HR at Workmax was <10 
bpm from estimated maximal heart rate (220-age) 3. Respiratory Exchange Ratio 
(RER, CO2/O2) was consistently >1.1 during Workmax and 4. Capillary lactate level 
was >8mmol/L, 90 seconds after exhaustion. If the test failed to achieve these 
4 qualifications the test was repeated 2-3 days later. In three cases (2 formerly 
preeclamptic women, 1 control subject) the test had to be repeated, all tests were 
eventually considered adequate.
Exercise training
Exercise training consisted of 12 weeks of HR-controlled cycle training (cycle 
ergometer, Corival, Lode BV, Groningen Netherlands) at 70-80% of VO2max for 2 to 
3 times per week (according most recent American College of Sports Medicine 
(ACSM) guideline)33. Participants trained twice a week during the first 6 weeks and 
3 times a week during the last 6 weeks. Each training session was supervised and 
was executed in the gymnasium of our laboratory.  Participants were instructed not 
to exercise in addition to the exercise protocol that they were given. During each 
training session, heart rate was continuously monitored and recorded (RS800CX, 
Polar Electro Inc, NY USA). Each training session started with 10 minutes warming-up 
at 50% of the heart rate reserve (HRR) above the resting heart rate. HRR was 
calculated as: HRR=HRmax-HRrest in which HRmax is the maximal heart rate measured 
during the fitness test at study entry and HRrest is the heart rate determined at rest. 
Training consisted of 40 minutes of cycling between 70 to 80% of the individual HRR 
above HRrest. Within their target heart rate zone, participants were free to choose the 
number of revolutions per minute (RPM). The training was completed by cooling 
down for 5 minutes at warming-up workload.
 
Statistical analysis
Statistical analyses were performed using SPSS 17.0 (SPSS, Chicago, IL) software. 
All data are reported as mean± SD unless stated otherwise. Normality of data was 
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tested using Kolmogorov-Smirnov tests. Statistical significance was assumed at 
p<0.05. Two-way repeated-measures ANOVA was used to examine differences 
between formerly preeclamptic women and control subjects (groups), to assess the 
effects of training (intervention) and to determine if the training effects differed 
between patients and control subjects (groups*intervention-interaction). Post-hoc 
Bonferroni analysis was used to correct for multiple comparisons. Pearson correlation 
coefficient was used to examine the relation between exercise-induced change in 
autonomic function (LF/HF ratio) and endothelial function (FMD) in both groups. 
Based on an anticipated difference in %FMD, which has a coefficient of variation (CV) 
of 6.7-10.5%32, between formerly preeclamptic women and control subjects of 4%, a 
power of the study of 90%, and an alpha level of .05, we needed 17 subjects per 
individual group. We based our group-size calculation for the intervention part of our 
study on an anticipated change in %FMD (primary outcome measure) of 2%, a power 
of 90% and an alpha of .05. Based on these assumptions, we required 18 subjects 
per group. To anticipate possible dropouts, we decided to include at least 20 subjects 
per group. 
Results
Included in the analysis were 24 women with a history of preeclampsia and 20 control 
subjects, after exclusion of 1 formerly preeclamptic woman (who became pregnant) 
and 2 control subjects (1 woman who became pregnant, 1 woman who did not finish 
the training). Mean age (32±4 vs. 32±4 years, P=.62) and post-partum interval (7±2 
vs.7±1 months. P=.88) were comparable between groups. Formerly preeclamptic 
women delivered at an earlier gestational age compared with control subjects (32 
[29-37] vs. 40 [38-41] weeks, P<.01) and delivered children with a lower birth weight 
compared with control subjects (1571±675 vs. 3532±311 grams).
Baseline values
Prior to training, physical fitness was similar in both groups (VO2max: controls: 
28.2±3.7; patients: 27.0±4.0 mL min-1 kg-1, P=.32), as were BMI, resting HR, fasting 
glucose and cholesterol concentrations (Table 1). In formerly preeclamptic women, 
group average values of SAP, DAP, MAP, fasting insulin and triglyceride concentrations 
and albuminuria were higher than in control subjects. Vascular diameters (CA, BA 
and SFA) were not different between groups. In formerly preeclamptic women, 
CA-IMT was larger and BA- and SFA-FMD responses were smaller than in controls 
(Table 2). Mean shear rate AUC, time-to-peak of FMD and vasodilation in response to 
GTN was not different between groups. In formerly preeclamptic women, the average 
LF/HF ratio was higher and BRS lower than in control subjects (Table 3).
122
CHAPTER 7
Ta
b
le
 1
   C
ha
ra
ct
er
is
tic
s 
of
 h
ea
lth
y 
co
nt
ro
ls
 a
nd
 fo
rm
er
ly
 p
re
ec
la
m
pt
ic
 w
om
en
, b
ef
or
e 
an
d 
af
te
r e
xe
rc
is
e 
tra
in
in
g
H
ea
lth
y 
co
nt
ro
ls
  
(n
=
20
)
Fo
rm
er
ly
 p
re
ec
la
m
p
tic
 w
om
en
 
(n
=
24
)
2-
w
ay
 A
N
O
VA
 (
P
-v
al
ue
s)
B
ef
or
e 
tr
ai
ni
ng
A
fte
r 
tr
ai
ni
ng
B
ef
or
e 
tr
ai
ni
ng
A
fte
r 
tr
ai
ni
ng
G
ro
up
In
te
rv
en
tio
n
G
ro
up
 X
 
In
te
rv
en
tio
n
B
M
I, 
kg
/m
2
26
.8
±
3.
4
25
.1
±
6.
8
25
.9
±
4.
9
24
.4
±
7.
0
.6
3
.0
4
.8
8
W
ai
st
 c
irc
um
fe
re
nc
e,
 c
m
93
±
10
91
±
10
92
±
12
89
±
11
.8
4
<
.0
1
.2
5
A
rt
er
ia
l p
re
ss
ur
e
S
ys
to
lic
, m
m
H
g
10
9±
6
10
4±
6
11
9±
10
*
11
2±
8
<
.0
1
<
.0
1
.3
9
D
ia
st
ol
ic
, m
m
H
g
66
±
6
63
±
6
74
±
7*
69
±
7
<
.0
1
<
.0
1
.1
9
M
ea
n,
 m
m
H
g
78
±
5
74
±
5
86
±
8*
80
±
7
<
.0
1
<
.0
1
.2
6
R
es
tin
g
 h
ea
rt
 r
at
e,
 b
p
m
63
±
9.
8
57
±
7.
6
77
±
8.
7*
59
±
8.
9
.1
5
<
.0
1
.0
3
B
io
ch
em
ic
al
 p
ar
am
et
er
s
Fa
st
in
g 
gl
uc
os
e,
 m
m
ol
/L
4.
7±
0.
5
4.
6±
0.
5
4.
8±
0.
5
4.
7±
0.
5
.5
1
.0
1
.3
2
Fa
st
in
g 
In
su
lin
, m
m
ol
/L
7.
7±
6.
9
5.
9±
4.
3
13
.3
±
9.
3*
8.
4±
5.
0
.0
4
<
.0
1
.0
4
H
O
M
A
-IR
 in
de
x
1.
7±
1.
8
1.
3±
1.
1
3.
0±
2.
3*
1.
8±
1.
1
.0
4
<
.0
1
.0
4
To
ta
l C
ho
le
st
er
ol
, m
m
ol
/L
4.
5±
0.
9
4.
1±
 0
.8
4.
6±
1.
0
4.
5±
1.
1
.4
5
<
.0
1
.1
4
H
D
L 
C
ho
le
st
er
ol
, m
m
ol
/L
1.
2±
0.
3
1.
3±
0.
3
1.
1±
0.
2
1.
2±
0.
2
.1
9
<
.0
1
.8
8
LD
L 
C
ho
le
st
er
ol
, m
m
ol
/L
2.
8±
0.
8
2.
5±
0.
7
2.
8±
0.
8
2.
7±
0.
8
.5
8
<
.0
1
.5
8
Tr
ig
ly
ce
rid
es
, m
m
ol
/L
0.
8±
0.
4
0.
8±
0.
3
1.
4±
0.
9*
1.
1±
0.
5*
.0
2
.1
8
.1
9
A
lb
um
in
ur
ia
, m
g/
m
m
ol
 c
re
at
0.
4±
0.
3
0.
4±
0.
3
2.
4±
4.
4*
1.
7±
3.
0*
.0
4
.0
7
.0
8
P
hy
si
ca
l fi
tn
es
s
VO
2m
ax
 , 
m
L 
m
in
-1
 k
g-
1
28
.2
±
3.
7
31
.9
±
3.
5
27
.0
±
4.
0
30
.4
±
5
.3
2
<
.0
1
.5
2
M
ax
im
al
 h
ea
rt 
ra
te
, b
pm
18
6±
9
18
5±
7
18
9±
7
18
9±
6
.0
8
.5
7
.3
2
M
ax
im
al
 V
E
, L
/m
in
96
±
20
10
8±
10
88
±
19
99
±
18
 
.0
7
<
.0
1
.7
4
M
ax
im
al
 w
or
k 
lo
ad
, W
at
t
19
5±
27
21
0±
22
18
8±
25
20
4±
27
.2
7
<
.0
1
.5
3
Va
lu
es
 a
re
 m
ea
n±
S
D
. 
* 
P<
0.
05
 c
om
pa
re
d 
w
ith
 c
on
tro
ls
 b
ef
or
e 
tra
in
in
g 
(t-
te
st
). 
B
M
I: 
bo
d
y 
m
as
s 
in
de
x.
  
H
O
M
A
-I
R
: 
H
om
eo
st
at
ic
 M
od
el
 A
ss
es
sm
en
t 
of
 I
ns
ul
in
 
R
es
is
ta
nc
e.
 H
D
L:
 H
ig
h 
D
en
si
ty
 L
ip
op
ro
te
in
. 
LD
L:
 L
ow
 D
en
si
ty
 L
ip
op
ro
te
in
. 
R
es
ul
ts
 2
-w
ay
 A
N
O
VA
: 
G
ro
up
: 
pa
tie
nt
s 
vs
. 
co
nt
ro
ls
. 
In
te
rv
en
tio
n:
 m
ai
n 
ef
fe
ct
 e
xe
rc
is
e 
p
ro
gr
am
. G
ro
up
 x
 in
te
rv
en
tio
n:
 in
te
ra
ct
io
n 
be
tw
ee
n 
gr
ou
ps
 a
nd
 e
xe
rc
is
e 
tra
in
in
g
123
CARDIOVASCULAR EFFECTS OF EXERCISE TRAINING 
7
Ta
b
le
 2
   V
as
cu
la
r c
ha
ra
ct
er
is
tic
s 
of
 h
ea
lth
y 
co
nt
ro
ls
 a
nd
 fo
rm
er
ly
 p
re
ec
la
m
pt
ic
 w
om
en
, b
ef
or
e 
an
d 
af
te
r e
xe
rc
is
e 
tra
in
in
g
H
ea
lth
y 
co
nt
ro
l s
ub
je
ct
s 
(n
=
20
)
Fo
rm
er
ly
 p
re
ec
la
m
p
tic
 w
om
en
 
(n
=
24
)
2-
w
ay
 A
N
O
VA
 (
P
-v
al
ue
s)
B
ef
or
e 
tr
ai
ni
ng
A
fte
r 
tr
ai
ni
ng
B
ef
or
e 
tr
ai
ni
ng
A
fte
r 
tr
ai
ni
ng
G
ro
up
In
te
rv
en
tio
n
G
ro
up
  X
  
In
te
rv
en
tio
n
C
ar
ot
id
 A
rt
er
y 
(C
A
)
  R
es
tin
g 
di
am
et
er
, m
m
5.
6±
0.
5
5.
6±
0.
5
5.
7±
0.
6
5.
6±
0.
4
.9
8
.9
9
.7
4
  I
M
T,
 µ
m
47
7±
65
42
3±
65
58
0±
92
*
53
0±
13
8
<
.0
1
<
.0
1
.8
6
  W
al
l t
o 
lu
m
en
 ra
tio
0.
08
6±
0.
01
2
0.
07
6±
0.
01
2
0.
10
4±
0.
02
*
0.
09
5±
0.
02
5
<
.0
1
<
.0
1
.8
6
B
ra
ch
ia
l A
rt
er
y 
(B
A
)
  D
ia
m
et
er
 a
t b
as
el
in
e,
 m
m
2.
8±
0.
3
3.
0±
0.
3
3.
0±
0.
3
3.
1±
0.
3
.1
5
<
.0
1
.1
0
  F
M
D
, %
11
.8
±
3.
5
13
.3
±
3.
6
5.
3±
2.
2*
8.
1±
2.
7*
<
.0
1
<
.0
1
.5
8
  S
he
ar
 ra
te
 A
U
C
, ·
10
3  s
ec
-1
27
.9
±
10
.4
27
.1
±
12
.7
26
.3
±
 1
1.
2
24
.3
±
13
.1
.4
4
.4
1
.9
3
  T
im
e 
to
 p
ea
k 
di
am
et
er
, s
ec
48
±
15
51
±
13
50
 ±
14
59
±
20
.2
6
.0
8
.4
3
S
up
er
fic
ia
l F
em
or
al
 A
rt
er
y 
(S
FA
)
  D
ia
m
et
er
 a
t b
as
el
in
e,
 m
m
5.
6±
0.
7
5.
8±
0.
6
5.
7±
0.
7
5.
7±
 0
.7
.9
0
.8
1
.8
4
  F
M
D
, %
8.
7±
3.
2
10
.5
±
2.
8
4.
9±
2.
1*
6.
1±
2.
2*
<
.0
1
<
.0
1
.9
8
  S
he
ar
 R
at
e 
AU
C
, ·
10
3 
s-
1
14
.5
±
9.
1
14
.7
±
5.
5
15
.8
±
10
.5
14
.4
±
9.
1
.8
2
.5
3
.6
9
  T
im
e 
to
 p
ea
k 
di
am
et
er
, s
ec
83
±
36
74
±
27
85
±
36
78
±
38
.6
2
.0
8
.8
8
  G
TN
, %
11
.9
±
4.
0
13
.0
±
3
10
.9
±
3.
3
12
.1
±
2.
1
.2
4
.0
4
.7
5
Va
lu
es
 a
re
 m
ea
n±
S
D
. *
 P
<
0.
05
 c
om
pa
re
d 
w
ith
 c
on
tro
ls
 b
ef
or
e 
tra
in
in
g 
(t-
te
st
). 
IM
T:
 in
tim
a 
m
ed
ia
 th
ic
kn
es
s,
 F
M
D
: fl
ow
 m
ed
ia
te
d 
di
la
tio
n,
 A
U
C
: a
re
a 
un
de
r t
he
 c
ur
ve
, 
G
TN
: 
gl
yc
er
yl
 t
rin
itr
at
e 
R
es
ul
ts
 2
-w
ay
 A
N
O
VA
: 
G
ro
up
: 
pa
tie
nt
s 
vs
 c
on
tro
ls
. 
In
te
rv
en
tio
n:
 m
ai
n 
ef
fe
ct
 e
xe
rc
is
e 
p
ro
gr
am
. 
G
ro
up
 x
 in
te
rv
en
tio
n:
 in
te
ra
ct
io
n 
be
tw
ee
n 
gr
ou
ps
 a
nd
 e
xe
rc
is
e 
tra
in
in
g.
124
CHAPTER 7
Ta
b
le
 3
   A
ut
on
om
ic
 c
ha
ra
ct
er
is
tic
s 
of
 h
ea
lth
y 
co
nt
ro
ls
 a
nd
 fo
rm
er
ly
 p
re
ec
la
m
pt
ic
 w
om
en
, b
ef
or
e 
an
d 
af
te
r e
xe
rc
is
e 
tra
in
in
g
H
ea
lth
y 
co
nt
ro
l s
ub
je
ct
s 
 
(n
=
20
)
Fo
rm
er
ly
 p
re
ec
la
m
p
tic
 w
om
en
 
(n
=
24
)
2-
w
ay
 A
N
O
VA
 (
P
-v
al
ue
s)
B
ef
or
e 
tr
ai
ni
ng
A
fte
r 
tr
ai
ni
ng
B
ef
or
e 
tr
ai
ni
ng
A
fte
r 
tr
ai
ni
ng
G
ro
up
In
te
rv
en
tio
n
G
ro
up
 X
 
In
te
rv
en
tio
n
H
ea
rt
 R
at
e 
Va
ria
b
ili
ty
 a
na
ly
si
s
  L
F 
po
w
er
, m
s2
  
10
05
±
32
9
91
1±
31
5
14
55
±
52
6*
11
06
±
44
2
<
.0
1
.0
7
.2
7
  H
F 
po
w
er
, m
s2
80
6±
25
9
96
5±
36
9
76
8±
27
6
78
9±
29
4
.0
4
.1
9
.4
1
  L
F/
H
F 
ra
tio
1.
3±
0.
4
1.
0±
0.
3
2.
2±
1.
0 
*
1.
5±
0.
6*
<
.0
1
<
.0
1
.5
1
  B
R
S
, m
s·
m
m
H
g-
1
17
.6
±
5.
7
22
.1
±
7.
9
8.
5±
3.
6*
12
.5
±
5.
1*
<
.0
1
<
.0
1
.8
6
Va
lu
es
 a
re
 m
ea
n±
S
D
. *
 P
<
0.
05
 c
om
pa
re
d 
w
ith
 c
on
tro
ls
 b
ef
or
e 
tra
in
in
g 
(t-
te
st
). 
LF
 L
ow
 F
re
qu
en
cy
, H
F:
 H
ig
h 
Fr
eq
ue
nc
y,
 B
R
S
 b
ar
or
ec
ep
to
r s
en
si
tiv
ity
 .R
es
ul
ts
 2
-w
ay
 
A
N
O
VA
: G
ro
up
: p
at
ie
nt
s 
vs
 c
on
tro
ls
. I
nt
er
ve
nt
io
n:
 m
ai
n 
ef
fe
ct
 e
xe
rc
is
e 
p
ro
gr
am
. G
ro
up
 x
 in
te
rv
en
tio
n:
 in
te
ra
ct
io
n 
be
tw
ee
n 
gr
ou
ps
 a
nd
 e
xe
rc
is
e 
tra
in
in
g.
125
CARDIOVASCULAR EFFECTS OF EXERCISE TRAINING 
7
Effects of training 
Twelve weeks of training improved physical fitness in both groups to the same extent, 
because VO2max increased by 14±8% in control subjects and 13±7% in patients 
(Table 1). Training reduced HRrest, SAP, DAP, MAP, BMI, waist circumference, fasting 
glucose, insulin, total cholesterol and LDL cholesterol concentrations in formerly 
preeclamptic women and control sunjects, while it increased HDL cholesterol. The 
reduction in HRrest and fasting insulin concentration was 14% and 13% respectively, 
which was more in formerly preeclamptic women than in control subjects. Training 
abolished differences in blood pressure and insulin resistance between formerly 
preeclamptic women and control subjects. Albuminuria and triglyceride concentration 
remained higher in formerly preeclamptic women than in control subjects after 
training (Table 1). Training reduced CA-IMT and increased BA- and SFA-FMD 
responses in formerly preeclamptic women and control subjects to a similar extent 
(Fig. 1) indicating improved endothelial function. Yet, values did not normalize in 
formerly preeclamptic women. Training did not affect shear rate AUC, time-to-peak of 
FMD or vasodilatation in response to GTN in either group (Table 2). Training reduced 
LF/HF ratios and increased BRS to a similar extent in both groups. Sympathetic 
dominance and the reduced BRS did not normalize in formerly preeclamptic women, 
and remained significantly elevated compared to trained control subjects (Table 3). 
Correlations. Training similarly improved autonomic functioning (delta LF/HF) and 
endothelial function (delta FMD) in women with a history of preeclampsia and control 
subjects. Training induced changes in sympathetic dominance and endothelial 
function correlate inversely in both BA and SFA. (Fig 2)
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Figure 1  Effect of exercise training on A. carotid artery intima-media thickness (CA, IMT) 
B. Brachial artery flow mediated dilation (BA, FMD) and C. Superficial femoral artery flow 
mediated dilation (SFA, FMD) in healthy control subjects (n=20) and formerly preeclamptic 
women (n=24). Before (black bars) and after (grey bars) 12 weeks exercise training. Error bars 
represent SE; * t-test formerly preeclamptic women compared with control subjects before 
training (P<.05 ).
A
B
C
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Discussion
The cardiovascular and autonomic effects of aerobic training in formerly preeclamptic 
women have not been studied previously. This study demonstrates that formerly 
preeclamptic women and healthy parous control subjects can improve their cardio- 
vascular risk profile with 12 weeks of exercise training. The improvement of components 
of the metabolic syndrome in both groups suggests reduced biochemical vascular 
stress. The cardioprotective effects of training in formerly preeclamptic women and 
Figure 2  Correlation between exercise induced changes in LF/HF ratio and changes in flow 
mediated dilation (FMD%) in A. Brachial artery (BA) and B. superficial femoral artery (SFA) in 
response to 12 weeks of exercise training in healthy control subjects (n=20) and formerly 
preeclamptic women (n=24). The dashed line represents the regression line of controls, and 
the thick black line represents the regression line of formerly preeclamptic women. R represents 
the Pearson correlation coefficient.
A
B
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healthy post partum women are further supported by the improved endothelial 
function (BA- & SFA- FMD), vascular structure (CA-IMT) and autonomic function (LF/
HF and BRS). Despite these improvements, exercise training did not normalize 
vascular and autonomic variables in formerly preeclamptic women. Interestingly, we 
found that exercise induced vascular improvements correlated with training induced 
changes in autonomic functioning in both healthy control subjects and formerly 
preeclamptic women. 
In our study, baseline physical fitness was not different between formerly preeclamptic 
women and controls. Our baseline data were similar to those of previous cross- 
sectional studies that reported increased prevalence of traditional cardiovascular 
risk factors6,8,33, vascular dysfunction9-11,35, increased vascular wall thickness12 and 
increased sympathetic activity13 in formerly preeclamptic women compared to control 
subjects. The comparable GTN responses between groups are in agreement with 
previous studies suggesting endothelial dysfunction, rather than vascular smooth 
muscle cell dysfunction in formerly preeclamptic women9,29. Our study adds the novel 
observation that endothelial dysfunction in formerly preeclamptic women represents 
a systemic process, because endothelial function was impaired in both BA an SFA 
and arterial wall was thickened in yet another vascular bed (CA). Another novel 
observation was the correlation between endothelial dysfunction and sympathetic 
dominance. High sympathetic outflow in conjunction with endothelial dysfunction is 
thought to have synergistic and detrimental effects on cardiovascular risk36. 
Particularly interesting is the potential of detecting these risk profiles in women at an 
early enough stage to benefit from low-cost interventions such as modification of 
lifestyle. 
The training program (12 weeks of cycling at 70-80% VO2max for 2 to 3 times per 
week) increased VO2max to the same extent in both groups. The improvement of 
physical fitness was within the expected range37. Training improved most traditional 
cardiovascular risk factors to the same extent in formerly preeclamptic women and 
control subjects. HRrest and HOMA reductions were more pronounced in formerly 
preeclamptic women than in control subjects. Most likely this reflects the higher 
baseline values in formerly preeclamptic women. The beneficial effects of exercise 
training cannot be explained by changes in traditional cardiovascular risk factors 
alone17, but also by direct effects on vasculature and autonomic nervous system. In 
our study, vascular and autonomic variables improved similarly in both groups. The 
effects in all studied arteries suggest a systemic effect of exercise training on the 
vasculature. Studies have demonstrated that exercise induced changes in shear 
stress provide the principal physiological stimulus to adaptation in vascular function 
and structure, likely by enhancing nitric oxide bioavailability38, but also by effects on 
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other angiogenic factors (e.g. endothelin-139, angiotensin-2, VEGF and oxidative 
stress)40. The change in FMD with training correlated inversely with the change in LF/
HF in both groups (Figure 2). This is in line with cross-sectional studies in healthy men 
that have shown that tonic elevation in sympathetic nerve activity is associated with 
increased IMT41 and reduced FMD42. These data suggest that FMD not only reflects 
NO mediated endothelial vasodilation but that FMD is also affected by alterations in 
sympathetic activity.
We did not observe a difference in baseline VO2max between formerly preeclamptic 
women and controls. This may originate from unintended selection of controls with 
relatively poor VO2max recruited by newspaper advertisement. Women with 
subjectively poor fitness may have had an incentive to participate in the study, 
knowing that their cardiovascular health would be assessed as well as improved by 
training. However, despite the similar VO2max, age and BMI between formerly 
preeclamptic women and control subjects, comparisons between groups indicate 
significant differences in metabolic, circulatory and autonomic profiles between 
groups. This observation suggests that these differences in circulatory and metabolic 
profiles do not originate from differences in a priori physical fitness levels. The 
formerly preeclamptic women included in our study were referred to our tertiary 
center. This may have led to overrepresentation of more severely complicated 
pregnancies, explaining the median gestational age of 32 weeks. Care should 
therefore be taken to extrapolate our findings to the general formerly preeclamptic 
population (including women who developed preeclampsia at term). In a previous 
study, we demonstrated that the prevalence of cardiovascular risk factors increase 
with a earlier onset of preeclampsia43. It is conceivable that the baseline differences 
between formerly preeclamptic women and controls are limited to a particularly high 
risk set of women. 
Another potential limitation is that participants were studied 6 to 12 months 
postpartum. Even though >80% of recovery takes place within 6 months, recovery 
may have been incomplete44. If one would assume that recovery in our study was 
only 80%, later testing at higher baseline fitness, using the same training program, 
most likely would have resulted in smaller training effects. Because the post-partum 
interval was similar for both groups, it is unlikely that the postpartum interval has 
affected the comparisons between formerly preeclamptic women and controls in our 
study.
Perspectives
Formerly preeclamptic women are at increased cardiovascular risk. The risk of a 
cardiovascular event after preeclampsia is estimated to be 2-fold compared to 
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women who had normotensive pregnancies. Because the risk of a cardiovascular 
event increases with age, absolute risk at 60-69 years would be 14.2% and 30.7% for 
a woman without and with a history of preeclampsia, suggesting that a woman who 
had preeclampsia might become eligible for primary prevention at an earlier age1. 
We observed that training markedly improved indicators of cardiovascular health in 
formerly preeclamptic women, suggesting reduction in the risk of recurrent 
preeclampsia and cardiovascular disease in later life. Our vigourous and supervised 
training program (12 weeks of cycling at 70% VO2max, 2 to 3 times per week) was 
unable to normalize vascular and autonomic variables in formerly preeclamptic 
women. One might argue that 12 weeks training is not long enough for formerly 
preeclamptic women to achieve full normalization of cardiovascular and metabolic 
functions. Our study is at least the proof of principle that the cardiovascular risk profile 
in formerly preeclamptic women is amenable to lifestyle interventions.  At any rate, 
our data support the recommendation of exercise training in post partum women, 
especially in women with a history of preeclampsia. Future studies will have to 
evaluate whether longer duration of exercise training, less supervised or different 
types of exercise training (resistance training, combined aerobic + resistance 
training) equally or even more effectively reduce cardiovascular risks and whether 
exercise training may improve future pregnancy outcomes in women with a history of 
preeclampsia.  Based on observations in other populations, but with longer training 
programs, it is likely that formerly preeclamptic women can continue to improve their 
cardiovascular risk profile with continued training45. This idea is supported by the 
general lack of interaction effects in our study, suggesting a similar response to the 
exercise stimulus between formerly preeclamptic women and controls. 
Conclusions
Exercise training in women with a history of preeclampsia improves traditional 
cardiovascular risk factors, endothelial function, vascular wall thickness and 
autonomic balance. Nonetheless after 12 weeks training, formerly preeclamptic 
women only reached a vascular and autonomic status that is comparable to sedentary 
control subjects, stressing the recommendation of prolonged exercise training in 
young women with a latent cardiovascular risk profile that is unmasked by their 
hypertensive pregnancy course. 
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Abstract
Blood flow patterns in conduit arteries characterised by high levels of retrograde 
shear stress can be detrimental for vascular health. In this study we examined whether 
retrograde shear rate and endothelial function are related in healthy control subjects 
and formerly preeclamptic women and whether this relationship is altered by exercise 
training. 
Formerly preeclamptic women (32±4 years, n=20) and control subjects (32±4 years, 
n=20), all 6 to 12 months post-partum, performed 12 weeks aerobic exercise training. 
We measured brachial artery shear rate (SR) and endothelial function by flow-mediated 
dilation (FMD, echo-Doppler). We additionally performed power spectral analysis of 
heart rate variability and calculated low-frequency/high-frequency (LF/HF) ratio. 
Antegrade SR was not different between groups, while retrograde SR was significantly 
higher and FMD% lower in formerly preeclamptic women compared with control 
subjects (both P<.05). Retrograde shear correlated strongly with FMD% in formerly 
preeclamptic women and controls (P<.05). LF/HF ratio inversely correlated with 
brachial artery retrograde SR and FMD% (both P<.05) in formerly preeclamptic 
women and controls. Exercise training reduced retrograde shear, improved FMD%, 
and reduced LF/HF-ratios similarly in both groups (all P<.05). Training-induced 
changes in retrograde SR correlated with changes in FMD% and LF/HF ratio. 
A higher brachial artery retrograde SR relates to lower brachial artery endothelial 
function, in both controls and formerly preeclamptic women. Exercise training 
improves retrograde SR, whilst the magnitude of this change correlated strongly 
with improvements in FMD and reductions in LF/HF ratio. Therefore, the impact of 
preeclampsia and exercise training on endothelial health may, at least partly, be 
related to retrograde shear rate. 
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Introduction
Shear stress, i.e. the frictional force of blood on the arterial wall,  represents a key 
stimulus for adaptation in artery function and structure1,2. Changes in shear stress 
directly influence the endothelium of arteries, which plays a crucial role in the 
regulation of blood flow and maintanance of the quaility of blood vessels. Across the 
cardiac cycle, shear stress demonstrates a typical pattern, flowing toward the 
periphery during systole (antegrade shear), and back to the heart during diastole 
(retrograde shear). Increases in shear stress are beneficial for arterial function, while in 
vitro and animals studies have demonstrated that shear stress patterns characterised 
by high levels of retrograde shear can increase the expression of pro-atherogenic 
genes (see reviews3-5) with consequent detrimental impacts for vascular health6. We 
recently observed within subjects, that an increase in retrograde shear rate is followed 
by an immediate “dose”-dependent decrease in endothelial function6. To date, no 
study has examined whether retrograde shear rate relates to endothelial dysfunction 
between humans and whether such relationships differ between healthy subjects 
and those with a priori endothelial dysfunction. We therefore measured endothelial 
function and resting shear pattern in healthy women and formerly preeclamptic women, 
the latter possessing endothelial dysfunction7. In the current study we hypothesised 
that increased levels of retrograde shear rate would be associated with lower 
endothelial function in healthy subjects as well as in those with endothelial dysfunction. 
The mechanisms that account for an increased risk of cardiovascular disease in 
women with a history of preeclampsia are not well understood, but endothelial 
dysfunction, which has been linked to atherosclerosis, persists in formerly preeclamptic 
women many years after an hypertensive pregnancy. Endothelial dysfunction and 
cardiovascular disease after preeclampsia may be attributable to preexisting risk 
factors8. A recent study of cardiovascular risk factors present before and after 
pregnancy suggest that nearly half of the elevated risk for future hypertension after 
preeclampsia can be explained by prepregnancy risk factors. However, further 
investigation will be necessary to determine whether preeclampsia itself may injure 
the endothelium and thereby increase the risk of atherosclerosis and cardiovascular 
disease. 
Exercise training is a stimulus which improves endothelial function in healthy subjects 
as well as in groups with a priori endothelial dysfunction9,10. To date, no study has 
specifically examined whether exercise training affects shear rate patterns, or also 
whether exercise training-induced changes in shear pattern relate to adaptations in 
endothelial function. Therefore, we examined the effects of 12 week exercise training 
on the relationships between retrograde shear and endothelial function. We 
hypothesized that exercise training would reduce retrograde shear and improve 
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endothelial function, without altering the reciprocal relationships between these 
factors. Previous data demonstrated that (changes in) retrograde shear is related to 
muscle sympathetic nerve activity11. To further explore this relation with activity of the 
autonomic nerve system, we examined autonomic modulation by power spectral 
analysis of resting heart rate variability and related this outcome to retrograde shear 
rate levels and endothelial function (before and after training). 
Materials and methods
Subjects
Twenty healthy female participants and 20 women with a history of preeclampsia 
participated in our study (Table 1). Preeclampsia was diagnosed in the previous 
pregnancy, if women had blood pressure of ≥140/90 mmHg, measured twice, six or 
more hours apart, and consistent proteinuria of ≥300 mg/24 hours after gestational 
week 20 in previously normotensive women. All subjects were 6 to 12 post-partum to 
control for the interval between delivery and cardiovascular evaluation, all women 
were primiparous. None reported having been diagnosed with cardiovascular 
disease, diabetes mellitus, insulin resistance or cardiovascular risk factors (such as 
hypercholesterolemia or hypertension). Subjects who smoked or were on medication 
of any type were excluded from participation. Informed consent was gained from 
all participants prior to the experimental procedures. The study procedures were 
approved by the local ethics committee of the Radboud University Nijmegen Medical 
Centre (CMO: 2008/226) and adhered to the Declaration of Helsinki. The study was 
registered at clinicaltrials.gov under id: NCT00900458.
Experimental design
Measurements and training were performed in the nonpregnant state, 6 to 12 months 
after pregnancy. Subjects were tested before and after 12 weeks of exercise training 
according to a standardized protocol.  All measurements, except for VO2max, were 
performed during the same visit. VO2max was tested 1 to 5 days from the other visit.
Measurements
Subjects reported to the laboratory after an overnight fast and were instructed to 
abstain from alcohol and caffeine for 16 hours, and not to perform any exercise in the 
24 hours preceding the measurements12. To minimize possible endocrine influences 
of the sex hormones on the cardiovascular and autonomic nervous systems, all 
measurements were performed in the follicular phase of the menstrual cycle, between 
day 3 and 1113,14. Upon arrival at the laboratory, body characteristics were measured. 
A venous blood sample was taken for fasting glucose and lipid profile and kidney 
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function (Aeroset, Abbot Laboratories, Illinois USA). All tests were performed under 
standardized conditions in a temperature-controlled room (22±0.5ºC). Subjects then 
rested in supine position for 20 minutes, followed by assessment of blood pressure. 
Blood pressure and heart rate were measured oscillometrically (Dinamap, Vital Signs 
Monitor 1846, Critikon, Tampa, Florida) at 3-minute intervals for 30 minutes at the 
right upper arm. We used the median values of 9 consecutive measurements. 
Measurements were done with the cuff size recommended for the arm circumference15. 
This was followed by assessment of autonomic balance and, subsequently, brachial 
artery blood flow and shear rate patterns and endothelial function via the flow-mediated 
dilation technique (FMD).
Brachial artery shear rate pattern and endothelium dependent, nitric oxide-mediated 
dilation (FMD). Vascular assessments were conducted in a quiet, temperature- 
controlled environment and in accordance with recent guidelines12. To examine 
brachial artery shear patterns and flow-mediated dilation (FMD), the arm was 
extended and positioned at an angle of ~80° from the torso. A rapid inflation and 
deflation pneumatic cuff (D.E. Hokanson, Bellevue, WA) was positioned around the 
forearm to provide a stimulus to forearm ischemia. A 10-MHz multi- frequency linear 
array probe, attached to a high-resolution ultrasound machine (T3000; Terason, 
Burlington, MA) was then used to image the brachial artery in the distal of the upper 
arm. Continuous Doppler velocity assessments were also obtained using the 
ultrasound, and were collected using the lowest possible insonation angle (always 
<60°). First, we performed a 1 minute baseline recording of brachial artery diameter 
and velocity to calculate the mean, antegrade and retrograde shear rate. Shear rate 
was defined as 4 · velocity/diameter16. Oscillatory shear index, an indicator of the 
magnitude of shear oscillation, was defined as area-under-the-curve (retrograde 
shear)/(antegrade shear + retrograde shear)11,17. The mean brachial artery blood flow 
was calculated based on continuous measurement of blood velocity and diameter of 
brachial artery (Flow= π·radius2 · velocity). Mean resting brachial blood flow of the 
one minute recording was taken. Brachial vascular resistance was subsequently 
estimated by dividing the mean arterial pressure by brachial artery blood flow.
Subsequently, the forearm cuff was inflated (>200 mmHg) for 5 minutes. Diameter 
and flow recordings resumed 30 sec prior to cuff deflation and continued for 3 
minutes thereafter12,16. Post-test analysis of brachial artery diameter and velocity was 
performed using custom-designed edge-detection and wall-tracking software, which 
is independent of investigator bias. Recent papers contain detailed descriptions of 
our analysis approach18. Peak diameter was automatically detected according to an 
algorithm and is described in detail elsewhere19. With this technique data could be 
analyzed with a temporal resolution of 30 Hz, and a spatial resolution of ~0.0065 cm 
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for diameter and ~1cm/s for velocity. Reproducibility of FMD using this semi-automated 
software possesses a CV of 6.7-10.5%6. The post-deflation shear rate data, derived 
from simultaneously acquired velocity and diameter measures, was used to calculate 
the area under the shear rate curve (SRAUC) for data up to the point of maximal 
post-deflation diameter for each individual20.
Physical Fitness. We examined physical fitness before and after a 12 weeks training 
program. Fitness was defined as the peak oxygen uptake (VO2max, mL min
-1 kg-1) 
during a maximal cycling test on a cycle ergometer (Excalibur Sport, Lode BV, 
Groningen NL). Tests were performed in the afternoon, after a light lunch ad libitum. 
The initial workload was set at 10W for 1 minute, followed by 10W increments every 
minute until complete exhaustion. Breath by breath oxygen uptake was measured 
using spiroergometric equipment (Quark CPET, Cosmed, Italy). Heart rate and 
rhythm were continuously recorded by 3 lead ECG. Maximal workload (Workmax) 
was defined as the last completed workload before exhaustion. Test performance 
was considered to be adequate when: 1. The increase in VO2 (mL) during Workmax 
was <150ml compared to the previous workload, indicating plateau formation in 
oxygen uptake, 2. HR at Workmax was <10 bpm from estimated maximal heart rate 
(220-age), 3. Respiratory Exchange Ratio (RER, CO2/O2) was consistently >1.1 
during Workmax, and 4. Capillary lactate level was >8mmol/L, 90 seconds after 
exhaustion. If the test failed to achieve these 4 qualifications the test was repeated 2-3 
days later. In three cases (2 formerly preeclamptic women, 1 control) the test had to 
be repeated, all tests were eventually considered adequate.
Autonomic function. We quantified autonomic modulation by spectral analysis from 
a 5-minute recording of spontaneous fluctuations in HR and BP21. Heart-rate and 
arterial blood pressure (ABP) were measured continuously at a sampling rate of 
100Hz using a finger ABP-monitoring device attached to the 3rd digit of the right hand 
(Finometer, Finapres BV, the Netherlands). Measurements were performed in a quiet, 
partially darkened room with subjects comfortably lying in the supine position. 
Posttest, these recordings were subdivided into data segments of 100s, overlapping 
for 50% and resampled at 5.12 Hz. Each segment was then analyzed with fast Fourier 
transformation that searches for rhythmic fluctuations in systolic blood pressure 
(BPsys) and pulse interval with a frequency range between 0 and 2.56 Hz. The 
amplitude of each fluctuation determines the power at each frequency. As an indicator 
of autonomic modulation we used the ratio of absolute low frequency (LF) and high 
frequency (HF) powers of the pulse interval representing the cardiac autonomic 
balance between the sympathetic and vagal system respectively (LF/HF)21.
141
SHEAR STRESS AND ENDOTHELIAL FUNCTION 
8
Exercise training
Exercise training consisted of 12 weeks of HR controlled cycle training (cycle 
ergometer, Corival, Lode BV, Groningen Netherlands) at 70-80% of VO2max for 2 to 3 
times per week. Participants trained twice a week during the first 6 weeks and 3 times 
a week during the last 6 weeks. During each training session, heart rate was 
continuously monitored and recorded (RS800CX, Polar Electro Inc, NY USA). Each 
training session started with 10 minutes warming-up at 50% of the heart rate reserve 
(HRR) above the resting heart rate. HRR was calculated as: HRR=HRmax-HRrest  in 
which HRmax is the maximal heart rate measured during the fitness test at study entry 
and HRrest is the heart rate determined at rest. Training consisted of 40 minutes of 
cycling between 70-80% of the individual HRR above HRrest. Within their target heart 
rate zone, participants were free to choose the number of revolutions per minute 
(RPM). The training was completed by cooling down for 5 minutes at warming-up 
workload.
Statistics
Statistical analyses were performed using SPSS 17.0 (SPSS, Chicago, Illinois) 
software. All data were reported as mean±SD unless stated otherwise, while 
statistical significance was assumed at P<.05. Two-way repeated-measures ANOVA 
were used to examine differences between groups and to assess the effects of 
training. Pearson’s correlation coefficient was used to examine the relation between 
retrograde shear rate, FMD and LF/HF ratio’s in both groups before and after exercise 
training.
Results
Baseline differences between healthy controls versus formerly 
preeclamptic women
Clinical and biochemical characteristics. Formerly PE-women demonstrated higher 
systolic and diastolic blood pressure and higher triglycerides, but all were within the 
normal range. Although fasting blood glucose levels were comparable between 
groups, formerly preeclamptic women had higher fasting insulin levels. Physical 
fitness at baseline was comparable between groups (Table 1).
Shear pattern and endothelial function. Mean brachial artery blood flow was not 
different between formerly preeclamptic women and controls (31±6 mL/min versus 
29±5 mL/min, respectively, P=.09). However, when correcting for differences in 
blood pressure, we found a significantly higher brachial artery vascular resistance in 
formerly preeclamptic women compared to control subjects (3.1±0.5 mL/min/mmHg 
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versus 2.6±0.5 mL/min/mmHg, P=.01). Antegrade and mean shear rate were not 
different between groups (102±21 s-1 versus 90±32 s-1, P= .17 and 68±20 s-1 versus 
73±28 s-1, P=.48 respectively), while retrograde shear rate was significantly higher in 
formerly PE-women compared to healthy controls (-33±13 s-1 versus -17±10 s-1 
P<.001) (Figure 1). Oscillatory shear index was significantly higher in formerly 
preeclamptic women compared to controls (0.6±0.3 versus 0.3±0.2, P=.002). A lower 
brachial artery FMD% was found in formerly preeclamptic women compared to 
control subjects (Table 2). A strong and significant correlation was found between 
brachial artery retrograde shear rate and FMD% in controls and formerly preeclamptic 
women, as well as for the pooled data set of controls and formerly preeclamptic 
women (Figure 2).
Figure 1  Baseline brachial artery mean (grey bars), antegrade (black bars)  and retrograde 
shear (white bars) rate in healthy women (controls, n=20) and women with history of preeclampsia 
(formerly PE, n=20) before and after 12-weeks exercise training. All women were 6-12 months 
post-partum. Error bars represent SE. * P < .05 compared to baseline. # P<.05 compared to 
healthy controls at baseline.
A Controls
B Formerly preeclamptic women
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Autonomic function. Absolute low-frequency and high-frequency power and LF/HF 
ratio were higher in formerly preeclamptic women compared to healthy control 
subjects (P=.01, P=.03  and P<.001 respectively) (Table 3). A correlation existed 
between the LF/HF ratio and brachial artery FMD% in the pooled data set (r=-0.62, 
P<.001), but also when examined in controls (r=-0.69, P=.001) and formerly 
preeclamptic women only (r=-0.42, P=.04) (Figure 3A). In addition, a strong and 
significant correlation was present between the LF/HF ratio and the retrograde shear 
rate for the pooled data set (r=-0.79, P<.001) as well as in both controls (r=-0.69, 
P=.001) and formerly preeclamptic women (r=-0.73, P<.001) (Figure 3B).
Impact of 12-week exercise training
Healthy controls and formerly preeclamptic women. Exercise training decreased 
blood pressure and tended to lower BMI in both groups (Table 1). Exercise training 
lowered fasting insulin levels and improved VO2max similarly in both groups (Table 1). 
Waist-to-hip-ratio, glucose, cholesterol, HDL, LDL, triglycerides and creatinine did not 
change after training (Table 1). Exercise training had no effect on resting mean and 
antegrade shear rate in both controls and formerly preeclamptic women (Figure 1). 
We observed a significantly reduced retrograde shear rate in controls after exercise 
training, but also in formerly preeclamptic women (Figure 1). In both controls and formerly 
preeclamptic women, twelve weeks exercise training improved brachial FMD% and 
Figure 2  Correlation between brachial artery retrograde shear rate and brachial artery flow- 
mediated dilation (FMD%, presented as a relative change from baseline diameter) in healthy 
women (controls, n=20) and women with preeclampsia during their pregnancy (formerly PE, 
n=20). All women were 6-12 months post-partum.
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lowered LF/HF (Table 2 and 3 respectively). The 2-way ANOVA interaction effect 
revealed that the magnitude of change in retrograde shear rate, FMD% or LF/HF ratio 
did not differ between controls and formerly preeclamptic women.
Correlations. The pooled data set revealed that the magnitude of the reduction in 
retrograde shear rate correlated with the improvement in FMD% (r=-0.61, P<.001, 
Figure 4A), but also with reduction in LF/HF ratio (R=0.60 P<.001, Figure 4B). When 
analysed per group both controls (r= -0.66 P=.002) and formerly preeclamptic 
Figure 3  Correlation between resting autonomic balance (LF/HF ratio) and brachial artery 
flow-mediated dilation (A, FMD%, presented as a relative change from baseline diameter) 
and brachial artery retrograde shear rate (B, s-1) in healthy women (controls, n=20) and women 
with preeclampsia during their pregnancy (formerly PE, n=20). All women were 6-12 months 
post-partum.
A
B
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women (r=-0.62, P=.004) showed a significant correlation between the change in 
retrograde shear and the training induced improvement of FMD%. In turn, the change 
in retrograde shear correlated strongly with the exercise-induced change in LF/HF 
ratio in patients (r=0.82, P<.001), but not in controls (r=0.37, P=.10) (Figure 4B). 
Figure 4  Correlation between the absolute change mediated by 12-weeks exercise training 
in brachial artery retrograde shear rate (s-1, a ‘negative’ change relates to a smaller retrograde 
shear rate, i.e. more towards ‘0’) and brachial artery flow-mediated dilation (A, FMD%, presented 
as a relative change from baseline diameter) and autonomic balance (B, LF/HF ratio) in healthy 
women (controls, n=20, open circles) and women with preeclampsia during their pregnancy 
(formerly PE, n=20, solid circles).
A
B
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Discussion 
This study has a number of novel findings. First, we demonstrated, using a between- 
subject approach, that brachial artery retrograde shear rate under resting conditions 
has a strong and inverse relationship with brachial artery endothelial function. This 
finding was observed in healthy subjects, but also in subjects with a history of pre- 
eclampsia who possessed brachial artery endothelial dysfunction. Second, in both 
groups, we found significant relationship between retrograde shear rate and estimated 
sympathetic dominance. Therefore, a higher resting retrograde shear rate correlates 
with the presence and magnitude of endothelial (dys)function in healthy humans as 
well as in formerly preeclamptic women. Third, we showed that exercise training is an 
effective strategy to diminish retrograde shear rate, and also to improve endothelial 
function and autonomic balance in healthy controls and formerly pre-eclamptic women. 
Finally, we demonstrated a strong correlation between the decrease in retrograde shear 
rate after training and the improvement after 12-weeks exercise training in endothelial 
function. Taken together, these findings suggest that retrograde shear relates to 
changes in arterial function in humans in vivo, with exercise training representing an 
effective strategy to improve retrograde shear rate and arterial function.
We compared two distinct groups who demonstrated differences in resting shear 
pattern and endothelial function. Women with a history of preeclampsia showed a 
higher retrograde shear rate compared to healthy controls. The higher levels of 
resting retrograde shear rate were accompanied by a significantly lower endothelial 
function, a well-established finding in women with a history of preeclampsia that is 
believed to contribute to their increased risk for future cardiovascular disease7,22-24 
The correlation between retrograde shear rate and endothelial function between 
subjects, is in line with the presence of endothelial dysfunction after an acute increase 
in retrograde shear using a within-subject approach6. Another novel observation was 
that the correlation between retrograde shear rate and endothelial function is present 
in healthy control subjects (i.e. ‘normal’ endothelial function) and formerly preeclamptic 
women (i.e. endothelial dysfunction). This suggests that the relation between 
retrograde shear rate and magnitude of the endothelial function is independent of a 
priori endothelial dysfunction in humans. 
The underlying mechanisms for the higher retrograde shear rate in previously PE 
women may relate to increases in vascular tone in the resistance vessel beds. Indeed, 
formerly PE-women demonstrated a significantly higher blood pressure compared 
to healthy controls, a finding which may be related to higher peripheral vascular 
tone compared to healthy controls. A potential explanation for the higher vascular 
resistance, and therefore retrograde shear rate, may relate to the sympathetic nervous 
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system. Padilla et al. recently found that acute elevations in muscle sympathetic 
nervous activity are associated with an increase in conduit artery retrograde and 
oscillatory shear11. Increased sympathetic activity has been demonstrated in formerly 
preeclamptic women25. In our study we examined LF/HF-ratio, which provides an 
indirect measure of (cardiac) sympathetic activity pattern, and we found that 
increased LF/HF ratio was associated with higher retrograde shear rate. While 
previous studies have convincingly reported a strong relation between the sympathetic 
nervous system and endothelial function, these studies assessed changes in this 
relation after acute elevations in sympathetic nerve activity26,27 rather than resting 
levels of activity such as in the present study. It should be noted that our measurement 
of LF/HF-ratio does not provide direct information about muscle sympathetic nerve 
activity. Although speculative, this provides evidence that higher retrograde shear 
rate may be related to activity of the sympathetic nervous system, and that subsequent 
increased retrograde shear rate may relate to changes in endothelial function. 
Recent studies have demonstrated that an increased retrograde shear rate in healthy 
older men is related, at least partly, to a decreased contribution of nitric oxide to 
vascular tone and/or increased alpha-adrenergic tone28-30. Similarly, such explanations 
may relate to our study, as changes in these vasoactive substances relate to the 
increased retrograde shear rate (or reversal in retrograde shear rate after training) in 
formerly preeclamptic women. Previous studies have demonstrated that higher levels 
of vasoactive constrictors (e.g. endothelin-131 or angiotensin-II)32 or impairment of the 
vasodilator pathways (e.g. NO-pathway)33 relate to an increased peripheral vascular 
tone, which may result in changes in shear rate patterns (or vice versa). Interestingly, 
activation of the endothelin-1 pathway and/or impairment of the NO-pathway are both 
hypothesised to contribute to the detrimental vascular adaptations in preeclampsia34. 
In addition, insulin may contribute to changes in shear patterns based on its ability to 
increase sympathetic nerve activity35. Interestingly, we observed higher insulin levels 
in formerly preeclamptic women in our study. Taken together, various pathways that 
(in)directly alter vascular tone potentially contribute to elevated retrograde shear 
levels and concomitant lowering of the endothelial function. 
 
Exercise training demonstrated a modest effect size on blood pressure and insulin, 
but not on any of the other parameters. This observation of a modest or even absent 
effect of exercise training on individual cardiovascular risk factors is reported 
previously. More specifically, a previous study found that only 40% of the beneficial 
effects of exercise training on cardiovascular risk can be explained by changes in 
traditional cardiovascular risk factors.   
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The observed effects of aerobic exercise training on blood pressure in our study are 
in line with a large meta-analysis that demonstrated a mean reduction of ~3 ± 
2.4mmHg with a more pronounced effect in (pre-)hypertensive population36. Other 
effects such as direct effects on the vasculature, might explain a part of the remaining 
cardiovascular risk reduction with exercise training. To support this notion, Green et. 
al. demonstrated that the effects of exercise on traditional cardiovascular risk factors 
do not relate to exercise induced changes in endothelial function37. Therefore, effects 
of exercise on endothelial function and shear pattern are unlikely a direct resultant of 
the changes in traditional cardiovascular risk factors, but may represent a direct 
effect of exercise training on the vessels.
A potential limitation of our study is the cross-sectional nature of the assessment of 
the relationship between retrograde shear rate and endothelial function. However, we 
have extended these between subject observations by performance of a 12-week 
exercise training study, which allowed for within subject comparisons. To our 
knowledge, our study provides the first data that indicates that exercise training in 
humans can reverse retrograde shear rate. A potential limitation of our study is that 
we presented our data as shear rate rather than shear stress. However,  we expect no 
differences in viscosity between groups and/or after training, while the length of a 
vessels is unlikely to change after training. As these are important assumptions in the 
calculation of shear rate/stress, we believe that this did not important impact upon 
our results. Another limitation relates to the method of examining the sympathetic 
nervous system, as we examined cardiac sympatho-vagal balance (LF/HF) derived 
from heart rate variability. Although related to peripheral (muscle) sympathetic nerve 
activity, care should be taken when LF/HF ratios are translated to vascular sympathetic 
tone because of possible differential sympathetic outflow between heart and 
vasculature. A fourth limitation is that our data does not allow to directly examine the 
relation between retrograde shear rate and FMD. However, our study was designed 
to examine the presence of such a relationship (and whether this depends on a priori 
endothelial dysfunction and fitness levels). Future prospective studies are warranted 
to further examine this relationship including causality. In this study women were all 
examined in the follicular phase of the menstrual cycle when estrogen levels are 
lowest. We expect no different responses in male subjects; however, generalization 
of our data to humans is speculative untill confirmed in male subjects. 
Perspectives
Data from animal studies have demonstrated an important role for retrograde shear 
or oscillatory shear pattern in the upregulation of pro-atherogenic and downregulation 
of anti-atherogenic genes, leading to an atherogenic endothelial phenotype5, 6. The 
presence of elevated levels of retrograde shear rate may therefore be a central feature 
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in the development of atherosclerosis and its complications, such as plaque instability 
or rupture. Women with a history of preeclampsia have increased risk of developing 
cardiovascular disease later in life24, possibly through the presence of endothelial 
dysfunction7,22,38. Elevated levels of retrograde shear in formerly preeclamptic women may 
provide a mechanistic link that explains the previously suggested relationship 
between endothelial dysfunction and development of cardiovascular morbidity. 
Furthermore, this study also highlights the potency of exercise training to improve 
retrograde shear rate, endothelial function and LF/HF-ratio, and therefore contribute 
to an improved cardiovascular risk after exercise training.
Conclusions
Results from the present study demonstrate that resting levels of retrograde shear 
rate are strongly related to endothelial function in humans. This finding was observed 
in healthy women and in women with a history of preeclampsia who exhibit brachial 
artery endothelial dysfunction. We also found that sympathetic dominance related to 
retrograde shear rate in healthy subjects as well as in formerly preeclamptic women. 
Moreover, these differences and correlations remained significant after 12-week exercise 
training, while the change in retrograde shear rate correlated significantly with the 
changes in FMD% and LF/HF-ratio. Therefore, our data provide evidence that a 
higher retrograde shear rate is strongly related to the presence and magnitude of 
endothelial dysfunction in healthy humans and those with an increased cardiovascular 
risk, with exercise training being able to change these parameters (without affecting 
the relation between them).
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This thesis includes seven studies with the purpose to better understand the 
hemodynamic profile that is characterized by low plasma volume in normotensive 
formerly preeclamptic women. This hemodynamic profile may contribute to the 
increased risk to develop recurrent hypertensive disease in future pregnancies and 
cardiovascular disease later in life in women with a history of preeclampsia. 
This thesis is grounded on five main research questions: 1. To what extent does 
nonpregnant plasma volume relate to the onset of preeclampsia and to the 
co-occurrence of other cardiovascular risk factors in women with a history of 
preeclampsia? (Chapter 2) 2. To what extent is the adult plasma volume determined 
at birth? (Chapter 3) 3. To what extent does nonpregnant plasma volume relate to the 
recurrence rate of preeclampsia and to the development of chronic hypertension 
after a pregnancy complicated by preeclampsia? (Chapter 4 and 5) 4. To what extent 
can plasma volume in formerly preeclamptic women be improved by means of 
aerobic exercise training in comparison with healthy parous control subjects? 
(Chapter 6) 5. What are the hemodynamic consequences of aerobic exercise training 
aimed at increasing plasma volume in women with a history of preeclampsia 
compared with healthy parous controls? (Chapter 6, 7 and 8)
We used these five main research questions to summarize and discuss our findings 
systematically in this final chapter. At the end of this chapter we will discuss future 
perspectives based on the implications of the studies included in this thesis. 
In summary, our studies show that the hemodynamic profile characterized by low 
plasma volume is the most prevalent risk profile in formerly preeclamptic women. 
The exact aetiology of low plasma volume is largely unknown, but we demonstrate 
that adult plasma volume is partially determined at birth depending on intra-uterine 
development. Prepregnant plasma volume links in a volume dependent manner with 
the recurrence risk of preeclampsia and it predisposes to chronic hypertension later 
in life in initially normotensive formerly preeclamptic women. Accordingly low plasma 
volume reflects latent hypertension in normotensive formerly preeclamptic women. 
Aerobic exercise training improves plasma volume and its’ associated venous 
 characteristics suggesting increased venous reserve capacity. We observed that 
12 weeks of vigorous aerobic exercise training normalized the traditional cardiovascular 
risk profile in formerly preeclamptic women and with it training improved endothelial 
function, arterial wall thickness and autonomic balance in post partum women. 
The exercise induced improvement in endothelial function correlated with changes in 
autonomic balance. A possible explanation for this correlation is autonomic induced 
changes in the shear characteristics of vascular blood flow affecting endothelial 
functioning. Taken together, our studies provide not only rationale to warrant follow-up 
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of blood pressure in normotensive formerly preeclamptic women, but also support 
the recommendation of lifestyle interventions including aerobic exercise as part of the 
cardiovascular risk management in women with a history of preeclampsia. 
1.  The occurrence of low plasma volume in women 
with a history of preeclampsia
The link between preeclampsia and cardiovascular disease later in life is well 
established1. Consequently many women nowadays undergo cardiovascular and 
metabolic testing, sometimes even additional thrombophilia screening, after their 
preeclamptic pregnancy to identify risk factors for future cardiovascular disease. 
Formerly preeclamptic women are tested under the assumption that these risk factors 
are modifiable and that improvement is beneficial for the outcome in next pregnancy 
and beyond. 
We structurally tested a large cohort of formerly preeclamptic women for the presence 
of cardiovascular risk factors and thombophilia 6-12 months after the complicated 
pregnancy (Chapter 2). So far, most studies involved only a single risk profile in relation 
to preeclampsia in the preceding pregnancy. Therefore any possible interrelation 
between separate risk profiles within women with a history of preeclampsia is currently 
unclear. Hence we analysed the co-occurence of circulatory abnormalities, metabolic 
syndrome, thrombophilia and hyperhomocysteinemia. When structurally tested for 
these risk profiles, 78% of formerly preeclamptic women had one or more abnormal 
profile. The most prevalent risk profile found in formerly preeclamptic women was the 
circulatory risk profile indicating latent or overt hypertension (66%). Low plasma volume 
suggesting latent hypertension in normotensive formerly preeclamptic women mainly 
accounted for the high occurrence of the circulatory risk profile. The prevalence of 
the traditional cardiovascular risk profile (metabolic syndrome) after preeclampsia 
was 15%, approximately 3 times higher than that in the general female population of 
comparable age. Of all metabolic factors tested, hyperinsulinemia indicating insulin 
resistance was the most common metabolic aberration found in formerly preeclamptic 
women. Apart from hyperhomocysteinemia, the prevalence of thrombophilia was 
comparable with those in the Dutch general population; therefore the added value of 
routine thrombophilia screening other than hyperhomo-cysteinemia after preeclampsia 
seems limited. 
The prevalence of the circulatory risk profile, hyperhomocysteinemia and all components 
of the metabolic syndrome other than obesity relate inversely with the gestational age 
at delivery in preceding pregnancy. This suggests a relationship between these risk 
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factors and severity of disease. Other studies have debated whether early and late 
onset preeclampsia are two distinct disorders resulting from different pathophysio-
logical mechanisms2,3. The observed continuous relationship between cardiovascular 
risk factors and gestational age at delivery in previous pregnancy fits best in a 
spectrum of severity of one and the same disease, rather than a dual aetiology of 
preeclampsia. Only prospective studies are however able to differentiate if aetiology 
differs between early vs. late onset preeclampsia. Increased body mass index is 
regarded as a strong independent risk factor for preeclampsia. Interestingly, we 
observed that constituents of the metabolic syndrome other than obesity related to 
the onset of disease in prior pregnancy. This implies that not obesity itself but rather 
the concomitant cardio-metabolic aberrations associate with severity of hypertensive 
disease in pregnancy. This observation is consistent with the perspective that obese 
women can be subdivided in either metabolically healthy or unhealthy phenotype4,5, 
the latter with a higher risk to develop cardiovascular disease later in life6.
After studying the prevalence of cardiovascular risk factors in a large cohort of 
preeclamptic women, it seems rational that cardiovascular risk management after a 
pregnancy complicated by preeclampsia should focus on controlling blood pressure 
and insulin resistance; especially after early onset preeclampsia (Chapter 2). It should 
however be noted that, although plausible, effectiveness of follow-up and altering 
cardiovascular risk factors in order to prevent adverse clinical outcomes after 
preeclampsia are yet to be proven. Meanwhile the American Heart Association, the 
European Society of Cardiology and the American College of Obstetrics and 
Gynecology now include preeclampsia as a risk factor for future cardiovascular 
disease with the recommendation of obtaining a history of preeclampsia and 
improving lifestyle behaviours for women with such a history7-9. 
Women who are hypertensive at the screening 6 to 12 months post partum clearly 
belong to a risk population for recurrent hypertensive disease in future pregnancies 
and cardiovascular disease later in life10,11. Much less is known about the apparently 
healthy, normotensive formerly preeclamptic women. Our study confirms earlier 
studies that approximately 50% of these normotensive formerly preeclamptic women 
have low plasma volume12. This thesis further focused at this population of normo - 
tensive formerly preeclamptic women. It is unknown if the observed low plasma volume 
status is pre-existent or rather a consequence of the preeclamptic pregnancy10. 
At any rate, the high prevalence of low plasma volume in normotensive formerly 
preeclampsia warrants further studies on the possible role of plasma volume in this 
population. 
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2. The aetiology of low plasma volume
The exact origin of the phenotype low plasma volume is currently unknown. In healthy 
persons, plasma volume remains relatively constant as a result of the complex 
interaction between neurohormonal systems involved in sodium and water 
homeostasis (Figure 1). The primary volume receptors monitoring volume status are 
stretch receptors in the cardiopulmonary circulation, the atria, the carotid sinus and 
aortic arch, and in the juxtaglomerular apparatus of the kidney. 
The extra-renal stretch receptors govern the activity of the sympathetic nervous 
system, the production of atrial natriuretic peptide (ANP) and antidiuretic hormone 
(ADH). In times of volume depletion sympathetic neural tone and the secretion of 
catecholamines by the adrenal medulla are enhanced. In contrast, in response to 
volume expansion, ANP is released by the cardiac atria13. ANP subsequently 
increases glomerular filtration rate, and decreases sodium retention in the proximal 
Figure 1 Schematic overview of the plasma volume regulation
ANP = Atrial Natriuretic Peptide; ADH = Anti-Diuretic Hormone
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tubule and collecting ducts of the kidney. ADH or vasopressin is released by the 
pituitary gland predominantly in response to hyperosmolality sensed hypothalamic 
receptors and to a lesser extent to volume depletion sensed by receptors in the 
carotids14. ADH augments water permeability in the collecting tubeles of the kidney, 
hence promoting water reabsorption. 
The renal receptors affect volume balance by influencing the renin-angiotensin- 
aldosterone system (RAAS). Renin secretion increases when circulating volume and 
renal perfusion pressure decreases15. Renin induces the conversion of angiotensinogen 
into angiotensin. Angiotensin has two major actions: arterial vasoconstriction and 
renal sodium and water retention both directly and by increasing the secretion of 
aldosterone from the adrenal cortex16-18. 
In addition to the stretch and osmolality receptors, pressure receptors (baroreceptors) 
mainly located in the carotid arteries and aortic arch, respond to variations in blood 
pressure by acting on the interplay between the orthosympathetic and parasympa-
thetic nervous system affecting cardiac inotropy and chronotropy and vascular 
constriction15. Effects of the baroreceptors may indirectly influence plasma volume 
status by acting on the volume capacity of the vascular system, primarily the venous 
system19. 
With so many complex interacting neurohormonal and cardiovascular factors contributing 
to the plasma volume status, it is challenging to determine the exact aetiology of low 
plasma volume status observed in 50% of the normotensive formerly preeclamptic 
women. To date, there have been few studies evaluating plasma volume regulation in 
formerly preeclamptic women. 
Non-pregnant formerly preeclamptic women with low plasma volume do not seem to 
be chronically vascular underfilled since compensatory neuro-hormonal changes 
such as elevated renin, angiotensin and aldosterone levels are lacking and baseline 
hemodynamic values are quite similar to their normal plasma volume counterparts12. 
In addition, reports on renal hemodynamics suggest that low plasma volume in these 
women is not supposed to be caused by primary renal dysfunction12,20. Studies 
demonstrate no difference between ANP levels in formerly preeclamptic women and 
parous controls21. Formerly preeclamptic women with low plasma volume however 
responded with increased ANP secretion upon volume loading, while in control 
subjects ANP levels remained unchanged20. In contrast, formerly preeclamptic 
women with low plasma volume responded to a single bout of exercise with a smaller 
rise in ANP compared with parous controls22. During an exercise period of 60 minutes 
women with low plasma volume showed reduced increase in stroke volume and 
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cardiac output and were unable to sustain this elevated stroke volume. Taken 
together, these observations are consistent with a reduced capacity of the vascular 
system to accommodate a relatively modest volume load or increase cardiac preload 
in times of increased arterial demands. Although resetting of the hormonal activity 
and/or sensitivity of their receptors cannot be ruled out as contributors to the low 
plasma volume levels in formerly preeclamptic women, it seems that the low plasma 
volume status may be best explained by a reduced volume capacity of the vascular 
system.
The venous system acts quantitatively as the most important volume reservoir23 and its’ 
dynamic capacity depends on venous tone which is under exclusive baroreceptor 
mediated sympathetic control19,24,25. Plasma volume status is therefore strongly 
influenced by both venous and autonomic characteristics. Reduced plasma volume 
may originate from a chronically higher resting sympathetic tone resulting in chronic 
venoconstriction and a consequent reduction of the functional capacity of the venous 
system26,27. Alternatively, plasma volume can be low as a result of structurally reduced 
dimension of the venous system as a consequence of intra-uterine inhibited venous 
development in line with the Barker hypothesis28. Both functional and structural 
reduction of the venous capacity will likely hamper the accommodation of the 
necessary plasma volume expansion in pregnancy.
In an effort to estimate the contribution of intra-uterine development to the adult 
plasma volume we have tested the hypothesis that women born small for gestational 
age have lower plasma volume in adult life, compared with women born appropriate 
or even large for gestational age. Asymmetrical fetal growth restriction is characterized 
by a disproportionately small abdominal circumference as consequence of loss in 
liver, kidney an intestinal volume29. This is thought to originate from selective growth 
failure of splanchnic organs as a consequence of fetal circulatory redistribution away 
from this abdominal region30. The splanchnic vascular bed forms quantitatively the 
most important volume reserve compartment. As only arteries have regenerative 
capacity, limited intra-uterine development of the venous splanchnic vascular bed 
may have long-lasting effects on total plasma volume. Our study demonstrated that 
women born small for gestational age are predisposed for lower plasma volume in 
adult life compared to counterparts who were born appropriate or large for gestational 
age (Chapter 3). Therefore our data suggest that reduced size of the splanchnic 
vascular bed at birth may indeed have impact on adult plasma volume. The contribution 
of intra-uterine development to the adult plasma volume is however estimated to be 
modest, only 14% of the variation in plasma volume between subjects could be 
explained by variation in birth centile, still higher than many other studied variables. 
It should be noted that we were unable to explain most of the variation in plasma 
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volume between individuals. This emphasizes the potential contribution of factors 
that functionally reduce the venous capacity, perhaps most notably sympathetic 
over activity. Some studies already demonstrated a higher sympathetic tone in 
formerly preeclamptic women with low plasma volume24,26,27.  The potential role of the 
sympathetic nervous system including baroreceptor functions and consequent 
venous wall properties should therefore be further studied in formerly preeclamptic 
women with low plasma volume. 
3.  Low plasma volume and recurrent preeclampsia 
and chronic hypertension 
Normotensive formerly preeclamptic women with low plasma volume are more likely 
to develop recurrent preeclampsia than their counterparts with normal plasma 
volume31. Our study shows that prepregnancy plasma volume in normotensive 
formerly preeclamptic women even contributes in a volume dependent manner to 
the risk of recurrent preeclampsia and fetal growth restriction (Chapter 4). This strongly 
suggests a continuum in the pathophysiological role of plasma volume in the 
development of hypertensive disease in pregnancy. But how does low plasma volume 
fit in a pathophysiological disease model of preeclampsia?
In pregnancy the maternal cardiovascular system undergoes profound changes in 
order to provide the growing fetus with oxygen and nutrients. In a healthy pregnancy 
these cardiovascular changes are characterized by a generalized reduction in 
systemic vascular resistance and a concomitant rise in plasma volume32. Together 
these adaptations result in a significant increase in blood flow. If the maternal 
circulatory systems adapts adequately, blood pressure in mid-pregnancy is about 
10% lower than in non-pregnant women while the intravascular plasma volume has 
increased with 40-50%33. This extra volume can only be accommodated without a 
consequent rise in blood pressure if the vascular system is sufficiently compliant. 
With the venous system acting as the most important volume reserve, a highly 
compliant venous system is essential in pregnancy. Studies have demonstrated that 
women with pre-pregnant low plasma volume have reduced plasma volume 
expansion in pregnancy34,35. If plasma volume expansion in pregnancy is blunted, the 
ability to increase cardiac preload is limited. Consequently the maternal cardiovascular 
system can only respond to the increased demands of advanced pregnancy by a 
compensatory rise in sympathetic tone. This will likely further constrict the venous 
system and increase heart rate creating an abnormal hyperdynamic circulation. The 
resulting sympathetically driven low-volume/high-output circulation will exert extra 
shear stress upon the endothelium, and eventually increase arterial vascular 
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resistance; thereby setting the stage for endothelial dysfunction and hypertension in 
pregnancy, or in clinical terms: preeclampsia25,34,36-38. 
Our study demonstrates also fetal consequences of low pre-pregnant plasma 
volume. We observed that as pre-pregnant plasma volume increases, the risk of a 
growth restricted neonate decreases proportionally independent of preeclampsia in 
subsequent pregnancy. In non-pregnant women with low plasma volume circulatory 
redistribution at the expense of uterine perfusion has already been demonstrated. It 
is therefore conceivable that if plasma volume expansion is also blunted in pregnancy, 
continued redistribution away from the uterine circulation affects fetal growth39. Based 
on the observed volume dependent relationships observed between prepregnant 
plasma volume and the occurrence of recurrent preeclampsia and fetal growth 
restriction in the next ongoing pregnancy it is conceivable that prepregnant plasma 
volume expansion may have a favourable effect on these outcomes in the next 
pregnancy. 
Because low plasma volume linearly linked with recurrent preeclampsia and fetal growth 
restriction, we hypothesized that low plasma volume may also provide a possible 
pathophysiological link between preeclampsia and the observed cardiovascular risk 
later in life. Early studies already linked low plasma volume with latent or borderline 
hypertension in other populations than formerly preeclamptic women40. Our prospective 
follow-up study demonstrates that 1 out of 6 (17%) of the normotensive formerly 
preeclamptic women develop chronic hypertension within the subsequent 5 years, 
and plasma volume linked inverse linearly with blood pressure measured 2 to 5 years 
later (Chapter 5). Other studies have attempted to unravel the pathophysiological 
pathway between low plasma volume and the gradual development of overt hyper- 
tension. These longitudinal studies in subjects with low plasma volume demonstrated 
a gradual change in hemodynamics from a hyperdynamic/low resistance circulation 
into a more hypodynamic/high resistance circulation with a consequent increase in 
blood pressure41. The hemodynamic transition resulting in chronic hypertension is 
thought to be secondary to a decrease in cardiac responsiveness and an increase in 
vascular responsiveness over the course of hypertension. In established hypertension, 
high vascular resistance is the hemodynamic hallmark, whereas a high cardiac 
output prevails in young mildly hypertensive individuals42,43. Combined blockade of 
sympathetic and parasympathetic cardiac receptors abolishes the elevation in 
cardiac output and the heart rate in these young borderline hypertensive patients with 
low plasma volume44, and an addition of alpha-adrenergic blockade to the cardiac 
blockade normalizes their blood pressure45. Consequently, the hyperkinetic state and 
the eventual blood pressure elevation in these individuals are likely to be neurogenic. 
The sympathetic overactivity is regarded as the key characteristic of neurogenic 
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hypertension. It is unknown if this sympathetic overactivity is primarily responsible for 
the observed low plasma volume status or rather a compensatory consequence of 
the low plasma volume. Prospective studies in formerly preeclamptic women including 
hemodynamics and autonomic functions may help explain the observed hypertension 
in formerly preeclamptic women. Eventually long follow-up of formerly preeclamptic 
women beyond the age of 50 will be necessary to determine the impact of low plasma 
volume on actual cardiovascular events. 
4.   Improving plasma volume status with  
exercise training
Ultimately, improving the plasma volume status may reduce the risk of hypertensive 
disease in future pregnancy and beyond. Aerobic exercise training is known to induce 
plasma volume expansion, although heterogeneity in the magnitude of plasma volume 
expansion upon exercise training has been described46. 
The beneficial effects of exercise training on the human cardiovascular system are 
nowadays indisputable47-49. Exercise training decreases risk for cardiovascular 
disease in a dose-dependent way. Approximately 60% of this decreased risk can be 
explained by the exercise-induced improvement in traditional cardiovascular risk 
factors, mainly by reducing blood pressure, insulin resistance and dyslipidaemia. The 
remaining 40% if often referred to as the so called ‘risk factor gap’50. Direct effects of 
exercise training on the vessel wall and changes in hemodynamics may explain this 
gap51; for example by improving endothelial functions, reduction of arterial wall 
thickness and reduction of sympathetic tone and perhaps plasma volume. 
To test how modifiable the cardiovascular risk profile in formerly preeclamptic women 
is, we have designed a case-control exercise training study using an integrative 
approach. This study design enabled us to study the effects of exercise training not 
only on the traditional cardiovascular risk profile, but also on plasma volume and 
venous characteristics (Chapter 6), arterial characteristics (including arterial wall 
thickness, endothelial function and arterial shear stress characteristics (Chapter 7 
and 8) and finally autonomic characteristics (sympathetic activity and baroreceptor 
sensitivity) (Chapter 7 and 8). 
Our 12-weeks aerobic exercise-training program improved cardiorespiratory fitness 
(VO2max) by ≈13% in both formerly preeclamptic women and healthy parous controls 
indicating a successful training stimulus. While formerly preeclamptic women show 
reduced plasma volume expansion in pregnancy, we demonstrate a similar plasma 
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volume expansion upon exercise training in formerly preeclamptic women (+12.1%) 
and healthy controls (+8.3%). Yet, after 12 weeks of aerobic exercise training formerly 
preeclamptic women had a plasma volume status that was comparable with 
pre-training sedentary controls. Continued training may theoretically further expand 
the plasma volume46. The key question remains if the observed exercise induced 
plasma volume expansion is enough to have an impact on recurrence risk of 
preeclampsia and fetal growth restriction and ultimately the development of chronic 
hypertension in formerly preeclamptic women. The mean plasma volume expansion 
induced by our 12-weeks exercise training in formerly preeclamptic women was 180 
ml/m2 (Chapter 6), a change that is larger than the difference in mean plasma volume 
between formerly preeclamptic women who developed recurrent preeclampsia and 
women who did not have recurrent disease in the next on-going pregnancy (Chapter 
4). Therefore, theoretically, if this exercise induced plasma volume expansion is 
extrapolated to the plasma volume dependent recurrence risk of preeclampsia and 
risk of delivering a growth restricted infant, exercise training should be able to offset 
the contribution of low plasma volume to these risks in future pregnancies. Likewise, 
based on the observed linear relationship between plasma volume and blood 
pressure 2-5 years later in formerly preeclamptic women (Chapter 5), the exercise 
induced plasma volume expansion theoretically corresponds with an estimated 
reduction in mean arterial pressure of approximately 7 mmHg. Obviously, these 
estimations assume a persistent plasma volume expansion and therefore a persistent 
active lifestyle as detraining is associated with reduction of plasma volume. Exercise 
training is likely to have an impact on more risk factors associated with increased 
recurrence risk of preeclampsia and chronic hypertension, therefore the beneficial 
effects may in fact even be higher. 
In normotensive formerly preeclamptic women we observed increased sympathetic 
activity and reduced venous compliance compared to parous controls, suggesting 
increased venous tone in formerly preeclamptic women. Our exercise study indicates 
that the exercise induced plasma volume expansion coincides with reduction of 
sympathetic activity and improvement of venous compliance. This implies an exer-
cise-induced functional improvement of the venous reserve capacity. We further 
analysed the venous reserve capacity, or in other words the ability of the venous 
system to mobilize blood volume, using a validated dynamic orthostatic stress test. 
The results of the head-up tilt testing revealed that that the ability of the veins to 
mobilize venous volume through venoconstriction was limited prior to exercise 
training but improved markedly with exercise training. The effects of exercise training 
on venous functioning were more pronounced in formerly preeclamptic women than 
in parous controls (Chapter 6). Since veins are under exclusive baroreceptor mediated 
sympathetic control, the increased venous tone observed in formerly preeclamptic 
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women prior to training might originate from abnormal baroreceptor functioning. We 
observed that baroreceptor sensitivity was significantly lower in formerly preeclamptic 
women compared to parous controls (Chapter 7) and training significantly improved 
baroreceptor sensitivity in both formerly preeclamptic women and parous controls. 
Training was however unable to normalize baroreceptor sensitivity in formerly 
preeclamptic women. The observed abnormal baroreflex control in formerly 
preeclamptic women is consistent with observations in subjects with (borderline) 
hypertension52,53. Structural changes in large arteries are often considered the 
predominant mechanism responsible for decreased baroreflex sensitivity and 
baroreceptor resetting in hypertension54. Although more recent evidence 
demonstrated that “functional” mechanisms also contribute to altered baroreflex 
responses, for example at the level of the peripheral sensory endings and within 
the central nervous system, or as a result of endothelial dysfunction with altered 
release of certain paracrine endothelial factors. The head-up tilt protocol with intact 
physiological reflexes does not allow us to determine if the autonomic changes 
are responsible for the observed reduced venous reserve capacity in formerly 
preeclamptic women or vice versa. This requires intervention studies with selective 
blockade of autonomic transduction. 
5.   Other hemodynamic effects of exercise training  
in women with a history of preeclampsia
When studying the traditional cardiovascular risk profile we observed that before 
exercise training formerly preeclamptic women differed from women who had an 
uneventful pregnancy by having a higher blood pressure and fasting insulin level, and 
more micro-albuminuria. Twelve weeks exercise training abolished all differences 
apart from micro-albuminuria between formerly preeclamptic women and controls. 
The improvement of components of the metabolic syndrome suggests reduced 
vascular stress. The effect of aerobic exercise training on insulin resistance was 
remarkably large in formerly preeclamptic women, underscoring the potency of 
aerobic exercise on insulin sensitivity. Other studies indeed demonstrated that young 
age, female sex, and a priori mild level of insulin resistance predict a relatively larger 
improvement of insulin sensitivity with exercise training55. 
The protective effects of exercise training are further supported by the observed 
improved endothelial function measured in two separate conduit arteries. We 
confirmed other studies demonstrating persistent endothelial dysfunction in formerly 
preeclamptic women compared to women who had an uneventful pregnancy56-58. 
Endothelial dysfunction measured with flow mediated dilation technique has proven 
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to be independently associated with cardiovascular disease burden and outcome in 
both low and high-risk populations59. Although 12-weeks exercise training significantly 
improved endothelial function, it was unable to normalize endothelial function in 
formerly preeclamptic women. The comparable vasodilation responses to sublingual 
nitrates between formerly preeclamptic women and controls confirm endothelial 
dysfunction rather than vascular smooth muscle dysfunction in women with a history 
of preeclampsia. Some exercise studies demonstrated a time-course in vascular 
adaptations to exercise training; first endothelial function improves, than arterial 
outward remodelling occurs after which endothelial function appears to return to 
baseline values after 8-12 weeks of exercise training60. We however observed in both 
formerly preeclamptic women and controls that after 12 weeks exercise training 
improved endothelial function as well as increased arterial diameter and reduced 
carotid wall thickness. It is likely that subjects with a priori endothelial dysfunction do 
not show complete return to baseline, this could explain the improved endothelial 
function in formerly preeclamptic women. It is disturbing that endothelial function 
after 12 weeks exercise training remains significantly lower in formerly preeclamptic 
women compared to controls. Perhaps longer training may restore endothelial 
function eventually. More difficult to explain is the fact that healthy parous controls 
demonstrate an almost equal improvement in endothelial function and arterial 
structure compared to subjects with a priori endothelial dysfunction. Theoretically 
this may reflect endothelial recovery back to the actual baseline value in sedentary 
post-partum women, even after an uneventful pregnancy. Alternatively, women may 
have a different time course of vascular adaptation to exercise training compared to 
men, in line with possible gender differences in exercise training responses as 
suggested in other studies. At any rate endothelial functions in postpartum women 
appear to respond well to the exercise stimulus, irrespective of their obstetric history. 
We observed that endothelial function correlated with autonomic balance in both 
formerly preeclamptic women and healthy controls. High sympathetic outflow in 
conjunction with endothelial dysfunction as we observed in formerly preeclamptic 
women is thought to have synergistic and detrimental effects on cardiovascular risk50. 
To study the relationship between endothelial functioning and the autonomic system 
we further analysed the vascular shear patterns in formerly preeclamptic women and 
controls before and after 12-weeks aerobic exercise training. Studies have 
demonstrated that exercise-induced changes in shear stress provide the principle 
physiologic stimulation to adaptation in vascular function and structure61. The blood 
flow-generated endothelial shear stress during repeated bouts of exercise induces 
altered gene expression in endothelial cells and induces the release of several factors 
which can influence the vascular endothelium and the underlying smooth muscle 
cells. One key factor is the nitric oxide release induced by shear stress via phosphor-
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ylation of endothelial NO Synthase. Therefore changes in shear stress directly 
influence the endothelium of arteries, which plays a crucial role in the regulation of 
blood flow and maintenance of the quality of blood vessels. Increases in the antegrade 
shear stress are believed to be beneficial for arterial function, while high levels of 
retrograde shear increase the expression of proatherogenic genes with consequent 
detrimental effects for vascular health62,63.  First we demonstrated increased levels of 
resting retrograde shear in formerly preeclamptic women compared to parous 
controls. Second, our study demonstrates a clear relationship between retrograde 
shear stress and endothelial function. Exercise training proved to be an effective 
strategy to diminish retrograde shear rate and also improve endothelial function and 
autonomic balance in both healthy controls and formerly preeclamptic women. The 
exercise induced changes in retrograde shear and endothelial function correlated 
with each other, underscoring the reciprocal dependency. The underlying 
mechanisms for the higher retrograde shear rate in formerly preeclamptic women 
may relate to increases in vascular tone in the resistance vessel beds. Indeed we 
observed higher vascular resistance and blood pressure in formerly preeclamptic 
women compared to parous controls. Higher insulin levels as demonstrated in 
formerly preeclamptic women, might (in) directly alter vascular tone via sympathetic 
modulation. Apart from sympathetic over-activity other pathways may explain the 
increased vascular tone, for example reduced contribution of nitric oxide to vascular 
tone or higher levels of vasoactive constrictors (endothelin-1 or Angiotensin-2). 
Taken together our exercise studies demonstrate important beneficial effects of 
aerobic exercise training on both traditional and non-traditional cardiovascular risk 
factors in formerly preeclamptic women who are known to be at increased risk of 
developing cardiovascular disease. Our studies can be seen as a “proof of principle” 
that exercise training can significantly impact both the traditional and non-traditional 
cardiovascular risk profile in women, especially after a pregnancy complicated by 
preeclampsia.
Future perspectives
The studies included in this thesis provide more insight into the cardiovascular risk 
profile in normotensive formerly preeclamptic women. We have demonstrated that 
post partum women respond well to the exercise stimulus, therefore aerobic exercise 
training has the potential to improve outcome of future pregnancy and perhaps 
reduce remote cardiovascular risk in formerly preeclamptic women. Further studies 
are needed to optimize the care of women with a history of preeclampsia.
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We still need to establish whether preeclampsia acts as a stress test to unmask 
women who are already at risk for cardiovascular disease, or whether pregnancy 
course itself induces the observed remote risk in women with a history of preeclampsia. 
Irrespective of causality, a key question is the extent to which pregnancy history can 
be used to improve the current cardiovascular risk-scoring systems for women such 
as the Framingham Risk score. At present these scoring systems are of debatable 
utility for women under the age of 70 years. If pregnancy outcome is useful for early 
CVD risk identification, the next question is whether early risk identification (e.g. at 
the post-partum evaluation) is a cost-effective way of reducing future CVD risk. 
The associations of preeclampsia and CVD are remarkably consistent. Although 
untested, the use of preeclampsia history to screen women for targeted CVD prevention 
has potential to improve public health, given the magnitude of the associations, the 
prevalence of preeclampsia and the importance of the CVD burden in women. 
Pregnancy complications occur early enough in a woman’s life to potentially offer a 
significant meaningful prevention by lifestyle intervention. 
We need to test the extent to which promoting exercise and healthy diet or in some 
cases even pharmacological prevention is effective in improving future pregnancy 
outcome and preventing CVD in young or middle aged women with a history of 
preeclampsia. It is important to examine if standard screening, prevention and 
therapy protocols can be optimized or tailored on the basis of a woman’s particular 
risk profile that is identified post partum. Based on our observation, cardiovascular 
risk management after preeclampsia should, at least initially, focus at controlling 
blood pressure and insulin resistance in the first years following the preeclamptic 
pregnancy. 
The exercise intervention used in this thesis involved a 12-weeks supervised vigorous 
aerobic training protocol. Effects of this specific training protocol cannot be 
extrapolated to expected effects of merely advising active lifestyle to women with a 
history of preeclampsia. The effectiveness of different modes and intensity levels of 
increasing physical activity level in post partum women still need to be established. 
Well known boundaries exist when implementing preventative lifestyle strategies. 
To begin, doctors and patients need to recognize the increased cardiovascular risk 
and the expected beneficial effects of an active lifestyle.  Second, practical concerns 
to implement a more active lifestyle need to be addressed. Active coaching may 
help introducing and enduring healthy behaviour. Interestingly some studies have 
indicated that the postpartum period is a stage in the life course of women, when 
women are particularly receptive to lifestyle interventions.
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Taken together future research requires large data sets that have prospectively 
collected accurate data on cardiovascular risk factors before, during and after 
pregnancy, into middle age and beyond when cardiovascular disease begins to 
emerge. Ultimately randomized controlled trials will be necessary to establish whether 
continued monitoring and early treatment of women identified at risk after a pregnancy 
complicated by preeclampsia are cost-effective ways to improve future pregnancy 
outcomes and reduce CVD risk in women. It remains a challenge in young individuals 
to demonstrate a clear reduction in cardiovascular disease because of the long 
follow-up period needed and the amount of potential confounders during this period. 
The use of surrogate markers of cardiovascular disease could be helpful (e.g. 
hypertension and endothelial dysfunction). Moreover the next pregnancy is an 
important relatively short-term outcome that should be taken into account in future 
studies.  
Meanwhile we need to improve our understanding of the pathophysiological pathways 
that lead to the hypertensive complications in pregnancy and cardiovascular disease 
later in life. Studying these pathways has been proven difficult given the existing 
heterogeneity among women who develop preeclampsia. In this thesis we have 
mainly focused on the potential role of low plasma volume. We observed that low 
plasma volume is closely linked with activity of the sympathetic nervous system either 
by cause or consequence. Better understanding of the hemodynamic and autonomic 
changes in women with a history of preeclampsia, may improve targeted screening 
and management in pregnancy and beyond. Ideally, these changes can be 
recognized even well before hypertensive disease develops in nulliparous women 
and subsequent tailored management may improve clinical outcome of pregnancy.
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SUMMARY
After a pregnancy complicated by preeclampsia, women are not only at risk to develop 
recurrent hypertensive disease in future pregnancies, but also have an increased risk 
to develop cardiovascular disease later in life. Preeclampsia and cardiovascular 
disease are thought to have disease mechanisms in common. The prevalence of 
cardiovascular risk factors is increased in women with a history of preeclampsia. 
Nowadays many women are tested for these risk factors for cardiovascular disease 
after a pregnancy complicated by preeclampsia, under the assumption that early 
recognition and modification is beneficial for future health. Although plausible, the 
effects of these early interventions are yet to be proven. 
In this thesis we studied the hemodynamic profile characterized by low plasma volume 
in normotensive formerly preeclamptic women. Low plasma volume is thought to 
reflect latent hypertension and may therefore represent an interesting mechanistic 
link between preeclampsia and remote cardiovascular disease. 
Chapter 1 introduces preeclampsia and the possible role of low plasma volume in the 
development of recurrent preeclampsia and future cardiovascular disease. It describes 
the potential of exercise training to improve plasma volume in women with a history 
of preeclampsia. Finally, the 5 main research questions are introduced that form the 
basis of this thesis. 
In Chapter 2 we studied the co-occurrence of risk factors for cardiovascular disease 
in a large population (n=1234) of formerly preeclamptic women. We examined the 
prevalence of a circulatory risk profile (hypertension or latent hypertension), metabolic 
syndrome, thrombophilia and hyperhomocysteinemia. We observed that the circulatory 
risk profile was the most prevalent risk profile (66%) present in formerly preeclamptic 
women. The high prevalence of this circulatory risk profile was mainly attributable to 
reduced plasma volume status. Apart from low plasma volume, formerly preeclamptic 
women often demonstrated insulin resistance. The prevalence of the circulatory risk 
profile, metabolic syndrome and hyperhomocysteinemia related inversely with the 
gestational age at delivery. This may indicate a relationship between these cardio- 
vascular risk factors and severity of disease in pregnancy either by cause or effect. 
Based on the observed prevalence of cardiovascular risk factors after preeclampsia, 
we believe that cardiovascular follow-up in these women should focus, at least 
initially, on controlling blood pressure and insulin resistance.
The exact origin of the phenotype low plasma volume is currently unknown. The venous 
system contains quantitatively the most blood volume and consequently acts as the 
most important volume reserve. Theoretically low plasma volume status may therefore 
originate from constitutionally reduced dimension of the venous system. In Chapter 3 
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we examined, in line with the Barker hypothesis, if intra-uterine growth restriction 
impacts adult plasma volume status. We linked women’s own birth weight centile with 
measured plasma volume in adulthood (n=280). We observed that birth weight 
correlated positively and independently with adult plasma volume. The contribution 
of birth centile to the adult plasma volume status is however limited; 14% of the 
variation in adult plasma volume could be explained with the birth centile. 
Women with prepregnant low plasma volume demonstrate reduced plasma volume 
expansion in pregnancy. This limited plasma volume expansion likely reflects 
hemodynamic maladaptation to the increased demands of pregnancy that may 
contribute to the hypertensive deterioration in pregnancy. In Chapter 4 we further 
examined the relationship between plasma volume status and recurrent preeclampsia in 
normotensive formerly preeclamptic women (n=178). The risk of recurrent preeclampsia 
and fetal growth restriction in subsequent pregnancy relates inversely and linearly 
to prepregnancy plasma volume in apparently healthy normotensive women. This 
observation suggests a certain continuum in the pathophysiological development of 
hypertensive disease during pregnancy depending on plasma volume status. This 
also implies that improving the plasma volume in advance of the next pregnancy may 
decrease the recurrence risk of preeclampsia. 
In Chapter 5 we hypothesized that low plasma volume not only predisposes to 
recurrent preeclampsia in subsequent pregnancy, but also to the development of 
hypertension in normotensive formerly preeclamptic women. We studied blood pressure 
and important covariates 2 to 5 years after the plasma volume measurement in n=104 
women. We observed that 1 out of 6 (17%) formerly preeclamptic women developed 
de novo hypertension within 5 years. Women with low plasma volume were more 
prone to develop hypertension than women with normal plasma volume. Therefore, 
low plasma volume indeed reflects a latent hypertensive profile that can become 
manifest within a few years after the preeclamptic pregnancy.
Improving plasma volume may reduce risk of recurrent preeclampsia and chronic 
hypertension in formerly preeclamptic women. Aerobic exercise is perhaps the best 
intervention to improve plasma volume. Based on the observation that formerly 
preeclamptic women demonstrate reduced plasma volume expansion in pregnancy, 
we hypothesized that formerly preeclamptic women may be less able to increase 
their plasma volume in response to exercise training compared with parous controls. 
In Chapter 6 we examined this hypothesis by studying n=25 normotensive formerly 
preeclamptic women and n=22 controls before and after a 12 weeks vigorous aerobic 
exercise training protocol. Exercise training improved plasma volume comparably in 
both groups. After 12 weeks aerobic training formerly preeclamptic women however 
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had a plasma volume status that was comparable to pretraining values of controls. 
Along with the plasma volume expansion, exercise training improved venous 
compliance and reduced sympathetic overactivity. Using a validated orthostatic 
stress model we demonstrated increased venous reserve capacity after exercise 
training. 
The effects of exercise training are not expected to be confined to the venous side of 
the circulation. In Chapter 7 we studied the effects of 12-weeks aerobic exercise 
training on important arterial characteristics: carotid intima media thickness (IMT) 
and brachial and superficial femoral artery endothelial function using flow-mediated 
dilation (FMD). Twelve weeks exercise training improved the traditional cardiovascular 
risk profile (e.g. components of the metabolic syndrome) in both groups suggesting 
reduced biochemical vascular stress. The exercise training even abolished differences 
in blood pressure and insulin resistance between formerly preeclamptic women and 
healthy parous controls. The protective effects of exercise training in post partum 
women were further supported by the reduced IMT and improved FMD after training. 
Despite these improvements, the 12-weeks exercise training did not normalize these 
vascular variables in women with a history of preeclampsia. Perhaps sustained aerobic 
training and/or other types of exercise training may induce continued improvement 
of vascular functions in formerly preeclamptic women. Interestingly, we observed 
that exercise induced improvements of endothelial functions correlated with training 
induced changes in autonomic functioning in both healthy control subjects and 
formerly preeclamptic women. 
The relationship between autonomic activity and endothelial function was further 
explored in Chapter 8. Sympathetic overactivity as observed in formerly preeclamptic 
women increases vascular resistance that affects blood flow patterns in the upstream 
conduit arteries. While blood flow patterns characterized by high levels of antegrade 
shear stress are beneficial for arterial function, retrograde shear stress is believed to 
be detrimental for vascular health. We studied the relationship between shear rate 
patterns, endothelial functions and sympathetic balance in formerly preeclamptic 
women and parous controls before and after 12-weeks exercise training. This study 
demonstrates strong correlations between retrograde shear and endothelial function 
in both formerly preeclamptic women and controls. Retrograde shear rate was higher 
in formerly preeclamptic women compared with controls and related to sympathetic 
overactivity. These observations provide mechanistic insight in the relationship between 
autonomic activity and endothelial function. Exercise training represents an effective 
strategy to reduce retrograde shear, decrease sympathetic overactivity and improve 
endothelial function. 
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In the final Chapter 9 we discussed our findings, reflect on the implications of our 
studies and suggest opportunities for future research. We conclude that the 
hemodynamic profile characterized by low plasma volume is highly prevalent in 
formerly preeclamptic women. Low plasma volume predisposes to recurrent 
preeclampsia in next pregnancy and reflects latent hypertension in normotensive 
formerly preeclamptic women. Our exercise studies can be seen as “the proof of 
principle” that post partum women respond well to the exercise stimulus. Aerobic 
exercise training improves plasma volume in formerly preeclamptic women and in 
healthy control subjects. Aerobic exercise may therefore contribute to reducing 
recurrence risk of preeclampsia and decrease risk to develop chronic hypertension 
later in life. Our studies support the advice to monitor blood pressure and recommend 
an active lifestyle in women with a history of preeclampsia; even if women are 
normotensive 6 to 12 months post partum. 
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Vrouwen bij wie de voorgaande zwangerschap werd gecompliceerd door een 
pre-eclampsie hebben behalve een toegenomen risico op hypertensie in toekomstige 
zwangerschappen, ook een toegenomen risico op hart- en vaatziekten op latere 
leeftijd. Men veronderstelt dat pre-eclampsie en hart- en vaatziekten tot op zekere 
hoogte een vergelijkbare ontstaanswijze hebben. Bij vrouwen met pre-eclampsie in 
de voorgeschiedenis worden vaker bekende risicofactoren voor hart- en vaatziekten 
aangetoond. Tegenwoordig worden veel vrouwen dan ook getest op de aanwezigheid 
van deze risicofactoren voor hart- en vaatziekten na een zwangerschap gecompliceerd 
door pre-eclampsie. Hierbij wordt aangenomen dat vroegtijdige herkenning en 
aanpassing van deze risicofactoren voor hart- en vaatziekten gunstig is voor de 
toekomstige gezondheid van deze vrouwen. Hoewel dit aannemelijk is, zijn de effecten 
van vroegtijdige screening en behandeling in deze groep vrouwen nog niet bewezen. 
In dit proefschrift bestuderen wij het hemodynamische profiel dat wordt gekenmerkt 
door een gering plasma volume bij normotensieve vrouwen met pre-eclampsie in de 
voorgeschiedenis. Gering plasma volume wordt gezien als een latente vorm van 
hypertensie en zou daarmee een interessante mechanistische link kunnen zijn tussen 
pre-eclampsie en cardiovasculaire aandoeningen op latere leeftijd. 
Hoofdstuk 1 vormt de introductie van dit proefschrift. In dit hoofdstuk wordt het 
ziektebeeld pre-eclampsie geïntroduceerd alsmede de mogelijke rol van een gering 
plasma volume in het ontstaan van (herhaalde) pre-eclampsie en het ontwikkelen 
van hart- en vaatziekten in het latere leven. Dit hoofdstuk besluit met de 5 voornaamste 
onderzoeksvragen waarop dit proefschrift is gebaseerd.
In Hoofdstuk 2 bestudeerden wij de prevalentie van risicofactoren voor cardiovascu-
laire aandoeningen in een grote groep vrouwen met pre-eclampsie in de voorgaande 
zwangerschap (n=1234). Wij onderzochten de prevalentie van een circulatoir risico 
profiel (hypertensie of latente hypertensie), metabool syndroom, thrombofilie en 
hyper homocysteinemie 6 tot 12 maanden na de gecompliceerde zwangerschap. 
Het circulatoire risico profiel bleek het meest voorkomende risico profiel (66%) te zijn 
bij vrouwen met pre-eclampsie in de voorgaande zwangerschap. De hoge prevalentie 
van dit circulatoire profiel was vooral toe te schrijven aan een gering plasma volume 
in deze groep vrouwen. Naast een gering plasma volume, bleken veel voormalig 
pre-eclamptische vrouwen insuline resistentie te vertonen. Het circulatoire risicoprofiel, 
metabool syndroom en hyperhomocysteinemie kwamen vaker voor naarmate de 
voorgaande zwangerschap vroeger werd gecompliceerd door pre-eclampsie. Dit 
impliceert een relatie tussen de prevalentie van deze cardiovasculaire risicofactoren 
en de ernst van pre-eclampsie in de voorgaande zwangerschap. Op basis van de 
prevalentie van cardiovasculaire risicofactoren na preeclampsie, zijn wij van mening 
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dat de cardiovasculaire follow-up in deze groep vrouwen zich initieel zou moeten 
concentreren op het reguleren van de bloeddruk en insuline resistentie.
De etiologie van het fenotype gering plasma volume is grotendeels onbekend. Het 
veneuze systeem bevat in kwantitatief opzicht het meeste bloedvolume en vormt 
daarmee de voornaamste volume reserve in het menselijk lichaam. Theoretisch zou 
een gering plasma volume daarom verklaard kunnen worden door constitutioneel 
beperkte dimensies van het veneuze systeem. In Hoofdstuk 3 onderzochten wij, in 
lijn met de Barker hypothese, of intra-uteriene groei restrictie invloed heeft op de 
plasma volume status op volwassen leeftijd. Wij vergeleken de geboortepercentielen 
van een groot aantal vrouwen met pre-eclampsie in de voorgeschiedenis (n=280) 
met het plasma volume dat werd gemeten op volwassen leeftijd. We toonden aan 
dat de geboortepercentiel positief en onafhankelijk correleerde met het plasma 
volume op volwassen leeftijd. De bijdrage van het geboortepercentiel aan het plasma 
volume op volwassen leeftijd is echter beperkt; 14% van de variatie in plasma volume 
kon worden verklaard met het geboortepercentiel van deze vrouwen. 
Vrouwen met een preconceptioneel gering plasma volume blijken een verminderde 
plasma volume expansie te hebben in de zwangerschap. Deze beperkte plasma 
volume expansie in de zwangerschap is waarschijnlijk een uiting van hemodynamische 
maladaptatie aan de zwangerschap en draagt mogelijk bij aan de hypertensieve 
ontsporing van de zwangerschap. In Hoofdstuk 4 onderzoeken wij de relatie tussen 
preconceptioneel plasma volume en de prevalentie van herhaalde pre-eclampsie in 
normotensieve vrouwen (n=178) met pre-eclampsie in de eerste zwangerschap. Het 
risico op herhaalde pre-eclampsie en foetale groeirestrictie in de volgende zwanger - 
schap blijkt omgekeerd evenredig samen te hangen met het preconceptionele 
plasma volume in ogenschijnlijk gezonde, normotensieve vrouwen. Deze observatie 
suggereert dat er een continuüm is in de pathofysiologische ontwikkeling van 
hypertensieve aandoeningen tijdens de zwangerschap welke afhankelijk is van de 
preconceptionele plasma volume status. Dit impliceert tevens dat plasma volume 
expansie voorafgaand aan de zwangerschap mogelijk bijdraagt aan de reductie van 
het risico op herhaalde pre-eclampsie. 
In Hoofdstuk 5 testten wij de hypothese dat gering plasma volume niet alleen 
predisponeert voor herhaalde pre-eclampsie in de volgende zwangerschap, maar 
ook voor het ontwikkelen van hypertensie in normotensieve voormalig pre-eclamptische 
vrouwen. Hiervoor bestudeerden wij de bloeddruk en belangrijke co-variabelen 2 
tot 5 jaar na de bepaling van het plasma volume in n=104 vrouwen. Een op de zes 
vrouwen (17%) ontwikkelde de novo hypertensie binnen 5 jaar. Vrouwen met een 
gering plasma volume ontwikkelden vaker hypertensie dan vrouwen met een normaal 
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plasma volume. Gering plasma volume reflecteert daarmee latente hypertensie bij 
voormalig pre-eclamptische vrouwen. 
Het verbeteren van het plasma volume zou kunnen bijdragen aan de reductie van het 
risico op herhaalde pre-eclampsie en chronische hypertensie bij vrouwen met 
pre-eclampsie in de voorgeschiedenis. Aerobe inspanning is wellicht de beste 
interventie om het plasma volume te laten toenemen. Gezien de beperkte toename 
van het plasma volume tijdens de zwangerschap bij vrouwen die pre-eclampsie 
ontwikkelen, is het de vraag of vrouwen met een pre-eclampsie in de voorgeschiedenis 
überhaupt in staat zijn om het plasma volume te vergroten middels aerobe inspanning 
in vergelijking met gezonde controle vrouwen. In Hoofdstuk 6 onderzochten wij het 
plasma volume in n=25 normotensieve voormalig pre-eclamptische vrouwen en n=22 
controles voor en na een 12-weken durende intensieve aerobe training. Het plasma 
volume steeg in beide groepen vergelijkbaar in reactie op de training. Na 12 weken 
aerobe training hadden voormalig pre-eclamptische vrouwen echter een plasma volume 
dat vergelijkbaar was met het gemiddelde plasma volume van de controle groep 
voorafgaand aan de training. Behalve het plasma volume, induceerde de aerobe 
training ook een verbetering van de veneuze vaatfunctie en nam de sympathische 
overactiviteit af. Door middel van een gevalideerd orthostatisch stress model konden 
wij aantonen dat de training daarmee de veneuze reserve capaciteit vergroot. 
De effecten van aerobe training zullen zich niet beperken tot de veneuze zijde van 
de circulatie. In Hoofdstuk 7 bestudeerden wij de effecten van 12 weken aerobe 
inspanning op belangrijke arteriële karakteristieken: de intima media dikte (IMT) 
gemeten in de halsslagader en de endotheelfunctie gemeten in de grote slagaders van 
arm en been. De endotheelfunctie werd gemeten door middel van flow gemedieerde 
dilatatie (FMD). Twaalf weken aerobe training verbeterde het traditionele risicoprofiel 
voor hart- en vaatziekten (oftewel de componenten van het metabole syndroom) in 
beide groepen; dit impliceert een vermindering van de biochemische stress op de 
vaatwand. Na 12 weken intensieve training waren de verschillen in bloeddruk en 
insuline resistentie tussen voormalig pre-eclamptische vrouwen en gezonde controles 
zelfs verdwenen. De beschermende effecten van aerobe training in postpartum 
vrouwen werd verder ondersteund door een afname van de vaatwanddikte en 
verbetering van de endotheelfunctie na training. Echter na 12 weken intensieve 
training bleken deze vaatkarakteristieken in voormalig pre-eclamptische vrouwen 
nog niet te zijn genormaliseerd. Wellicht dat aanhoudende aerobe training en/of 
andere vormen van training voortgaande verbetering bewerkstelligt. De door aerobe 
training geïnduceerde verbetering van de endotheelfunctie correleerde met de 
training geïnduceerde veranderingen van de activiteit van het autonome zenuwstelsel 
in zowel gezonde controles als in voormalig pre-eclamptische vrouwen.
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De relatie tussen de activiteit van het autonome zenuwstelsel en endotheelfunctie 
werd verder onderzocht in Hoofdstuk 8. Sympathische overactiviteit zoals werd 
aangetoond in voormalig pre-eclamptische vrouwen verhoogt de vasculaire weerstand; 
dit heeft direct weerslag op het doorstromingsprofiel in de stroomopwaarts gelegen 
arteriën. Bloeddoorstromingspatronen die worden gekarakteriseerd door hoge mate 
van voorwaartse (antegrade) frictiekrachten op de vaatwand zijn gunstig voor de 
arteriële vaatfunctie; overwegend achterwaartse (retrograde) frictiekrachten daarentegen 
worden verondersteld schadelijk te zijn voor de gezondheid van bloedvaten. Wij 
bestudeerden de relaties tussen arteriële doorstromingsprofielen, endotheelfunctie 
en de activiteit van het autonome zenuwstelsel in voormalig pre-eclamptische vrouwen en 
gezonde controles, voor en na een 12 weken intensieve aerobe training. Deze studie 
toonde aan dat er een sterke correlatie bestaat tussen retrograde frictiekrachten op 
het endotheel en de endotheelfunctie in zowel voormalig pre-eclamptische vrouwen 
als in gezonde controles. Deze retrograde frictiekrachten waren toegenomen in 
voormalig pre-eclamtische vrouwen in vergelijking tot gezonde controles en correleerden 
eveneens met sympathische overactiviteit. Deze observaties geven inzicht in de 
relaties tussen de activiteit van het autonome zenuwstelsel en endotheelfunctie. 
Intensieve aerobe training vormt een effectieve strategie om de retrograde frictie-
krachten op de vaatwand te beperken, sympathische overactiviteit te reduceren en 
endotheel functie te verbeteren. 
In het laatste Hoofdstuk 8 bediscussiëren wij onze bevindingen, reflecteren wij op 
de implicaties van onze studies en geven wij tot slot suggesties voor toekomstig 
onderzoek. We concluderen dat het hemodynamische profiel dat wordt gekarakteriseerd 
door een gering plasma volume frequent voorkomt bij voormalig pre-eclamptische 
vrouwen. Gering plasma volume predisponeert voor herhaalde pre-eclampsie in 
de volgende zwangerschap en weerspiegelt latente hypertensie in normotensieve 
voormalig pre-eclamptische vrouwen. Onze aerobe training studies tonen aan dat 
postpartum vrouwen in beginsel goed responderen op een intensieve training stimulus. 
Aerobe training verbetert het plasma volume in zowel voormalig pre-eclamptische 
vrouwen als gezonde controles. Deze training geïnduceerde plasma volume expansie 
draagt mogelijk bij aan een reductie van de herhaalkans op pre-eclampsie en een 
afname van chronische hypertensie bij vrouwen met pre-eclampsie in de voor-
geschiedenis. Onze studies ondersteunen het advies om de bloeddruk te blijven 
controleren en een actieve leefstijl te promoten bij vrouwen die een pre-eclampsie 
hebben doorgemaakt, zelfs wanneer vrouwen initieel normotensief zijn na de 
gecompliceerde zwangerschap.
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adviezen en alle hulp bij de analyse van de vele echocardiografie beelden. 
Wim Oyen en Marjo van de Ven, van de afdeling nucleaire geneeskunde, bedankt 
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